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Carbohydrates are ubiquitous both in nature as biologically active compounds and 
in medicine as pharmaceuticals. Although there has been continued interest in the synthesis 
of carbohydrates, chemical methods require specialized knowledge and hence remain 
cumbersome. The need for development of rapid, efficient and operationally simple 
procedures has come to the fore. This dissertation focuses on the development of a fully 
automated platform that will enable both experts and non-specialists to perform the 
synthesis of glycans. Existing automated methods for the synthesis of oligosaccharides are 
highly sophisticated, operationally complex, and require significant user know-how. By 
contrast, high performance liquid chromatography (HPLC) equipment-based automation 
introduced by our lab represents a highly accessible method of synthesis. This approach 
offers operational simplicity by delivering all reagents using standard liquid handling 
components and convenient real-time reaction monitoring of every step using detectors and 
standard computer software and interface. Many operations still require the operator 
intervention, and the entire technology remains semi-manual.  
Building upon promising preliminary results, this dissertation aimed to generate a 
universal platform for the fully automated synthesis of glycans. To achieve the complete 
automation of the solid phase synthesis that has the potential to revolutionize glycan 
synthesis, this dissertation focuses on the following aspects: 1) the development of new 
concepts for chemical glycosylation applicable to stereoselective formation of challenging 
1,2-cis glycosidic bonds; 2) implementation of autosamplers and switch valves as new 
components to achieve operator-less automation; and 3) the development of new 
chemically stable resins for solid phase synthesis. With these key developments, we have 
acquired a reliable and simple platform for fully-automated oligosaccharide synthesis. The 
proof of concept was assessed by the synthesis of a number of target glycans. Synthesis of 
iii 
 
carbohydrates and other classes of biomolecules using this user-friendly and fully-
automated platform will accelerate discovery in many scientific disciplines, most 
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1.1. Introduction: carbohydrates, oligosaccharides, biological roles and medical 
implications 
Carbohydrates, the “essential molecules of life,”1 play key roles in various 
biological processes. Carbohydrates are involved from the very beginning of life: 
fertilization occurs through carbohydrate-protein interaction.2 Carbohydrates 
contribute to human health by facilitating joint lubrication, cell growth, and the 
inflammatory and immune responses.3 The exponential increase in interest in 
sugars and the notable growth of all areas of glycosciences also reveals the 
involvement of carbohydrates in processes detrimental for human health. Viral 
infections, bacterial- and parasite-related diseases, metastasis, and rejection of 
transplanted tissues are only a few of these processes that can be mentioned.4  The 
pathogenesis of diabetes, septicemia, cancer, pneumonia, malaria, AIDS, and 
hepatitis are all carbohydrate-mediated processes. Understanding the roles of 
carbohydrates in these processes has stimulated many biomedical discoveries 
involving glycosciences.5-7 Investigation of carbohydrate composition,8 
conformation,9 interaction with other molecules and with themselves10,11 are some 
other areas of inquiry in the field. Isolation of carbohydrates from natural sources 
represents a viable approach to providing samples for the biological testing of 
these molecules.  However, it is chemical synthesis that allows access to both 
natural carbohydrates and their mimetics, which are often of interest due to their 
therapeutic4,12 or diagnostic13-15 potential. Challenges related to the synthesis and 
purification of carbohydrates and the lack of universal methods applicable to all 
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systems is the key bottleneck of glycosciences. As a result, examples of large-scale 
development of carbohydrate-based pharmaceuticals including heparin and its 
analogs,16,17 antibiotics,18,19 glycoconjugate-based vaccines,20-24 and other 
applications6,7,25 are still rare. 
Oligosaccharide sequences are found in numerous natural compounds and 
constitute the core of many therapeutics. The presence of glycans in glycoproteins, 
glycolipids, glycosaminoglycans and in other conjugates presents a treasure of 
potential information on cellular differentiation and condition. Over half of all 
proteins in the human body are N- or O-glycosylated3 and cell surfaces present a 
rich multitude of glycolipids and glycosaminoglycans, in addition to the presence 
of a variety of free oligosaccharides.26 Glycans carrying information of biological 
significance are found in every body fluid, on cell surfaces, and within cells. 
Glycan biomarker discovery is accelerating aided by advances in 
separation, mass spectrometric analysis,27-29 and in glycan-lectin array 
technologies.30 Efforts to map the entire glycome of a cell have recently been 
reported.31 Glycans have been identified as markers for many different forms of 
cancer including breast, colon, lung, etc.32-34 Increases or decreases in the levels of 
certain glycans and changes in branching patterns can indicate the presence and 
progression of disease.35 For example, one study showed that prostate cancer can 
be distinguished from benign prostatic hypertrophy via distinction of a specific 
glycoform by lectin binding.36 In cerebrospinal fluid, the presence of a unique N-
linked glycan on transferrin has been used to distinguish Alzheimer’s disease from 
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a condition arising from abnormal metabolism.37 Profiling of N-glycans on IgG 
has been found useful for following the metabolic disorder of galactosaemia.38 
Many families of glycoconjugates represent important therapeutic targets. 
High mannose, hybrid, and complex N-glycan families (Figure 1.1A) that are 
involved in many fundamental processes,39-41 as well as in mediation of the 
pathogenesis of cancers,42 AIDS,43 Alzheimer’s disease,37 etc.38 have stimulated 
many synthetic developments.41,44-51 Another representative example is the 
globoside family of glycosphingolipids (Figure 1.1B, Neu –N-acetylneuraminic 
acid, Fuc - fucose) whose members present a broad range of significant biological 
roles as glycan biomarkers. For example, Gb3 is overexpressed in colorectal 
adenoma cells,52 in Burkitt’s lymphoma cells,53 and in breast and ovarian cancer.54 
Gb3 is found on the glycolipid that accumulates in the lysosomes of individuals 
suffering from Fabry disease.55 Iso-Gb3 is found on natural killer T cells.56 Gb4 
has been found to be enhanced and attached to longer fatty acid chains in vascular 
endothelial cells undergoing an inflammatory response.57 Stage-specific embryonic 
antigens SSEA-3 and SSEA-4 are glycosphingolipids found on the surface of 
human embryonic stem cells but not on differentiated cells.58 SSEA-4 was found 
expressed in a variant of non-small cell lung cancer cells,59 and on embryonal 
carcinoma cells in the ovaries.60 Globo-H is a target antigen for the development of 
vaccines against prostate and breast cancer,61 for which clinical trials are 
underway. Globo-H and SSEA-3 have been found expressed on breast cancer stem 
cells.62 Many synthetic developments have been applied to the synthesis of 
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globosides, and Globo-H in particular.63-68 More examples of the value of glycans 
and glycoconjugates as biomarkers are steadily emerging. 
 
 
Figure 1.1.  Representative structures of common linear and branched 
oligosaccharide motifs 
Oligosaccharides or glycans can be obtained by isolation from natural 
sources or prepared enzymatically and/or chemically. All three major approaches 
are viable, but none yet can significantly outperform the others. This chapter is 
dedicated to chemical synthesis, which, in spite of recent progress, remains 
challenging. As a result, synthesis of even moderately complex glycans and their 
conjugates still require significant resources. This limits accessibility of these 
essential targets to only a small circle of glycoscientists and inhibits their industrial 
production and application. Recent development of dependable techniques for 
oligosaccharide synthesis using traditional manual synthesis are introduced in 
Section 1.2 of this chapter. An overview of very attractive and potentially 
transformative automated technologies that are expected to facilitate access to 
oligosaccharides is presented in Section 1.3. 
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A majority of complex sugars are oligomers in which monomeric units 
(monosaccharides) are connected via glycosidic bonds. The latter are obtained by 
glycosylation, a reaction discussed in section 1.2.1. Certain mechanistic 
conventions discussed in section 1.2.1. have been established and many factors 
that affect the outcome of glycosylations discussed in sections 1.2.1. are known. 
Nevertheless, chemical glycosylation remains challenging. Oligosaccharide 
synthesis brings about further challenges. Both traditional and expeditious 
strategies are known. Various one-pot strategies that offer a streamlined access to 
oligosaccharides have been developed. Supported and tagged synthesis has also been 
investigated. In particular, solid-phase synthesis, widely used in the preparation of 
oligopeptides and oligonucleotides, has also been applied to the preparation of 
oligosaccharides. This approach can streamline synthesis by eliminating the need 
to purify reaction intermediates and by simplifying the removal of excess reagents. 
Similar advantages are seen in the tagged synthesis wherein soluble polymer 
supports, ionic liquids and fluorous-based protecting groups have successfully 
been used to expedite oligosaccharide assembly. 
Dedicated attempts to automate oligosaccharide synthesis resulted in the 
development of a number of platforms and technologies for their automated 
chemical synthesis. These developments are reviewed in section 3. Early attempts 
by Takahashi and Wong to develop the automated chemical syntheses in solution 
set the benchmark in the fiel. Those early attempts have also shown difficulties 
associated with the automation. To expedite polymer supported oligosaccharide 
synthesis, Seeberger introduced an automated approach. The automation was 
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initially based on a modified peptide synthesize. In 2012, Seeberger et al. reported 
the “first fully automated solid-phase oligosaccharide synthesizer”. Around the 
same time Pohl, Demchenko-Stine, and Nokami have developed alternative 
automation platforms discussed in sections 1.3.3, 1.3.5, and 1.3.6. Operation of all 
automated synthesizers is controlled by a computer. The greatest advantage of 
employing the computer interface along with liquid handling hardware and 
software is to allow recording successful automated sequences that can be then 
repeated over and over with an expected high degree of reproducibility. 
 
1.2. Traditional manual synthesis of oligosaccharides 
Glycosidic linkages are obtained by glycosylation, a reaction of the 
nucleophilic displacement of an anomeric leaving group (LG) on the glycosyl 
donor by a hydroxyl group of the glycosyl acceptor.69 The remaining functional 
groups of both reaction counterparts (hydroxyl groups, amines, and carboxylic acid 
groups) are masked with respective temporary protective groups. A detailed 
mechanism of chemical glycosylation is unknown, but certain aspects, factors, and 
pathways have been established.70-93 With a notable progress in the field of 
chemical glycosylation,83,86-88,94 this reaction remains challenging. Beyond that, 
traditional stepwise oligosaccharide synthesis requires careful strategic planning to 
achieve protecting and/or leaving group introduction/removal between 
glycosylation steps. In addition, purification and reagent separation become 
difficult with large oligosaccharide sequences. Many selective, chemoselective, 
and regioselective strategies have been developed to streamline oligosaccharide 
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synthesis by reducing the number of additional steps.95 Other advanced techniques, 
such as solid-phase synthesis,96,97 have been developed to streamline 
oligosaccharide synthesis. These approaches reduce the need to purify reaction 
intermediates and simplify the excess reagents removal. 
 
1.2.1. Chemical glycosylation 
The glycosylation reaction is the central reaction in glycochemistry. 
(Scheme 1.1) The glycosylation involves a promoter or activator-assisted reaction 
between a glycosyl donor and glycosyl acceptor. Along with the formation of a 
glycosidic bond, a new chirality center is produced. Therefore, particular care 
should be taken of stereocontrol. Discussed below are basic principles of chemical 
glycosylation and factors that have an effect on the reaction outcome. In addition 
to the glycosylation reaction, there are many competing processes that may 
simultaneously occur. Side reactions that often complicate stereocontrol of 
glycosylation and may have a profound effect on yields include, but are not limited 
to, migration, elimination, cyclization substitution, and redox reactions.69,98 
 
Reaction mechanism 
The promoter-assisted departure of the leaving group leads to the formation 
of a glycosyl cation that is stabilized via an oxacarbenium ion intermediate 
(Scheme 1.1). The acceptor attack on the flattened oxacarbenium intermediate can 
take place either from the top or the bottom face of the sugar ring. As a result, 
uncontrolled glycosylations may lead to the formation of mixtures of 1,2-trans and 
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1,2-cis glycosides. Typical glycosylation conditions favor a unimolecular SN1 
mechanism, or may proceed at the SN1-SN2 interface,
99 and the reaction involves 
four major steps.100 
Step 1. Formation of the activated donor as a result of the interaction of the 
LG and the promoter (Scheme 1.1 A-B). This step can be either reversible or 
irreversible depending on the type of the leaving group used and the method of 
activation.93 There are a few reports indicating that the glycosyl acceptor attack 
may be directed to the activated donor.101-106 This SN2-like displacement pathway 
is desirable because it would allow for the stereospecific inversion of the 
stereochemistry at the anomeric carbon. Step 2. Dissociation of the LG, a typically 
irreversible expulsion of the activated leaving group (LGA), is the rate-
determining step (RDS). It leads to the formation of a glycosyl carbocation and/or 
its stabilized resonance form, an oxacarbenium ion. The latter is often responsible 
for scrambling the stereoselectivity of the reaction. Other intermediates, the 
existence of which is often ignored, or whose impact on the reaction is 
underestimated, may also form at this stage with or without counteranion B. Step 
3. As a consequence of the sp2-hybridization of the anomeric (C-1) carbon and the 
existence of the oxacarbenium ion in a flattened half-chair conformation the 
subsequent attack of the glycosyl acceptor is possible from both the bottom face of 
the ring (pathway a) and the top face (pathway b). As a result, “uncontrolled” 
glycosylation often leads to the formation of a mixture of products. Step 4. Upon 
the proton transfer the formation of the glycosidic bond becomes irreversible (the 
termination step).80 




Scheme 1.1.  General outline of the chemical glycosylation reaction 
The earliest reactions performed by Michael,107 Fischer,108 and Koenigs/Knorr109 
at the turn of the 20th century showcased the complexity of the glycosylation reaction. At 
that stage, glycosylations of sugar acceptors were quite inefficient and even the synthesis 
of disaccharides represented a challenge. The first attempts to solve this problem gave 
rise to the development of new activators.110-112 The early attempts to improve the 
glycosylation reaction have also revealed the necessity to find a delicate balance between 
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Building blocks: glycosyl donors and acceptors 
One of the main directions has been the investigation of leaving groups beyond 
the original halides, hemiacetals, and peracetates introduced by Helferich in 1933.115 
Thus, in the 1970s - early 1980s a few new classes of glycosyl donors were 
developed.116,117  This first wave introduced thioglycosides,118-121 1,2-orthoesters,122,123 O-
imidates,124,125 thioimidates,126-128 and glycosyl fluorides129 as alternative leaving groups. 
Many glycosyl donors introduced during that period have become common even to this 
day. The next wave of new methods arrived in the late 1980’s. Among the new leaving 
groups introduced were glycosyl esters/carbonates,130-132 thiocyanates,133 diazirines,134 
xanthates,135 glycals,136,137 phosphites,138,139 sulfoxides,140 sulfones,141 selenium 
glycosides,142 alkenyl glycosides,143-145 and heteroaryl glycosides.146 These developments 
were followed by a variety of more recent methodologies and improvements. These 
include glycosyl iodides,147 phosphates,148 Te-glycosides,149 sulfonylcarbamates,150 
disulfides,151 2-(hydroxycarbonyl)benzyl glycosides,152 novel thio-153,154 and O-
imidates155,156 as well as alkynyl-based leaving groups.157-166 In addition, a variety of very 
recent methodologies167-169 have brought the use of classic glycosyl donors, such as 
glycals,170,171 hemiacetals,105,172,173 or halides174,175 to an entirely different level of 
flexibility and versatility. 
Beyond studying the anomeric leaving group, protecting group effects have been 
investigated. Seminal work of Lemieux70 and Fletcher,176,177 has led to appreciation that 
the reactivity of glycosyl halides and the stereoselectivity of glycosylation is directly 
correlated to the nature of the protecting groups, especially at the neighboring C-2 
position. The participation of the neighboring 2-O-acyl substituent typically leads 
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to the formation of 1,2-trans linkages.73,178 In this case, the oxacarbenium ion can 
be further stabilized via an acyloxonium (dioxalenium) intermediate. Since the 
bottom face of the sugar ring in the acyloxonium intermediate is blocked, the 
glycosyl acceptor will approach from the top face (Figure 1.2A). Following this 
method, a 1,2-trans linkage is typically produced with high stereoselectivity, 
however, sometimes 1,2-orthoesters or 1,2-cis-linked glycosides are formed. 
Demchenko and co-workers introduced glycosyl donors equipped with a 2-O-
picolinyl ether participating group that provides entire 1,2-trans stereoselectivity in 
glycosylations (Figure 1.2B).179,180 Mlynarski and co-workers investigated ortho-
nitrobenzyl (NBn) as a participating group.181 Liu and co-workers investigated 
another alkyl participating group, o-cyanobenzyl (CBn) at the C-2 position of a 
glycosyl donor.104 An interesting feature of this glycosylation method is that a 
single glycosyl donor can yield either α- or β-linked products depending on the 
nature of the glycosyl acceptor. 
 
Figure 1.2.  Directing neighboring participating groups at C-2 
The presence of a non-participating group at C-2 such as benzyl is typically 
necessary for the synthesis of 1,2-cis glycosides. However, the non-participating 
substituent alone cannot provide stereocontrol, which makes the synthesis of 1,2-
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cis glycosides much more challenging. Although the anomeric effect favours the 
formation of the α-product,182 the stereoselectivity of uncontrolled glycosylations 
can be low. In these cases, other factors for controlling stereoselectivity such as 
structural features of the reactants and reaction conditions become increasingly 
important. For example, Boons et al introduced chiral auxiliaries capable of 
producing trans-decalin-like intermediates depicted in Figure 2C.183-187 This 
opposite face of the ring type of participation helps to obtain 1,2-cis linked 
glycosides with very high stereoselectivity.188 Turnbull and co-workers designed a 
similar concept showing that an oxathiane donor is also capable of highly α-
selective glycosylations.189,190 Fairbanks showed the versatility of 2-(thiophen-2-
yl)methyl derivatives for stereoselective 1,2-cis glycosylation.191 
The effects of remote substituents, particularly those capable of steric 
hindrance, powerful electron-withdrawal, or long-range participation, have been 
known for some time.192-196 Observed for a variety of sugar series including D-
galacto,197,198 L-fuco,199,200 L-rhamno,201 D-manno,202 and D-gluco203 the remote 
effects can be weaker than those by the C-2 substituent. More recent studies, by 
Kim et al,204 Nifantiev et al,205 Crich et al,206,207 Hung et al,208 and others209,210 
showed how important the remote effects can be. A somewhat unexpected effect 
was noted for remote picolinyl ethers (Pic) and picoloyl esters (Pico). While 2-
picolinyl participates at the anomeric center via the six-membered ring 
intermediate (see Figure 1.2B)180 the action of the remote groups is different. It has 
been demonstrated that the nitrogen atom of the remote picolinyl/picoloyl groups 
is able to form a hydrogen bonding with the hydroxyl group of the glycosyl 
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acceptor. This leads to high syn-selectivity with respect to the picolinyl/picoloyl 
substituent.211 This reaction named H-bond-mediated aglycone delivery or HAD 
gave high α-gluco212 and β-manno213 selectivity even at room temperature. As an 
extension to this study, the synthesis of β-mannan213 and α-glucans214 has been 
reported. Mong and co-workers applied 6-O-picoloyl-2-deoxy glycosyl donors to 
stereoselective synthesis of β-glycosides.215 Very recently, De Meo216 and Tsai217 
investigated the effect of picoloyl substituents on sialylations. Yang et al employed 
a similar 2-quinolinecarbonyl group to stereoselective synthesis of β-D- and β-L-
arabinofuranosides.218 
Torsional effects induced by the cyclic protecting groups may also affect 
both the reactivity of glycosyl donors and/or the stereoselectivity of glycosylations. 
The work by Crich et al. on the synthesis of β-mannosides76,87,219-221 is the best 
known example of the deactivating (and stereodirecting) effect of the 4,6-O-
benzylidene substituent. Benzylidene effect is due torsional strain222 that restricts 
the conformational flexibility of the pyranose ring and also enhanced electron-
withdrawal.223 A variety of other cyclic groups have been investigated. In 
particular, studies of 2-amino glycosyl donor protected with 2,3-trans-
oxazolidinone by Kerns et al,224-227 Oscarson et al,228 Ye et al,229-232 and Ito et 
al,233,234 yielded useful techniques for the synthesis 1,2-cis glycosides and glycosyl 
donors with switchable selectivity. Crich et al. demonstrated the utility of the 2,3-
O-carbonate protection for α-selective for mannosylation and 
rhamnosylation,206,235 as well as β-glucosylation.236 The effect of 3,4-O-carbonate 
protection is weaker and it shows a slight bias toward β-selectivity.237 The 4,5-
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O,N-oxazolidinone protection of sialyl donors often provides high yields and α-
stereoselectivities in sialylations and helps to suppress competing elimination.238-
240 
The effect of the glycosyl acceptor on the stereoselectivity of glycosylation 
has also been investigated. The mechanistic outline of the glycosylation reaction 
(vide supra) implies that the RDS is unimolecular and should not be affected by 
the nature of the glycosyl acceptor (Scheme 1.1). However, the donor-acceptor 
mismatch concept of Paulsen241 and Fraser-Reid/Lopez242-246 as well as the double 
stereo-differentiation phenomenon247 present a strong counterargument. In fact, 
different selectivities are often obtained for different glycosyl acceptors. Typically, the 
alcohol reactivity is inversely correlated with the stereoselectivity whereas the most 
reactive hydroxyls give the lowest α/β-ratios. For instance, glycosylation of axial 4-OH 
of galactose often gives excellent 1,2-cis stereoselectivity. Occasionally, primary 
hydroxyl groups can lead to higher selectivity than their secondary counterparts, 
particularly for reactions partially proceeding via the bimolecular mechanism. Toshima et 
al introduced a new technique that is based on the chiral recognition of aglycones.248 
 
Reaction conditions 
Several other factors including temperature, solvent, amount and type of 
promoter used can influence the outcome of chemical glycosylation by affecting its 
stereoselectivity and yield. Kinetically controlled reactions at low temperatures 
favor the formation of β-linked products,249,250 although opposite results have also 
been obtained.251,252 The solvent effect on the stereoselectivity of glycosylation 
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reactions has been widely studied.256,258-263 In general, polar reaction solvents 
increase the rate of the β-glycoside formation via charge separation between O-5 
and β-O-1. If the synthesis of α-glycosides is desired, CH2Cl2, ClCH2CH2Cl or 
toluene would be suitable candidates as the reaction solvents. However, there are 
more powerful forces than simple solvation. Thus, ethereal solvents are beneficial 
for α-selective glycosylation because diethyl ether,253 tetrahydrofuran,253 and 
dioxane254 have a tendency to form the equatorial O-linked intermediate. 
Conversely, nitrile solvents help the formation of β-glycosides because there 
reactions were thought to proceed via the axial glycosyl nitrilium cation 
intermediate.195,255 More recently, the Mong group suggested that in addition to the 
anomeric effect the formation of 1,2-cis nitrilium species is further reinforced by 
the participation of the oxygen atom at C-2.256 This would results in the formation 
of the glycosyl oxazolinium intermediate that is leading to the β-product as a result 
of the top-face nucleophilic attack. 255,257-262 
Many decades ago, glycosylations of unreactive acceptors were very 
inefficient.109,110 Initial attempts to improve the glycosylation reaction by 
Zemplen111 and Helferich112 have also showed that faster reactions may result in 
lower stereoselectivity.113,114 Some reactive glycosyl donors can be activated under 
Lewis acid catalysis. The best-known examples of these leaving groups include 
trichloroacetimidoyl (TCAI),263,264 N-phenyl trifluoroacetimidoyl (PTFAI),265 and 
phosphites/phosphates.266 The use of transition metal catalysts based on 
palladium267,268 and nickel270,271 developed by Nguyen et al for TCAI donors offers 
new opportunities for stereocontrol.167 Many other current methodologies for 
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glycosylation, such as glycosylation with S-aryl/alkyl thioglycosides, use 
stoichiometric promoters. Bi(V)269,270 and Au(III)191 catalyzed activations of 
thioglycosides represent other new promising directions in glycosylation 
chemistry.169,269 Recently there has been an explosion in the study of gold-
catalyzed activation of alkynes to exploit the low oxophilic character of gold and 
the excellent functional group compatibilities these catalysts exhibit.159,162,271-274 
Another emerging approach is the use of (thio)ureas as organocatalysts for 
glycosylations with glycosyl chlorides.170,174,175,275,276 The underpinning idea for 
developing alternative methodologies for the promotion of glycosyl chlorides is to 
avoid the heavy metal catalyst utilized in traditional Koenigs-Knorr reactions.109,110 
Ye and co-workers developed a catalytic system that makes advantage of the 
hydrogen-bond donor ability of urea.174 These activation conditions allowed for 
smooth glycosidation of per-benzylated galactosyl, mannosyl and rhamnosyl 
chlorides. The glycosides were achieved in high yields and excellent α-
stereoselectivities, but these reactions required the use of benzene as a solvent, 
high temperature, and long reaction times. For example, as depicted in Scheme 
1.2A, activation of donor 1.1 with the urea-derived catalyst 1.3 for the reaction 
with glycosyl acceptor 1.2 in the presence of K2CO3 afforded disaccharide 1.4 in 
excellent stereoselectivity and yield. A phosphine additive, TTMPP, was found 
advantageous in achieving good selectivity with glucosyl donors. 
Very recently, Jacobsen and co-workers studied a series of chiral thiourea 
catalysts for the activation of glycosyl chlorides.175 In contrast to the previous 
example, the reaction affords disaccharides with high β-stereoselectivity, even in 
Matteo Panza | UMSL 2019 | Page  18 
 
the absence of the neighboring participating group. The direct access to the 
formation of β-mannosides is another advantageous application of this reaction. 
For example, as depicted in Scheme 1.2B, activation of donor 1.5 with the chiral 
thiourea-derived catalyst 1.7 for reaction with glycosyl acceptor 1.6 in the presence 
of isobutylene oxide (IBO) afforded disaccharide 1.8 in high β-stereoselectivity 
and yield. IBO is used as an electrophilic trap to scavenge HCl produced in these 
reactions. The reaction mechanism has been studied and some features, such as 
stereospecific inversion, in combination with the independence from the 
stereochemical relationship between electrophile and nucleophile suggest the SN2-
like nature of the displacement. 
In addition, over the recent years there has been a noticeable shift in focus 
of the mechanistic glycosylation chemistry field towards studying stereoelectronics 
and conformation of the starting material and key reaction 
intermediates.74,75,77,79,80,82,84,91,100,172,223,277-290 While the stereoelectronic and 
conformational effects on reactivity have been studied extensively, the impact of 
these effects on stereoselectivity remains elusive. Although some model studies 
helped to establish general trends,75,82,277-280,290,291 practical application of the 
conformational factors to stereocontrol of glycosylation is still limited. Reagent- or 
additive-controlled glycosylations and reactions with reagent-dependent 
switchable selectivity are becoming active areas of research.105,292-299 
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Scheme 1.2. Examples of urea and thiourea-based organocatalytic reactions 
Special cases and indirect methods 
While some sugar series follow general trends, there are classes of 
compounds and linkages that require special methods. These special cases of 
glycosylation include the following major classes of compounds. 2-
Deoxysugars,300,301 that are discussed in a separate review in this special issue.302 
2-Amino-2-deoxy sugars,303 require additional steps and a careful selection of 
suitable protecting groups at C-2, most commonly 2,2,2-trichloroethoxycarbonyl 
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(Troc) or phthaloyl (Phth) for the synthesis of 1,2-trans and azide for the synthesis 
of 1,2-cis linked glycosides. The difficulty of the direct β-mannosylation304 was 
addressed by developing a variety of indirect approaches such as C-2 oxidation-
reduction, C-2 inversion, anomeric alkylation, and intramolecular aglycone 
delivery (vide infra).305,306 Crich and co-workers discovered that 4,6-O-
benzylidene protected donors provide excellent β-manno stereoselectivity.76,87,219-
221 The HAD method developed by Demchenko provides nearly complete β-
selectivity in mannosylation at room temperature.213 Other useful approaches to the 
synthesis of β-mannosides include Kim’s o-carboxybenzyl leaving group 
approach152 and van der Marel’s C-5 carboxylate approach.307-310 
An area of intramolecular glycosylation has also been developed to enhance 
the production of difficult glycosidic linkages. A better stereocontrol is achieved 
by tethering the reaction counterparts and restricting the glycosyl acceptor 
attack.311-318 The best known example, intramolecular aglycone delivery (IAD), 
was introduced by Barresi and Hindsgaul.319 Over the years, IAD has evolved into 
a powerful means to perform glycosylations of complex targets with high 
efficiency and yields.320-323 The major improvement of this approach has emerged 
with the implementation of a 2-napthylmethyl group (Nap) as a tether group.323 A 
representative example is depicted in Scheme 1.3. The treatment of a mixture of donor 
1.9 and acceptor 1.10 with 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) produces a 
mixed acetal that can be directly glycosidated in the presence of MeOTf and 2,6-di-tert-
butyl-4-methylpyridine (DTBMP) followed by acetylation to give disaccharide 1.11 in an 
excellent yield of 90% and complete β-selectivity.323 Initially investigated for the 
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synthesis of β-mannosides, α-glucosides, and β-arabinofuranosides,323 this 
approach was extended to the synthesis of β-rhamnosides324 and other challenging 
targets.315,325-331 
The synthesis of 1,2-trans furanosides can be achieved with 2-O-acylated 
glycosyl donors.332,333 The synthesis of 1,2-cis furanosides is more difficult due to 
high conformational flexibility of the five-membered ring and lack of the anomeric 
effect. Recent advancements make use of glycosyl donors with the furanose ring 
locked into a single conformation This was achieved with 2,3-anhydro,334,335 3,5-
O-(di-tert-butylsilylene),336,337 or 3,5-O-tetraisopropyldisiloxanylidene338 
protection. Young and co-workers successfully applied the HAD approach to 1,2-
cis glycofuranosylation.218 
In spite of extensive efforts and notable progress, the chemical synthesis of 
α-sialosides also remains challenging.339-344 Destabilizing electron-withdrawing 
carboxylate and the lack of a substituent at C-3 often drive sialylation reactions 
toward competitive elimination. This side-reaction leads to the formation of a 2,3-
dehydro derivative. In addition, the lack of a participating group means that 
stereoselectivity of sialylations can be low. To overcome these problems, a variety 
of leaving groups, participating auxiliaries, and activation conditions for 
sialylations have been developed. In recent years, it became evident that the 
remote N-substituent at C-5 may have a strong effect both on stereoselectivity of 
sialylations and the reactivity of sialyl donors.342 A particular advance has been 
made with 4,5-O,N-oxazolidinone derivatives,238-240 and more recently with 5-
isothiocyanate,345 that provide high yields and stereoselectivities in sialylations and 
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help to suppress the competing elimination.  An investigation of the effect of remote 
picoloyl groups at C-4 in the presence of excess of triflic acid offered new mechanistic 
insights into the sialic acid chemistry.216 This methodology has been extended in to the 
synthesis of 7,8-di-picoloylated donors bearing benzoyl protection at the other 
positions.217 
 
Scheme 1.3.  Synthesis of β-mannosides via intramolecular aglycone delivery 
A number of methods that do not include a formal glycosylation step have 
been developed.346,347 Since these indirect procedures include multistep syntheses 
practical application of these techniques is envisaged for the synthesis of 
glycosidic linkages that cannot be easily accessed by conventional technologies. 
O’Doherty developed a well-rounded methodology for Pd(0)-catalyzed 
glycosylations, wherein carbohydrate chirality centers are installed post-
glycosylationally. The de novo asymmetric synthesis methodology was 
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instrumental for obtaining many mono-, di-, and oligosaccharide derivatives by 
means of palladium-catalyzed reactions.348-351 
 
1.2.2. Oligosaccharide synthesis 
Glycosylation is only part of the challenge synthetic chemists confront during the 
synthesis of oligomeric sequences. A traditional stepwise approach requires additional 
manipulations after each glycosylation step. This multi-step reaction cycle is then 
repeated again until oligosaccharide of the desired chain length is obtained. This becomes 
increasingly inefficient at the advanced stages of the assembly,95,352 often leads to a 
dramatic drop in yield, and as a consequence, lesser availability of glycans. Many 
advanced strategies that streamline oligosaccharide assembly by minimizing or even 
eliminating leaving or protecting group manipulations between coupling steps are based 
either on chemoselective or on selective activation of leaving groups.95 One-pot strategies 
help to expedite the oligosaccharide synthesis further. The one-pot sequences typically 
consist of the glycosylation steps only, but a minimal number of deprotection steps may 
also be included. Since all the sequential reactions are performed in a single flask (pot), 
the purification is only performed at the stage of the final product and purification of the 
intermediates is not required. 
 
Conventional linear and convergent block synthesis 
A traditional stepwise approach requires additional synthetic steps for the 
conversion of the disaccharide intermediate into the second-generation glycosyl donor or 
acceptor. Modified disaccharides are then coupled with a glycosyl donor (or acceptor) to 
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obtain a trisaccharide. This reaction sequence is then repeated again until oligosaccharide 
of the desired chain length is obtained. Despite the need for additional protecting group 
manipulations between the glycosylation steps the linear approach is still in common use 
and a relevant example, the synthesis of the blood-group determinant H-type II 
pentasaccharide 1.23 is depicted in Scheme 1.4.353  
 
Scheme 1.4.  Conventional linear oligosaccharide synthesis with alternating 
glycosylation and deprotection steps 
Galactosyl phosphate 1.12 is glycosylated with acceptor 1.13 in the presence of 
trimethylsilyl trifluoromethanesulfonate (TMSOTf), followed by removal of the 
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temporary levulinoyl (Lev) protecting group. The sequence is repeated with TCAI and 
phosphate donors, as well as Lev and 2-azidomethylbenzoyl (AMB) removable 
protecting groups, to afford the target pentasaccharide in 60% overall yield. Numerous 
improvements of this basic concept include the use of solid-supported synthesis354 or 
fluorous protecting groups355 that significantly facilitate separation of products from the 
reactants (vide infra). The convergent building block approach is a faster way to obtain 
larger oligosaccharides.356-358 According to this strategy, oligosaccharide fragments are 
pre-synthesized and then converged by means of a glycosylation reaction. 
 
Scheme 1.5. Convergent block synthesis of ganglioside GP3 
Additional protection/deprotection steps may still be required but the over-all assembly is 
faster due to the use of oligomeric building blocks. The block synthesis is particularly 
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useful for the purpose of the introduction of a “difficult” linkage at an earlier stage of the 
saccharide assembly.359 Convergent block synthesis also streamlines the formation of 
oligosaccharide sequences containing two or more repeat units. 
A relevant recent example, the synthesis of ganglioside GP3, developed by Kiso 
and co-workers is illustrated in Scheme 1.5.360  The synthesis of this complex structure 
was designed to avoid the introduction of “difficult” units including ceramide, α-galacto, 
and unusual internal α-sialo linkages. Tetrasaccharides 1.24 and 1.25, both of which were 
obtained using a convergent [2+2] glycosylation strategy, were coupled in the presence of 
N-iodosuccinimide (NIS) and trifluoromethanesulfonic acid (TfOH) at 0 °C. As a result, 
an octasaccharide was obtained in 91% yield. The latter was reprotected and converted 
into TCAI donor 1.26 that was coupled with glycosyl ceramide acceptor 1.27 in the 
presence of TMSOTf affording the target ganglioside 1.28 in 77% yield. The recent 
synthetic effort in the area of convergent assembly field49,361-368 has culminated in the 
synthesis of a large mycobacterial arabinogalactan oligosaccharide containing 92 
monosaccharide residues (92-mer) by Ye and co-workers.369 
 
Expeditious strategies for oligosaccharide synthesis 
Expeditious strategies streamline oligosaccharide assembly by minimizing or 
even completely eliminating manipulations between coupling steps.95 All of these 
approaches can be classified into the following major categories. First, chemoselective 
approaches wherein the reactivity of building blocks is modulated by the protecting 
groups. Second, selective approaches that are based on selective activation of certain 
leaving groups. Third, preactivation-based approaches that can be used with any 
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protecting and leaving groups. Fourth, regioselectivity-based approaches rely on the 
differential reactivity of different acceptor groups. 
Fraser-Reid’s seminal work on armed-disarmed approach showed that the 
building block reactivity can be modulated through the choice of protecting groups.370,371 
Thus, benzylated (electronically activated, armed) building blocks are significantly more 
reactive than their acylated (Bz, disarmed) counterparts (Scheme 1.6A).  Usually, 
protecting groups in both reaction components and careful selection of mild reaction 
conditions have to be taken into consideration to allow direct chemoselective activation 
of the armed glycosyl donor over the disarmed glycosyl acceptor.  The convenience of 
this approach is that the same leaving group can be used for all building blocks in the 
sequence.  However, “protecting groups do more than protect,”372 and this can affect the 
stereochemical outcome and limit the scope of the method. For instance, the classical 
armed-disarmed approach can only lead to the formation of cis-trans-patterned 
oligosaccharide sequences. 
In recent years, the scope of the original armed-disarmed concept has been 
expanded373 and a number of efforts to quantify or even predict the reactivity of building 
blocks have been reported by Fraser-Reid,222,374 Ley,375 Wong,376 and others.377 Wong’s 
study also revealed a number of building blocks that extend beyond the traditional armed-
disarmed boundary. Boons showed that 2,3-O-carbonate protected glycosyl donors are 
less reactive than disarmed acylated derivatives.378 Subsequently, Demchenko reported 
that 2-Bn-3,4,6-tri-Bz protected donors are even less reactive than their disarmed per-Bz 
counterparts (superdisarmed). This unexpected protecting group effect was explained by 
the existence of the O2/O5 cooperative effect that takes into consideration the 
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stabilization of reaction intermediates, rather than only the electronics of the starting 
material.379 In this case, the destabilization of the glycosyl cation is due to the electron 
poor environment of O-5 and the lack of anchimeric assistance. 
Two concepts for superarming glycosyl donors have also emerged, further 
expanding the original scope of the armed-disarmed approach. First, Bols showed that 
superarming can be achieved by changing the equatorial-rich 4C1 conformation to an 
axial-rich skew-boat conformation by creating steric congestion with TBDMS protecting 
groups at the C-2, 3 and 4 positions.84,285-288 These donors showed a hefty 20-fold 
increase in reactivity over the armed per-benzylated counterparts because the 
conformational change simplifies transition of the starting material into the oxacarbenium 
ion that is most stable in the all-axial half-chair arrangement.75,277,278,280,291 Second, 
Demchenko reported building blocks wherein the superarming was achieved via the 
O2/O5 cooperative effect. Glycosyl donors equipped with the superarming 2-Bz-3,4,6-tri-
Bn pattern were 10-fold more reactive than their armed counterparts.380-382 In this case, 
the stabilization of the glycosyl cation is possible both from the electron rich O-5 and 
from 2-Bz via the anchimeric assistance.  With the two different approaches to superarm 
glycosyl donors, conformational and anchimeric, Bols and Demchenko jointly developed 
2-Bz-3,4-di-TBS protected glycosyl donor. Glycosylations with the hybrid donors were 
swift, high yielding and β-selective.383,384  
This study showed that the conformational arming is a powerful tool to increase 
the reactivity and to achieve excellent yields. The anchimeric arming effects are weaker, 
but the participation ensures complete 1,2-trans selectivity. 
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Scheme 1.6.  Chemoselective (A) and selective (B) activation approaches to 
expeditious oligosaccharide synthesis 
Another general concept to expedite oligosaccharide synthesis is to achieve 
selective activation of different leaving groups, and it is practically independent of the 
nature of the protecting groups (Scheme 1.6B).  One example presented below has a 
unique alignment of six different leaving groups, which were selectively activated 
affording hexasaccharide 1.39 in only five steps (Scheme 1.7).385 First, thiocyanate 
glycoside donor 1.29 was activated with Cu(OTf)2 over S-thiazolinyl (STaz) acceptor 
1.30 in 89% yield. Subsequently, disaccharide 1.31 was coupled with S-benzoxazolyl 
(SBox) glycosyl donor 1.32 in the presence of benzyl bromide to achieve the 
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trisaccharide 1.33 in 67% yield. The latter was coupled with fluoride acceptor 1.34 in the 
presence of MeOTf to produce tetrasaccharide 1.35 in 87% yield. Tetrasaccharide 1.35 
was then reacted with SEt acceptor 1.36 in the presence of AgClO4/Cp2ZrCl2 to afford 
the pentasaccharide 1.37 in 84% yield. Lastly, the coupling of O-pentenyl acceptor 1.38 
with the pentasaccharide 1.37 using MeOTf as an activator produced hexasaccharide 1.39 
in 72% yield. 
 
Scheme 1.7.  Hexasaccharide synthesis in five selective activation steps 
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Among all known selective activation strategies,95 Ogawa’s orthogonal concept is 
arguably the most advantageous.386,387 This technique used two chemically distinct 
glycosylation reactions and the selective activation of two orthogonal leaving groups is 
then reiterated (Scheme 1.6B). 
The classic variation of the orthogonal activation involves building blocks bearing 
S-phenyl and fluoro leaving groups.388 As shown in Scheme 1.8, phenyl thioglycoside 
1.40 is selectively activated over fluoride acceptor 1.41 in the presence of NIS/AgOTf. 
The fluoro leaving group of disaccharide 1.42 is then activated over thioglycoside 
acceptor 1.43 in the presence of Cp2Hf2Cl2/AgOTf. This selective activation sequence is 
then reiterated to provide tetrasaccharide 1.44. Ideally, the orthogonal approach allows 
for an unlimited number of reiterations of the two orthogonal leaving groups, which is 
conceptually very attractive.  
 
Scheme 1.8.  Orthogonal activation of phenylthio glycosides and fluorides 
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In practice, however, the yields, which are typically inversely correlated to the 
size of the glycosyl donor involved, decreased dramatically at the later stage of the 
assembly. A number of complementary combinations of orthogonal leaving groups and 
conceptual modifications have been implemented.385,387,389-399 
A number of concepts for selective activation have been introduced.145,398,400  For 
example, in the two-step activation approach both glycosyl donor and glycosyl acceptor 
initially bear the same type of a leaving group. In order to couple these two reactants, a 
different leaving group is introduced into the glycosyl donor. Upon the selective 
activation of the donor, this two-step activation sequence can be reiterated. Discovered 
for thioglycoside conversion into bromides356 this approach was extended to other 
systems.371,401-403 For example, Danishefsky’s reiterative assembly approach involving 
glycal precursors that are converted into 1,2-anhydrosugars with dimethyldioxirane 
(DMDO)404 clearly illustrated the versatility of this strategy.137,405-407 Thus, 1,2-
anhydrosugar 1.47 generated from glycal 1.46 could be activated over glycal acceptor 
1.48 in the presence of ZnCl2 to afford 1,2-trans-linked disaccharide 1.49 in 81% 
(Scheme 1.9). The epoxidation-glycosylation sequence can be then reiterated to yield 
larger oligosaccharides. 
More recently, the versatility of the two-step activation was demonstrated by a 
one-pot pre-activation procedure,408-410 according to which S-tolyl glycosides are 
converted in situ into a reactive intermediate. These pre-activation types of couplings 
cannot be formally classified as oligosaccharide synthesis via selective activations and it 
occupies its own niche.66,229,230,232,237,260,411-416 This strategy is particularly advantageous 
in conjunction with the one-pot oligosaccharide synthesis that will be discussed below. 
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Scheme 1.9.  Glycal-epoxide method for iterative oligosaccharide synthesis 
A number of useful expeditious approaches are based on regioselectivity of 
different acceptor groups. Thus, a two-directional strategy for glycan synthesis makes use 
of a building block capable of reacting first as a glycosyl donor and then as an acceptor. 
For example, building block 1.50 is first glycosidated with the reactive glycosyl acceptor 
1.51 and then glycosylated directly at the deactivated position (synthesis of 1.54, Scheme 
1.10).417 Hydroxyl deactivation can be achieved by introducing electron-withdrawing 
groups at surrounding positions. The use of temporary masking moieties (trityl, silyl) that 
can act as protecting groups in the first step and then be removed directly during 
glycosylation, has become a logical extension of this technique.418,419 The use of the 
glycosyl donor/acceptor unit on the solid support is another efficient way to “deactivate” 
the hydroxyl moiety in comparison to the solution-based acceptor (vide infra).420 
 
Oligosaccharide synthesis in one pot 
One-pot strategies allow to streamline glycan synthesis because all glycosylations 
are performed in a single flask (pot) and do not require purification of intermediates.421-
423 All one-pot strategies are based on the following five major concepts.  The first 
approach discovered by Kahne and co-workers,424 remains the only pure one-pot concept 
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because the synthesis is performed with all reaction components present in the reaction 
flask from the beginning. In all other approaches, the reactants are added sequentially, 
typically upon the consumption of the first batch of compounds. 
 
Scheme 1.10.  Two-directional approach for the synthesis of pentasaccharide 1.54 
The fact that all reactants are present from the beginning implies that fine-tuning 
of all reaction components is required. According to this concept, the most reactive 
leaving group reacts with the most reactive hydroxyl first. Subsequent reaction between 
the second-ranked reactive leaving group and second-ranked hydroxyl takes place after 
the first step has been completed, etc.  The concept of the conformational superarming 
developed by Bols et al.287,288 was also applied to a one-pot synthesis with all three 
reaction components present from the beginning.287,384 
The second approach is based on chemoselective activation wherein the reactivity 
of the glycosyl donor and acceptor is differentiated by varying the electronic properties of 
protecting groups.375-377 A relevant example is shown in Scheme 1.11 (synthesis of 1.59) 
wherein the sequential activation of 1.55, 1.56, and 1.57 was based on their relative 
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reactivity, which was found to be 17000/162.8/13.1, respectively.376 In contrast to the 
first concept, building block 1.57 is added only after the reaction between 1.55 and 1.56 
is completed, etc. 
 
Scheme 1.11.  One-pot synthesis of tetrasaccharide 1.59 via chemoselective 
activation 
The third approach is based on selective activation of one leaving group over 
another. Since the number of leaving groups that can be aligned for multi-step sequential 
activation is still limited only few examples are known. Highlighted herein is the 
synthesis of a linear tetrasaccharide derivative 1.62 that was accomplished in 73% yield 
over three sequential glycosylation steps.425 This was achieved by the stepwise activation 
of SBox donor 1.60 over S-ethyl glycoside 1.61. The S-ethyl moiety of the disaccharide 
intermediate was then activated over STaz acceptor 1.30. Finally, the STaz leaving group 
of the trisaccharide intermediate was activated for the reaction with glycosyl acceptor 1.2 
(Scheme 1.12). 
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Scheme 1.12. One-pot synthesis of tetrasaccharide 1.62 via sequential selective 
activation of building blocks equipped with different leaving groups 
The fourth approach is based on pre-activation and hence it is practically 
independent of the building block reactivity. A representative example illustrated in 
Scheme 1.13 deals with a straightforward synthesis of the tumor associated carbohydrate 
antigen Globo-H hexasaccharide.66 Thus, preactivation of fucosyl donor 1.63 at -78 oC 
with p-TolSCl and AgOTf was followed by the addition of acceptor 1.64 along with a 
hindered base 2,4,6-tri-(t-butyl)-pyrimidine (TTBP). The temperature was then increased 
to -20 oC and the trisaccharide intermediate was formed. The reaction mixture was cooled 
again to -78 oC followed by the addition of AgOTf and p-TolSCl. After that, galactose 
acceptor 1.65 and TTBP were added and the reaction mixture was warmed to -20 oC. 
When acceptor 1.65 has disappeared, the temperature was lowered to -78 oC and the 
sequence was reiterated for glycosylation of lactose acceptor 1.66. The resulting Globo H 
hexasaccharide -1.67 was formed in 47% yield based on the four-component reaction 
that required only 7 h to complete the assembly. 
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Scheme 1.13.  Preactivation-based one-pot synthesis of Globo-H hexasaccharide 1.67 
The fifth concept for one-pot oligosaccharide synthesis relies on the 
differentiation between various hydroxyl groups, such as primary vs. secondary or 
equatorial vs. axial, have been explored.426 
 
1.2.3. Supported and tagged oligosaccharide synthesis 
Further breakthroughs in the area of synthetic chemistry came with the 
development of supported or tagged organic synthesis techniques. As a consequence, the 
last two decades have also witnessed dramatic improvements in the area of supported 
oligosaccharide synthesis. Supported synthesis is very attractive as it allows for the rapid 
synthesis of oligosaccharide sequences without the necessity of purifying (and 
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characterizing) the intermediates. Another important advantage of supported 
oligosaccharide synthesis is that it simplifies reagent excess removal. It can be achieved 
either by filtration if insoluble polymer or other solid phase supports are used or, 
alternatively, by fractionation, extraction or precipitation if soluble polymer supports or 
other supports/tags are employed. 
 
Synthesis on solid phases 
Solid-phase synthesis using insoluble polymer supports (beads)96,97 has been 
widely used in the preparation of many classes of molecules of interest.96,97,427,428 
Preparations of oligopeptides429 and oligonucleotides430 have been reported using 
insoluble supports. Merrifield431 was the first to report the synthesis of peptide chains 
using polystyrene beads. The introduction of solid phases into the carbohydrate synthesis 
is credited to Fréchet and Schuerch who reported the first oligosaccharide synthesis on 
solid support.432 Since those pioneering studies, the solid-phase synthesis has been widely 
utilized in a routine preparation of oligosaccharides and glycopeptides, and it is attracting 
renewed attention in connection with combinatorial chemistry433 and automation.354,434 
The two main strategies used for solid-phase synthesis of oligosaccharide are 
called donor-bound and acceptor-bound. In the first approach depicted in Scheme 1.14A, 
the acceptor is bound to the resin either through the anomeric position or one of positions 
away from the anomeric center.  This approach has an important conceptual advantage by 
using highly reactive solution-based monosaccharide donor. As a result, the yields remain 
high, even at the advanced stages of the assembly. With the increasing size of the 
Matteo Panza | UMSL 2019 | Page  39 
 
oligosaccharide, the solid phase bound reaction sites extend further into solution phase, 
which also contributes to high yields that are achieved by means of this strategy. 
 
Scheme 1.14.  Glycosylation on polymer support 
The second concept, the donor-based approach depicted in Scheme 1.14B, relies 
on the donor bound to the polymer support. After the glycosylation has occurred, the 
temporary protecting group on the acceptor is turned into a suitable leaving group and the 
chain elongation steps can be reiterated. In principle, the chain elongation can be 
continued directly, if a suitable set of orthogonal leaving groups is chosen. However, the 
main disadvantage of the donor-bound approach relates to the origins of the glycosylation 
mechanism. Glycosyl donors are much more prone to side reactions than are glycosyl 
acceptors. Donor that underwent a side reaction, or simply was hydrolyzed, cannot 
conduct further chain elongation and this will ultimately terminate the oligosaccharide 
sequencing.  
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Figure 1.3. Solid supports for oligosaccharide synthesis: Merrifield’s resin (A), 
Tentagel (B) and JandaJel (C) 
Also, the templated approach outlined in Scheme 1.13C, wherein both 
components are connected to the same polymer support has been investigated.  Two-
directional techniques, combining conventions of approaches A and B are also 
known.63,420 
Polymer beads or resins are the most commonly used supports for solid-phase 
synthesis. Polystyrene beads crosslinked with 1% divinylbenzene found broad acceptance 
in all fields since their introduction by Merrifield (Figure 1.3A).431 Initially invented for 
peptide synthesis applications, the resin was successfully introduced into the solid phase 
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synthesis of oligosaccharides.432 The high loading capacity and the compatibility with 
many reaction conditions have been crucial for the popularity of polystyrene-based 
resins. Since then, different solid supports with different swelling characteristics have 
been explored: polystyrene grafted with different lengths of polyethylene glycol (PEG) 
groups led to the development of Tentagel (Figure 1.3B), Hypogel and Argogel. 
These resins are able to swell efficiently in both polar and non-polar solvents and 
are capable of higher loading capacity. Another approach made use of modifying the 
cross-linker by employing a tetrahydrofuran-derived bridge (Figure 1.3C).435 This resin 
has been commercialized with the tradename of JandaJel. Although polystyrene resins are 
fairly inert, it is noteworthy that some of these resins tend to partially decompose in the 
presence of large amounts of TMSOTf.435 To address possible instability of polymeric 
resins, non-swelling porous materials have been also been evaluated for solid-supported 
oligosaccharide synthesis, and controlled-pore glass436 and nanoporous gold437,438 are two 
of such materials to mention (vide infra). 
The linker plays a central role in the synthesis of oligosaccharides using solid-
phases. Due to its labile nature, the linker itself has to be taken into account for 
orthogonality in respect to all protecting (or leaving) groups that will be manipulated 
during the various steps. For the same reason, various linkers stable under many different 
conditions have been developed for carbohydrate synthesis.354,439 In addition to known 
and widely used protecting group-derived linkers, such as succinoyl, alkoxybenzyl, and 
silyl-based linkers, a new wave of photoreactive, metathesis or hydrogenation-removable 
linkers had emerged.44,440-455 In the subsequent effort to develop new linkers with a 
versatile installation and/or removal profile, recent developments included Reichardt’s 
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spacer/linker,452 as well as Seeberger’s “Lenz linker,”456 safety catch linker,457 and 
photocleavable linker.458 Some examples of recently developed linkers are summarized in 
Figure 1.4. 
 
Figure 1.4. Recently introduced linkers for polymer-supported oligosaccharide 
synthesis 
More recently, Seeberger at al. developed a traceless photocleavable linker that is 
capable of producing oligosaccharides with the free reducing end.459 The linker offered 
stability and yields comparable to the parent structure, making it a suitable choice for 
future applications. The cleavage is achieved using a flow photoreactor, shown to be far 
more efficient than the classical batch reactors.460 
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Scheme 1.15.  Acceptor-bound approach to the synthesis of oligosaccharide 1.73 
As mentioned, most of the solid-phase syntheses involve glycosyl acceptor-bound 
approach.  One of the classical examples of this approach involves Schmidt’s synthesis of 
a branched saccharide 1.73 depicted in Scheme 1.15.461 Lactose derivative 1.68 was 
attached glycosidically to the carboxypolystyrene resin support in the presence of 
TMSOTf. The chain was then extended by sequential removal of the orthogonal 
protecting groups fluorenylmethoxycarbonyl (Fmoc) with triethyl amine Et3N and Lev 
with hydrazine acetate. Upon cleavage from the resin, achieved by the treatment with 
NaOMe/MeOH, and subsequent global acetylation with Ac2O/pyridine hexasaccharide 
1.73 was obtained in 43% overall yield. 
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Scheme 1.16.  Chiral auxiliary-assisted synthesis of 1,2-cis-linked oligosaccharide 
1.79 
 
More recently, Boons et al. reported the synthesis of all-α-linked oligosaccharide 
1.79 using chiral auxiliary mediated 1,2-cis glycosides on polymer support.186 As 
depicted in Scheme 1.16, glucosyl donor 1.74 was attached glycosidically to the 
hydroxypolystyrene resin support in the presence of TMSOTf.  The chain was then 
extended by sequential removal of the orthogonal protecting groups Fmoc (with 
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piperidine) and allyloxycarbonyl (Alloc) with Pd(PPh3)4. Upon cleavage from the resin 
and subsequent reprotection pentasaccharide 1.79 was obtained in 25% overall yield. 
 
Scheme 1.17.  Donor-bound synthesis of pentasaccharide 1.82 
Most of the known syntheses involve a glycosyl acceptor-bound approach, but 
examples involving glycosyl donor bound have also emerged. As reported by 
Danishefsky et al,462 glycal 1.80 was attached to a Merrifield resin via a silyl linkage in 
the presence of diisopropylethylamine (DIPEA, Scheme 1.17). The polymer-bound glycal 
was then epoxidized with DMDO and the resulting 1,2-anhydro sugar was glycosidated 
with acceptor 1.80 in the presence of ZnCl2 to provide the immobilized disaccharide. 
This synthesis was reiterated until the desired oligosaccharide was obtained. The latter 
was then cleaved off by the treatment with Bu4NF/AcOH to afford pentasaccharide 1.82 
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in 58% yield.  Another similar examples of the donor-bound approach include the 
synthesis of the Leb blood group antigen354,463 and selective activation of the SBox donor 
over solution phase thioglycoside acceptor.464 
 
Scheme 1.18.  Orthogonal synthesis of a combinatorial library on solid phase 
The application of orthogonal strategy, which is another example of a donor-
bound approach in polymer supported synthesis, was introduced by Ogawa.465 A more 
recent example of this approach is illustrated in Scheme 1.18. As reported Kanie et 
al.,391,392 polymer-bound donor 1.83 was activated selectively over fluoride acceptor 1.84 
in the presence of dimethyl(methylthio)sulfonium trifluoromethanesulfonate (DMTST). 
The immobilized glycosyl fluoride was then activated over S-phenyl acceptor 1.85 in the 
presence of Cp2Hf(OTf)2. Finally, the immobilized S-phenyl trisaccharide was 
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glycosidated with octanol in the presence of DMTST.  The resulting oligosaccharide was 
cleaved off and all eight diastereomers of 1.86 were separated by HPLC to provide a 
useful combinatorial library.  
 
Scheme 1.19. Peptide-templated oligosaccharide synthesis on polymer support 
391Short peptide chains immobilized on the solid support have been investigated 
as templates for streamlining the oligosaccharide synthesis by Fairbanks et al.466-468 and 
Warriner.469 As shown by Warriner, conjugate 1.87 containing the hydroxyproline-linked 
glycosyl donor and acceptor pair with the glycine unit in between produced (1→4)-linked 
disaccharide 1.89 in high yields (Scheme 1.19). A differential and highly substrate 
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orientation-dependent stereoselectivity was observed by employing differently sequenced 
templates, such as 1.88. 
 
Scheme 1.20.  STICS: Surface-Tethered Iterative Carbohydrate Synthesis 
The application of emerging nanomaterials to organic synthesis has created the basis of 
the STICS (surface-tethered iterative carbohydrate synthesis) technology is a 
functionalized ‘stick’ made of chemically stable high surface area nanoporous gold that 
allows performance of cost efficient and simple synthesis of oligosaccharide chains.438 
Nanoporous gold can be prepared by dealloying Ag from Au-Ag alloy or from Au-Ag 
alloy electrodeposited onto a gold surface in the presence of nitric acid.470-473 As depicted 
in Scheme 1.20, a stack on NPG plates, carrying acceptor 1.91 anchored to the gold 
surface with a thiolate linker, is assembled in a Teflon-shelved reactor. The 
oligosaccharide assembly is accomplished by alternating the glycosylation, deprotection, 
washing, and drying steps. Thus, 6-O-TBDPS protected S-benzoxazolyl (SBox) glycosyl 
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donor 1.90 was coupled to the immobilized acceptor 1.91 in the presence of MeOTf. 
Then, after a rinse, the tethered disaccharide intermediate was treated with Bu4NF to 
remove the silyl group to afford the second generation glycosyl acceptor. After being 
dried in vacuum, the latter was reacted with SBox donor 1.60. At the end of the synthesis, 
the oligosaccharide can be cleaved off from the gold surface offering a useful potential 
alternative both for directed and combinatorial synthesis. 
 
Tagged synthesis (soluble polymer supports, ionic, fluorous) 
Soluble polymer supports, many of which are based on a polyethyleneglycol 
core, have also found their application in oligosaccharide synthesis. This method has 
emerged to address problems of the resin-supported synthesis associated with slow 
reactions and reactivity mismatch between unreactive solid-phase based and highly 
reactive solution-based reactants.474,475 These supports, and everything attached to it, 
are freely soluble in the reaction media, but could be precipitated by the addition of 
diethyl ether or other suitable solvent and recovered by filtration.476-478 
Alternatively, nanofiltration or a size-exclusion separation offer other possible 
alternatives for separation of polymer-bound molecules and the rest of the reaction 
components.479 An elegant synthesis that combines advantages of the soluble polymer-
supported technology and convergent building block strategy was applied to the synthesis 
of hexasaccharide 1.100 (Scheme 1.21).480 In this application, fluorenylmethoxycarbonyl 
(Fmoc) and diethylisopropylsilyl (DEIPS) are used as temporary substituents that could 
be removed with Et3N and TBAF, respectively, without affecting the linker. The 
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polymer-bound intermediates obtained, such as 1.98, could be purified by re-
crystallization from absolute ethanol. 
 
Scheme 1.21.  Synthesis of dimeric Lex hexasaccharide using soluble polymer 
support 
Amongst other improvements of the supported oligosaccharide synthesis, fluorous 
tags incorporating a long per-fluorinated alkyl chain allow the separation of all 
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fluorinated from non-fluorinated species by partitioning between perfluorohexanes and 
methanol (or toluene). For the synthesis of oligosaccharide 1.105 shown in Scheme 
1.22.355  
 
Scheme 1.22.  A fluorous tag-assisted synthesis of pentasaccharide 1.10 
Triol 1.101 was protected at the O-2, O-3, and O-4 positions with fluorous 
protecting groups, using DCC/DMAP-mediated coupling with the fluorous acid 1.102. 
The resulting “tagged” compound was detritylated with CSA (camphorsulfonic acid) and 
LiCl to provide acceptor 1.104. The latter was glycosylated with glycosyl donor 1.103 in 
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the presence of TMSOTf in EtOC4F9–diethyl ether to provide the respective tagged 
disaccharide. Desilylation with HF in pyridine followed by glycosylation were reiterated 
until the desired pentasaccharide 1.105 was obtained. More recently, less heavily 
fluorinated tags and compounds have found a broad application in automated synthesis 
(vide infra). 
Another promising technique for tagged oligosaccharide synthesis that makes use 
of an ionic-liquid support has recently emerged.481,482 Ionic liquid-supported assembly 
also expedites oligosaccharide synthesis by eliminating the need for chromatographic 
purification of the intermediates. After the desired reaction of the tagged compound has 
been completed, the reaction mixture is concentrated. The excess of organic reagents is 
removed by extraction with low polarity solvents in which the tagged compounds are 
insoluble. Using the same principle, the inorganic reagents are eliminated with aqueous 
washings to afford the pure target compound tagged with the ionic liquid. This approach 
is illustrated by a synthesis that incorporates elements of an orthogonal strategy making 
use of alternating activations of STol and F leaving groups and the convergent approach 
depicted in Scheme 1.23.483,484 (1-Methylimdazoliumhexafluorophospho) acetyl ionic 
liquid tag was introduced via the corresponding 6-chloroacetylated starting material by 
reaction with N-methylimidazole and potassium hexafluorophosphate. The tagged 
mannosyl fluoride donor 1.106 was glycosylated with thioglycoside acceptor 1.107 to 
afford the IL-tagged disaccharide 1.110. Meanwhile, the analogous disaccharide 1.111 
was produced using thioglycoside 1.108 as the donor and fluoride 1.109 as acceptor. 
Each disaccharide was split into portions, and the tag was removed from one portion. 
This gave a library of two disaccharide donors (1.110 and 1.111) and two disaccharide 
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acceptors (1.112 and 1.113) that were converged to produce two tetrasaccharides. One of 
the tetrasaccharides was untagged to produce glycosyl acceptor 1.114. Finally, the 
synthesis is concluded with a [4+4] glycosylation between the tagged tetrasaccharide 
fluoride donor and thioglycoside acceptor 1.114 to afford the final mannan 
octasaccharide 1.115. Gouhier and co-workers485 reported efficient 1,2-cis glycosylations 
using ionic liquid-supported thioglycoside in a two-directional419,420 manner. 
 Scheme 1.23. Convergent/orthogonal ionic liquid-tagged synthesis of mannans 
 
1.3. Automated synthesis of oligosaccharides 
All traditional oligosaccharides contain multiple glycosidic linkages. This linkage 
is obtained by a glycosylation reaction, which, in spite of significant progress overviewed 
in Section 1.2.1 remains challenging due to the requirement to achieve stereocontrol and 
suppress side reactions. Beyond that, as overviewed in Section 1.2.2, oligosaccharide 
synthesis offers further challenges that may require further manipulations between each 
glycosylation step. Due to significant advances, the chemical synthesis of many glycans 
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can now be streamlined by using various methods and strategies in solution.  Solid-phase 
and tag-assisted syntheses, which were overviewed in Section 1.2.3, eliminate the need 
for purifying intermediates and simplify the removal of excess reagents. Following 
significant advancements in the preparation of peptides429,486 and oligonucleotides,430 
since 1971 solid-phase synthesis has become a viable means for the preparation of 
oligosaccharides. 
However, there are significant differences between glycosylations in solution and 
solid-phase synthesis that particularly affect glycosylation. Among a plethora of leaving 
groups developed, a vast majority of glycosylations in solution make use of 
thioglycosides487-490 and TCAI.125,263,264,491,492 Solid phase synthesis commonly demands 
highly reactive TCAI, PTFAI265,493,494 or phosphates.148,495-499 A series of novel S- and O-
imidates have been tested in reactions on solid phases, but their comparison with more 
common donors showed no drastic difference.438,464,500-502 The use of thioglycosides as 
donors in solid phase has also been reported (vide supra), but their relatively low 
reactivity profile and the requirement for stoichiometric promoters limit their application. 
Only recently, the use of thioglycosides in solid phases has been brought to practical 
realization.503 
The discoveries made over the course of traditional synthesis, wherein all 
manipulations are performed manually have laid the basis for considering their 
automation as an aid in synthesis manipulations. Automation introduces an idea of 
operational simplicity, attractive for transferable methods and the development of 
accessible methods for glycan production is essential for further innovations and practical 
applications in all areas of glycosciences. The development of automated 
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oligosaccharides synthesizers offers a potential of revolutionizing the way 
oligosaccharides are produces. Hence, the development of a broadly useful technology 
for scalable and transformative automation has emerged as a timely and significant area 
of research. 
Many automation platforms make use of a computer interface and liquid handling 
equipment. This helps to minimize the human error factor and improve the 
reproducibility of results and transferability to other platforms.504,505 The underpinning 
idea of automation is that a successful automated sequence is recorded as a computer 
program that can then be reproduced with a “press of a button”.  In addition, many 
automation platforms implement some tool for real-time reaction monitoring, which, in 
turn, helps reduce the reaction time and the amount of reagents and solvents needed. This 
section is dedicated to the overview of major research efforts dedicated to the refinement 
and implementation of various automated platforms that have emerged in the past decade 
following early efforts to automate solution-phase manual synthesis by Wong376,506,507 
and Takahashi,508 and Seeberger’s peptide synthesizer-based platform for automated 
synthesis on solid phase.509,510 Discussed below is the development of “the first fully 
automated solid-phase oligosaccharide synthesizer” by Seeberger et al., initially in its 
experimental form,456 that in 2014 was marketed as Glyconeer 2.1. Also discussed are 
other automation efforts, primarily by Takahashi,511,512 Pohl,513 Demchenko/Stine,514 and 
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1.3.1. Early developments 
As aforementioned, Wong et al. assigned relative reactivity values (RRVs) to a 
wide library of building blocks that were then used for oligosaccharide assembly in one-
pot.376  The determination of RRVs was made with tolylthio glycoside donors activated in 
the presence of an NIS/TfOH promoter system under standardized reaction conditions.  
The reactivity data was then compiled into a computer program named Optimer376 that 
was used to synthesize various oligosaccharides.516-518 Refer to Scheme 1.10 for a 
relevant example of a reactivity-based oligosaccharide synthesis in one pot. Not being 
strictly automated, this approach brought up an idea of standardizing the reactions and 
using computers in quantifying and even predicting the reactivity of different building 
blocks. Fraser-Reid,374 Ley,375,519,520 and others521 also created relative reactivity scales 
for oligosaccharide synthesis. 
Takahashi et al. investigated a number of platforms for the automation of 
solution-based oligosaccharide synthesis in one-pot. While the Wong approach was 
strictly chemoselective, in applications executed by Takahashi, selective activation of 
different leaving groups was employed. In 2000, they adapted a semi-automated parallel 
synthesis instrument Quest-210 by Argonaut Technologies, to the one-pot synthesis of 
linear and branched oligosaccharides.508Thus, for the synthesis of trisaccharide 1.119 
shown in Scheme 1.24, bromide donor 1.116 was selectively activated over thioglycoside 
acceptor 1.117 in the presence of AgOTf. The anomeric thiophenyl leaving group of the 
resulting disaccharide intermediate was then activated by the addition of NIS, TfOH, and 
glycosyl acceptor 1.118 to afford trisaccharide 1.119 in 79% yield over two steps. 
Takahashi and co-workers further extended this effort to a number of automation 
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platforms, such as L-COS by Moritex, that allowed to automate temperature control, 
stirring, and rate of reagent addition for deprotection and glycosylation steps.511,522512,523 
The synthesizer could be supplemented with Combi Flash automated chromatograph to 




Image used with permission from Professor John Rimoldi 
Scheme 1.24.  Solution phase automation of the oligosaccharide synthesis in one pot 
using parallel synthesizer Quest 210 
. 
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1.3.2. Peptide synthesizer-based automation 
The automated approach Seeberger and co-workers relied on is the acceptor-
bound one, where donor and promoter are in liquid phase.509 Since the early 
developments are already discussed in detail in other review articles,25,498,510,523-525 we 
will only briefly overview the key milestones and achievements. The main focus in this 
discussion will be placed on the dedicated effort and progress towards the synthesis of 
difficult glycosidic linkages. The instrument introduced by Seeberger and co-workers 
was derived from an Applied Biosystems Inc. Model 433A peptide synthesizer. It was 
modified to allow for performing reactions at low temperatures that were deemed 
necessary for the oligosaccharide assembly.509 The solid support chosen was Merrifield 
resin, well known in the peptide world, for its good chemical inertness and ideal swelling 
properties in solvents utilized in glycan assembly. As it has been discussed previously, 
the choice of the linker is critical since it should resist conditions required during the 
synthesis. An olefin-type linker was chosen, for its versatility and good behavior in both 
acidic and basic media, as well as the mild cleavage conditions. In the first synthesis 
depicted in Scheme 1.25, octenediol-functionalized resin 1.121 was glycosylated with 
TCAI donor 1.120 (10-fold excess) in the presence of TMSOTf. The ester group was 
then cleaved using Zemplen conditions to generate the disaccharide acceptor. The 
glycosylation and deprotection steps were repeated until the oligomers of the desired 
length, up to decasaccharide, had been achieved. Each step was performed in two 
iterations, to avoid the formation of deletion sequences, and hence maximize the yield 
and simplify the final purification. The linker was the removed using Grubbs’ catalyst to 
afford penta-, hepta- and decasaccharides 1.122a-c equipped with the anomeric pentenyl 
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moiety. The high promise of the automated approach was evident immediately. Thus, 
heptasaccharide 1.122b was synthesized in 24 h in 42% over-all yield. In comparison, 




Scheme 1.25. The synthesis of oligosaccharides 1.122a-c using a modified peptide 
synthesizer 
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After this first milestone and with the intention of extending the scope of the new 
technology, the subsequent efforts performed by Seeberger et al. focused on the synthesis 
of oligosaccharides containing various challenging linkages.458,526-528 This included sialic 
acids,529 furanosides,530 1,2-cis glycosides,67 glycopeptides,460 and branched 
oligosaccharides.509 The expertise acquired in the development of this methodology for 
the synthesis of various glycosidic linkages and sequences led to an impressive synthesis 
of Globo-H hexasaccharide.67 As shown in Scheme 1.26, phosphate donor 1.123, was 
used to glycosylate hydroxylated resin 1.121 using TMSOTf as a promoter. The 
temporary Fmoc substituent at C-4 was removed using piperidine leading to the 
formation of the polymer-bound disaccharide acceptor. Fmoc is commonly used in 
oligosaccharide synthesis because it is highly stable in acidic conditions common for 
glycosylation and it is easily removable in mildly basic conditions. In this particular 
application, The cleavage product of Fmoc, dibenzofluorene, is a convenient marker to 
monitor the progress of the reaction via colorimetric assay.531 The synthetic sequence 
consists of glycosylation steps with two or three iterations, using either glycosyl 
phosphate (1.123-1.126) or glycosyl PTFAI donors (1.127 and 1.128) followed by the 
deprotection of the Fmoc group with piperidine. 
The final product 1.129 was cleaved off the solid support using ethylene in the 
presence of Grubbs’ catalyst532 in 30% yield. The stereoselectivity of the 1,2-cis 
glycosylation step was enhanced by using diethyl ether, which is known to favor the 
formation of axial products (vide supra). As aforementioned, Globo H is an important 
synthetic target of high biomedical significance for the development of anti-cancer 
vaccines.22,25,533-537 The biological importance of the Globo-H antigen is so widespread 
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throughout the scientific community that many synthetic approaches have been 
developed.63-66,68 
 
Scheme 1.26.  Automated synthesis of Globo H hexasaccharide 
Seeberger and co-workers also developed reaction conditions to achieve β-
mannosylation on solid phase using an automated approach.538 They started from the 
methodology developed by Crich539 involving 4,6-O-benzylidene protected mannosyl 
donors bearing a sulfoxide leaving group. In the original procedure, the donor is pre-
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activated with Tf2O and then reacted with the nucleophile. To adjust the procedure to the 
automated synthesis, the solvent adopted was dichloromethane, and the pre-activation 
was abolished. Unfortunately, although the selectivity of the test reaction was high, the 
yields were only moderate at best. On this basis, the next method of interest was the o-
carboxybenzyl donor developed by Kim.152 After the initial study in the solution phase 
that revealed high yields and selectivities, the selected donor was tested on solid phase to 
synthesize a series of di- and trisaccharides. The stereoselectivity fluctuated from 3.5:1 to 
9:1 in favor of the desired diastereomer, showing a partial erosion of the selectivity 
compared to that achieved in reactions in solution.  
 
Scheme 1.27.  Automated synthesis of β-mannosides 
Further, to facilitate the elongation of a sequence containing a β-mannosidic 
linkage, the donor was equipped with a triisopropylsilyloxymethyl ether (Tom) at C-3.540 
This protecting group is removed under the same mild conditions as those that make the 
silyl protecting group ideal for synthetic application. The Tom substituent, however, is 
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much less bulky than conventional silyl protecting groups, which is strategically 
significant for β-mannosylation.541 The donor was successfully used in the synthesis of a 
trisaccharide containing multiple β-linkages in excellent yield and good selectivity 
(Scheme 1.27). Mannose trisaccharide 1.133 was isolated in 50% yield as a mixture of 
anomers (8:1:1.3) and the pure β,β-linked product was isolated by HPLC. Van der Marel, 
Codee, and their co-workers have successfully applied a similar approach to the synthesis 
of ManA oligosaccharides.542 
 
1.3.3. Fluorous-tag assisted automated synthesis 
Fluorous tag-assisted technology has emerged as a new and attractive approach to 
oligosaccharide synthesis with good prospects for automation. As discussed previously, 
extensively fluorinated species and highly fluorinated protecting groups allow for the 
separation of the fluorine-containing components, typically glycosyl acceptors, from the 
non-fluorinated glycosyl donors, with the principle of different phase partitioning 
between per-fluoroalkenes and methanol.355 On the other hand, Seeberger showed that 
the chemistry of solution-based microreactors, developed in the late 1990’s, could be 
applied to carbohydrate chemistry.543 The benefits of using a microreactor include: 
safety, a much greater control of the reaction temperature, and compatibility with various 
analytical techniques. Microreactors are amenable to automation and the syntheses can be 
scaled up by increasing the number of reactors. 
By merging these two technologies, fluorous-tagged synthesis and chemistry in 
microreactors, the synthesis of a homotetramer 1.136 was accomplished as depicted in 
Scheme 1.28.497  Three different syringe pumps delivered the solutions through the inlets 
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into the mixing zone. The concentration can be controlled by the concentration of the 
original solution and the flow-rate at which each reagent is delivered into the system. The 
reaction occurs inside the reaction loop.  Glycosyl phosphate donor 1.134 was first 
glycosidated with fluorous tag 1.135 in the presence of TMSOTf. 
 
Scheme 1.28. Fluorous tag supported synthesis of a tetrasaccharide 1.136 in a 
microreactor 
This was followed by the removal of the Fmoc group with piperidine and TBAF 
to afford the fluorous monosaccharide acceptor. Tetrabutylammonium fluoride proved 
necessary for removal of the 6-O-TMS by-products.  The latter was glycosylated with 
donor 1.134 and the deprotection-glycosylation sequence was repeated until the desired 
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compound has been obtained. The product was then cleaved off from the fluorous support 
by the treatment with Grubbs’ catalyst to provide tetrasaccharide 1.136. The reaction can 
be followed by pairing the reactor with different detection systems including UV-vis 
detectors, IR or mass spectrometers.  
 
 
Image used with permission from Victoria Kohout (Professor Nicola Pohl’s group) 
Scheme 1.29. Automated synthesis of pentamannose 1.140 using fluorous support 
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The reaction times for the glycosylations were 20 sec for the formation of the 
disaccharide, and 60 sec each for the tri- and tetrasaccharides.  The yields for the 
reactions after purification were 97, 90, and 95% for the di-, tri-, and tetrasaccharides, 
respectively. 
The Pohl group applied the fluorous tag-assisted glycosylation approach to 
developing an alternative automation technology. This was accomplished by using a 
commercially available automated liquid handler and the fluorous solid phase extraction 
(FSPE) technique (Scheme 1.29).513 The handler was modified to accommodate 
cartridges for the FSPE. In this approach, the fluorous-tagged glycosyl acceptor 1.138 
was glycosylated using an excess of TCAI donor 1.137 in the presence of TMSOTf as the 
promoter. The obtained tagged disaccharide was then separated using an automated three-
step FSPE. This consists of loading into a separation column, and elution of all fluorine-
free components using 20% solution of water in methanol. At last, the retained 
fluorinated molecules are released from the solid-phase using methanol or THF, which 
are fluorophilic solvents. 
This procedure can be automated by using commercially available devices 
capable of applying a positive pressure at the top of the column or, alternatively, vacuum 
at the exit of the eluate. After purification, the disaccharide was treated sequentially with 
TBAF and hydrazine to remove TMS and Lev protecting groups, respectively. The 
resulting triol acceptor 1.139 was tri-glycosylated using TCAI donor 1.120, to afford the 
desired pentasaccharide 1.140 in an excellent yield of 92%. 





Figure 1.5. The split-valve set-up for the alternate-pump system 
In an effort to pair an automated purification to the automated solution-phase 
synthesizer, Pohl’s group worked on HPLC as the preferred instrument to accomplish this 
purpose. An alternate-pump system that differs from a direct-pump design because it is 
based on recycling the analyte through two identical columns using a 10-port switch 
valve was utilized.544 The advantage of this alternate-pump design is that peak 
broadening is avoided. The broadening is caused by the internal volume of the mobile-
phase solvent pump the analyte goes through, when pumped back into systems with 
direct-pump design. The valve switches between two different positions, A and B, as 
shown in Figure 1.5. Starting from position A, the compound elutes through the first 
column and the UV detector. When the analyte reaches the half of the second column, the 
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system switches to position B, so that the second column is directly connected with the 
first one. When the compound travels back to column 1, halfway through column length, 
the system switches back to position A and the system is now back to the original set up, 
with the UV detector between column 1 and 2. Thus, the analyte passes through the 
detector every odd-numbered column, so after every run through column 1, for its purity 
to be assessed. 
After choosing the purification set-up, the most suitable stationary phase was 
selected. Three different phases were considered: the commonly used C5, a phenyl hexyl, 
and a pentafluorophenyl (PFP) modified silica.  The latter two were found superior in the 
separation of both monosaccharides and oligosaccharides with methanol as organic 
modifier. In particular, after numerous tests, the PFP-modified silica was found to be 
more suitable for the separation of acylated monosaccharides and aromatic group 
protected compounds, whereas the phenyl hexyl-modified silica worked better towards 
acyl protected oligosaccharides, respectively.545 This new methodology was used to 
purify the product of a reaction conducted in the automated synthesizer. The authors 
detected that sugars equipped with achiral linkers proved to be the most challenging 
compounds to purify through manual separation. In this case the product was successfully 
purified using a PFP-modified stationary phase and seven effective columns. 
Over the recent years, the Pohl group has applied the fluorous tag assisted 
automated synthesis to the synthesis of a number of glycan sequences.546-549 Among this, 
is the synthesis of manno oligosaccharides connected via challenging β-linkages. This 
approach was based on the C-5 carboxylated mannosyl donor methodology developed by 
van der Marel for manual reactions.307 At first, the synthesis of 1,4-linked β-
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oligomannosides was automated using alternative glycosylation, TBS-deprotection steps 
to achieve the mannuronic hexasaccharide 1.144 sequence (Scheme 1.30).547 After each 
glycosylation and deprotection step a FSPE is performed before reiterating the procedure 
to elongate the chain. 
As shown in Scheme 1.30, mannuronic acid donor 1.141 was used to glycosylate 
fluorous-tagged glycosyl acceptor 1.142 in the presence of TMSOTf as the promoter. The 
resulting disaccharide was treated with TBAF and acetic acid to remove the TBS 
protecting group and was subsequently purified using the automated FSPE. The sequence 
was repeated three times with the automated purification. The fourth iteration, followed 
by the benchtop purification, afforded the tagged compound 1.142. The latter was 
reinjected into the synthesizer, the TBS group was removed using tetrabutylammonium 
fluoride, and the resulting compound 1.143 was purified using FSPE. At the end of the 
assembly, the carboxyl groups are reduced with DIBAL-H using the automated platform 
to afford the desired β-linked hexamannose 1.144. More recently, Tang and Pohl applied 
a similar approach to the synthesis of other positional isomers of mannans.549 For the 
synthesis of 1,2- and 1,3 linked oligomers, glycosyl donors bearing an easily removable 
temporary PMB substituent at the respective positions were employed. At the end of the 
sequencing the mannuronates were reduced with lithium triethylborohydride before the 
final benzyl removal leading to excellent yields. In the case of the synthesis of 1,6-linked 
mannans, the reduction of the carboxylic group is performed before the subsequent 
glycosylation instead of the protecting group removal.549  
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Scheme 1.30.  The automated synthesis of β-mannuronan and β-mannan 
Excellent stereoselectivity for the glycosylation of all positions has been 
achieved; however, the elongation of the 1,2-, 1,3- and 1,6-linked oligomannans beyond 
trisaccharides proved to be difficult. The reasons for this are not clear, but it could relate 
to the increased steric demand as the size of the acceptor increases. 
This approach was also applied to the synthesis of branched, all-mannosylated N-
linked glycan structures.546 The core N-glycan structure is characterized by the presence 
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of a β-mannoside carrying two α-mannosides at O-3 and O-6 (refer to Figure 1.1). As 
shown in Scheme 1.31, the formation of the difficult linkage is addressed using the 
strategy of the C-5 carboxylate methodology (vide supra). The branching point has a 
PMB to mask O-3 and the carboxylic group working both as directing and protecting 
group.  
 
Scheme 1.31. Automated sequence to obtain a branched oligomannan fragment 
from N-glycans 
The automated sequence consists of the glycosidation of donor 1.145 with the 
fluorous tag 1.146. p-Methoxybenzyl group is removed in the presence of CAN, followed 
by the automatic purification of the tagged monosaccharide using the FSPE. Further 
benchtop purification to eliminate the undesired α-isomer afforded mannuronate 1.147 in 
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78% yield. The latter was reduced to obtain free hydroxyl at the C-6 position and the 
product was purified. The subsequent glycosylation performed with six equivalents of 
donor allowed for bis-mannosylation. Benchtop Zemplen reaction afforded trisaccharide 
1.148 in 50% yield. The synthesis was completed by removing the benzyl group and the 
fluorous tag. 
 
1.3.4 Glyconeer 2.1 as a dedicated oligosaccharide synthesizer 
After proving that a peptide synthesizer-based apparatus may be a viable platform 
for oligosaccharide synthesis, Seeberger and co-workers took one step further. In 2012, 
they reported the “first fully automated solid-phase oligosaccharide synthesizer”.456 This 
dedicated apparatus is a sophisticated system, consisting of a syringe pump-driven part 
and a solenoid valve-driven part. The reaction vessel is double-jacketed to allow for the 
circulation of the cryogenic fluid. It is connected to the inlet tubes to avoid splashing of 
the solution injected and to allow for washing the vessel walls. The bottom of the vessel 
is equipped with a porous glass filter and pipelines that can be directed to waste or to a 
fraction collector. An exhaust opens only if a positive pressure of argon is used. This also 
helps to assure the compete isolation from external atmosphere. The system is built with 
two syringe pumps, but only one is used. 
It is filled exclusively with 1,2-dichloroethane to avoid solvent contamination. 
Four rotary valves are designated to regulate the delivery of building blocks and reagents 
for activation and deprotection. The solenoid valves are used to deliver solvents, mix 
reactions solutions, and manage the waste delivered from the reaction vessel. 




Scheme 1.32.  Automated synthesis of N-glycan core using the dedicated synthesizer 
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In addition to the parts already described, a cryostat operating between -50 °C and 
-90 °C and a fraction collector are important features of the synthesizer. The instrument is 
paired with a computer that helps to design, record and control glycosylation and 
deprotection protocols. This set-up provides complete automation for reactions, 
temperature control, cleavage, and collection of the final product. The complexity and the 
number of channels available, combined with the positive pressure of Argon throughout 
the whole system make the Glyconeer 2.1 the most complete and versatile synthesizer 
currently available, allowing for achieving a significant variety of reaction conditions. 
The versatility of the new system was tested by performing the synthesis of a range of 
oligomers, including a high mannose type branched glycan 1.153 as illustrated in Scheme 
1.32. The new linker 1.150 was also developed for this purpose. This linker helps to 
assure better stability during the glycosylation conditions. 
The chitobiose portion of the core pentasaccharide sequence was assembled first, 
using glycosyl donor 1.149 for both units. After the two glycosylation-deprotection 
cycles a challenging β-mannosyl residue was introduced by utilizing glycosyl donor 
1.131 equipped with the 2-(hydroxycarbonyl)benzyl leaving group originally developed 
by Kim and co-workers. Subsequent treatment with TBAF to remove the silyl protecting 
group at C-3 and a selective opening of the benzylidene group afforded the desired 3,6-
diol, which was subjected to bis-mannosylation using glycosyl donor 1.151 to afford a 
branched pentasaccharide. Cleavage from the solid support was performed using MeONa 
affording the precursor 1.152 as a mixture of two anomers (α/β = 1/3) in 3.5% overall 
yield. Preparative HPLC separation was used to isolate the desired product, which 
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underwent global deprotection using hydrogenation to afford the final product in 78% 
yield. 
 
Scheme 1.33.  Automated synthesis of manno triantamer 1.160 
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Subsequently, relying on a similar technology, Seeberger et al obtained an α-
(1→6)-linked oligomannan sequence containing 30 monosaccharide residues 
(triantamer).550 To achieve this challenging target, a modified Merrifield resin 1.155 
carrying a photocleavable linker was used. The solid support was repeatedly glycosylated 
using phosphate donor 1.154 in the presence of TMSOTf as a promoter (Scheme 1.33).  
To avoid the formation of many deletion sequences and to make the final 
separation easier, the unreacted hydroxyls were capped with Ac2O in pyridine. Piperidine 
in dimethylformamide was used for the cleavage of the Fmoc protecting group from C-6 
to afford the next generation glycosyl acceptor. The presence of benzoyl esters on the 
other positions allowed for complete stereoselectivity of the glycosylation reactions and 
high yields. The 29-mer resulting from 28 iterations of the glycosylation-capping-
deprotection sequence, was then glycosylated with donor 1.156, equipped with a spacer 
to perform a very effective cap-and-tag purification.Therefore, upon removal of the 
oligosaccharide 1.158 from the solid support, a conjugation step to magnetic beads 
through the ε-aminocaproic ester spacer was performed. The purification step consisted 
of a magnetic separation of the tagged 30-mer 1.159, followed by release using Zemplen 
conditions also to remove benzoyl protecting groups. Finally, hydrogenation was 
performed to free the terminal amine of the linker from the Cbz group, resulting in the 
fully unprotected 30-mer 1.160, obtained in 1% yield, which corresponds to 96% yield 
per synthetic step. 
In the further development of the Glyconeer synthesizer, Seeberger et al 
successfully synthesized mannosyl 50-mer 1.162 (penindamer), the longest sequence ever 
obtained with a solid phase automated approach.551 The approach is similar to the one 
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used for the synthesis of the 30-mer, although an important methodological advancement 
has emerged with the implementation of the ethylthio glycoside as glycosyl donor. In this 
application, the glycosyl donor 1.161 was activated with NIS in the presence of TfOH at -
40 °C. The temperature was immediately ramped up to -20 °C and the reaction was 
completed in 20 min. The study of the most suitable building block brought highlight to a 
donor carrying a permanent benzoyl group at position 2, to assure neighboring group 
participation and therefore high selectivity. C3 and C4 are protected with arming 
benzyls370 and position C6 is carrying a temporary Fmoc group, removed with Et3N in 
DMF every iteration. To facilitate the purification process, which revealed to be 
challenging for deletion sequences longer than n-5, a capping step was introduced after 
every glycosylation step. Furthermore, in the latest cycles, from 46 to 50, a second 
glycosylation was added to the sequence to ensure even better conversion during the 
elongation (Scheme 1.34). Since these additional steps are expensive in terms of time, a 
25-mer was synthesized as a proof of concept, to show that the capping steps become 
necessary only in the latest stages of the sequence. The approach proved to be successful 
allowing an easy separation of the desired product from the shorter oligomers and a 
higher average yield for each step. The purification was achieved by HPLC before the 
deprotection steps and later on using dialysis and size exclusion chromatography. 
For expanding the scope of the automated oligosaccharide synthesis, the 
Seeberger group also worked on refining reaction conditions for the formation of other 
challenging glycosidic linkages. For example, a number of efforts were dedicated to the 
formation of sialylated oligosaccharides. Previously, sialic acid containing disaccharides 
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Image used with permission from Professor Todd Lowary 
Scheme 1.34.  Automated synthesis a 50-mer 1.162 using Glyconeer 2.1 
More recently,499 the use of  more sophisticated sialyl building blocks based on 
the 4,5-oxazolidinone chemistry238-240 allowed for direct sialylation in the synthesizer. 
These new sialyl donors were also equipped with chloroacetyl protecting groups at 
position C-7 and C-8 and position C-9 was protected with Fmoc. A similar protecting 
group pattern, along with the phosphate leaving group, showed good levels of reactivity 
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in sialylation reactions in solution developed by Wong and Wu.552 After optimizing the 
glycosylation conditions and reaction temperature this approach was successfully applied 
to the automated synthesis of α-(2,6)-linked sialosides.  
 
Scheme 1.35.  Automation of the sialylation reaction 
A representative example is shown in Scheme 1.35 wherein the target 
disaccharide was synthesized from building blocks 1.161 and 1.162. The immobilized 
disaccharide 1.165 was obtained from the reaction of the photocleavable linker 1.155 
with donor 1.163 in the presence of TMSOTf. 
Capping of the unreacted linker with acetic anhydride in pyridine, followed by 
removal of the Fmoc protecting group with triethylamine (TEA) in dichloromethane 
afforded the immobilized acceptor. Phosphate sialyl donor 1.164 was then activated in 
the presence of TMSOTf. Finally, the photocleavage provided the target compound 1.165 
in 10% overall yield. The yields for the formation of α-(2,3)-linkages were lower. 
Another approach to sialooligosaccharides involved a chemoenzymatic synthesis.553 
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According to their strategy a desired oligosaccharide sequence was assembled using the 
synthesizer first. After the cleavage from the solid support, the target compound 
underwent the entire protecting group removal followed by enzymatic sialylation. This 
step was accomplished in the presence of α-(2,3)-sialyltransferase from Pasturella 
Multocida that was originally introduced by the Chen group.554 As a result, the desired α-
(2,3)-linked products were isolated in in 78-89% yields.553 
 
Scheme 1.36.  Automation of 1,2-cis glycosylation 
Seeberger and co-workers also studied the automated synthesis of 1,2-cis-linked 
residues that are abundant both in microbial glycans and in the mammalian glycome. In 
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particular, reactions assisted by the remote group participation were of particular interest 
to this application. An overview of compounds 1.170-1.176, synthesized using the 
Glyconeer 2.1, is depicted in Figure 1.6. 
 
Figure 1.6. Representative 1,2-cis-linked oligosaccharides synthesized using 
Glyconeer 2.1 
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A systematic study of differently protected galactosyl and glucosyl donors was 
performed.555  The highest stereoselectivity was obtained with the galactosyl donor 
carrying acetates at the C-3 and C-4 positions. Glucosyl donor required esters at the C-3 
or C-6, and depending on the desired propagation site, either a removable Fmoc 
carbonate or more permanent acetate were used. A representative example is the all α-
linked oligomer 1.169 depicted in Scheme 1.36, achieved from glucosyl donors 1.166, 
1.167 and 1.168. Thus, donor 1.166 was glycosylated in the presence of NIS and triflic 
acid to the photocleavable linker. The Fmoc protecting group was removed with 
triethylamine in DMF to obtain the immobilized monosaccharide acceptor. 
 
Scheme 1.37.  Automated synthesis of β-manno-linked dodecasaccharide 1.179 
The sequence was repeated to obtain the disaccharide, then donor 1.167 was 
glycosylated in the previous conditions and Fmoc protecting group was removed, 
affording the immobilized trisaccharide. Finally, donor 1.168 was reacted with the 
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trisaccharide acceptor and photocleavage was performed to afford the final 
tetrasaccharide 1.169 in 20% overall yield and with excellent α selectivity. 
Among other useful methodologies for the synthesis of 1,2-cis-linked 
oligosaccharides is the solid-phase synthesis of β-mannosides developed by Codee and 
co-workers.542 Glyconeer 2.1 was used as a platform for automation of glycosidation of 
mannuronic acid donor 1.177 equipped with a N-phenyltriflouroacetimidoyl leaving 
group. Glycosylations promoted with TfOH at -40°C produced oligosaccharides in high 
yields and complete β-selectivity. Thus, as depicted in Scheme 1.37, a 1,2-cis-linked 
dodecasaccharide 1.179 was synthesized in 11% overall yield. Donor 1.177 was first 
coupled to linker 1.178 and each glycosylation step was repeated twice with about 90% 
coupling efficiency. The Lev protecting group removal was achieved with hydrazine 
acetate in a mixture of pyridine and acetic acid. Upon completion of the assembly, 
cleavage from the solid support was performed using a metathesis reaction with ethylene 
in the presence of Grubbs I catalyst. Complete selectivity of the target compound was 
proven by NMR. 
Within a plethora of applications for the Glyconeer 2.1 automated synthesizer, 
there has been the synthesis of a number of oligosaccharides containing furanosyl 
residues. The first result accomplished was the synthesis of a series of linear and 
branched oligoarabinofuranides,530 as depicted in Scheme 1.38. Thus, ethylthio glycosyl 
donor 1.180 is glycosidated with linker acceptor 1.150, followed by removal of Fmoc 
group at C-5 in the presence of piperidine in DMF. The donor 1.181, used for branching, 
is coupled to the immobilized monosaccharide in the presence on NIS and triflic acid, 
followed by treatment with piperidine in dimethylformamide to remove both Fmoc 
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protecting groups. The resulting disaccharide was treated with donor 1.180 in the 
presence of NIS and TfOH, followed by deprotection step, in two iterations, to obtain the 
immobilized pentasaccharide. Finally, treatment with sodium methoxide in methanol and 
catalytic hydrogenation afforded the target compound 1.182 in 63% yield. The synthesis 
was completed in only 42 hours. The first application of the use of furanose building 
blocks in solid phase was the synthesis of oligoxylanopyranosides.556 These structures are 
based on a linear series of β-(1,4) linked xylosides with the furanoses as branches in 
selected position. The oligosaccharides obtained in good yield are used to study the 
binding preference of anti-xylan monoclonal antibody557 on microarray systems.558 
The other two series of compounds synthesized by Seeberger and co-workers are 
type I and II arabinogalactan (AG).559,560 These are present in plant cells and they can be 
useful to study arabinogalactan-directed antibodies binding specificity. Type I is present 
in pectic polysaccharide as a decoration of the main backbone and characterized by β-
(1,4) linkages connecting Gal units for the linear chain, and the branching is achieved by 
α-(1,3) bonds between arabinofuranosides and galactosides.561  
Type II, on the other hand, is present as a highly branched polysaccharide 
attached to a hydroxyproline-rich peptide structure. The linear backbone of the glycan is 
based on β-(1,3) linkages while the branching occurs through β-(1,6) bonds.562 The 
arabinofuranoses present on the branching are connected by α-(1,3) linkages as in the 
case of the Type I AG. The target compounds were obtained in good to excellent yields. 
The effort in the assembly of various arabinofuranosides containing oligosaccharides 
culminated in the formation of two complex structures containing the former and 
mannopyranosides.563 
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Scheme 1.38. Synthesis of the branched hexasaccharide composed of multiple 
arabinofuranosyl residues 
These oligosaccharides are present on the cell surface of the Mycobacterium 
tuberculosis564 and constitute a synthetic challenge for their complexity. Three different 
building blocks are required for the assembly of the product. They are all ethylthio 
glycosides and protected with Fmoc on the position of elongation and branching. Another 
important application of this dedicated system is to the synthesis of different families of 
GAGs (glycosaminoglycans). These compounds are connected to a transmembrane core 
protein, with the function of transducing signals to the interior of the cells from 
extracellular environment.17 
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The first target was chondroitin sulfate, containing β-D-glucuronic acid and N-
acetyl-β-D-galactosamine, presenting various sites of acetylation and sulfation. The 
advantage of the solid phase in the preparation of this polysaccharide is the establishing 
of a general method that with a few building blocks allows reaching a wide number of 
targets, hence the possibility of better understanding their biological relevance. 
 
Scheme 1.39. Synthesis of a chondroitin sulfate 
The selected chondroitin sulfate-A and chondroitin sulfate-C hexasaccharides are 
similar in structure and differ only in the site of sulfation along the chain. As in cases 
previously described here, donors contain the phosphate leaving group, the selected 
protecting group for the chain elongation is Fmoc, allowing mild cleavage conditions, 
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while Lev esters mask the hydroxyl used for the introduction of sulfates. The amino 
group in the galactosyl building block 1.183 carries a trichloroacetate as a protecting 
group and the linker 1.155, already utilized by Seeberger and co-workers, is UV labile. 
The synthetic sequence is based on the coupling step with alternating GalNAc 1.183 and 
GlcA 1.184 building blocks followed by deprotection of the Fmoc group. The acetylation 
at the end of the chain, the Lev group removal and the sulfation are also performed using 
solid phase protocols, affording the desired compound 1.185 in good yield (Scheme 
1.39). 
The second target was dermatan sulfate, which is a polysaccharide composed by a 
disaccharide repeating unit, consisting of N-acetyl-β-D-galactosamine and L-iduronic 
acid.565 Seeberger et al. developed a synthesis of a di- and a tetrasaccharide using the 
Fmoc protection at the oligosaccharide propagation position and the Lev ester at the 
future sulfation sites. Galactosamine is readily available in a small number of steps while 
iduronic acid requires a more complex synthesis.566 Both donors are equipped with 
phosphate leaving group and the linker utilized is the photocleavable one found in many 
other automated assemblies developed by the group. The yield of the two compounds 
obtained, a disaccharide and a tetrasaccharide, are high and consistent even when the 
larger acceptor is involved, averaging both 93% for each step.567 
Other families of GAGs studied by Seeberger and co-workers include oligo-N-
acetyllactosamine and keratan sulfate.563 The automated glycan assembly was employed 
to achieve a fast and facile access to a large library of compounds. For this purpose, the 
photocleavable linker and three orthogonal protecting groups (Fmoc, Lev and Nap) have 
been utilized. The orthogonal protecting groups gave a streamlined access to keratan 
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sulfate oligosaccharides with differential sulfation sites. The obtained products were 
printed on microarrays and used to study the interaction with viral receptors. One of the 
keratan sulfate tetrasaccharides was identified as a specific interaction partner of receptor 
AAVrh10. 
 
Scheme 1.40. The synthesis of hyaluronic acid fragments 
Codee and co-workers reported the synthesis of different chains of hyaluronic 
acid (HA), another common class of GAGs.542 HA is a major component of connective 
tissue and extracellular matrix. Besides structural functions, HA has a role in 
inflammatory response, cell-cell adhesion and recognition. Being able to access 
fragments of HA would be beneficial for studying its interaction with protein CD44, 
related to tumors proliferation. Common challenge for all GAG syntheses is the low 
reactivity of building blocks that has been addressed by applying them in large excess. As 
depicted in Scheme 1.40, the assembly started with PTFAI glucosamine donor 1.186 that 
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was coupled with linker 1.178 in the presence of TfOH. The chain is then elongated with 
the removal of the temporary Lev protecting group and subsequent glycosylation with 
disaccharide donor 1.187. After repeating the glycosylation-deprotection cycle, the 
products are released through olefin metathesis and purified using HPLC to afford the 
desired hepta-, undeca- and pentadecasaccharide in 26, 32 and 18% yield, respectively. 
To show the versatility and the wide range of application the automated glycan 
assembly system is suitable for, Seeberger and co-workers developed a sequence where 
peptide and oligosaccharide solid phase syntheses are coupled.460 Homogeneous 
glycopeptides are extremely valuable, because regularly these compounds are isolated in 
heterogenous mixtures that make difficult the determination of structure-activity 
relationship. Normally the strategies for construction of a glycopeptide require the pre-
formation of glycosylated amino acids in solution phase.368,568 The presented approach is 
advantageous because it utilizes a simple building block, readily available and with 
minimum synthetic requirements. Elongation of the peptide chain proceeds through Fmoc 
approach, using HBTU as coupling reagent and piperidine to remove the protecting 
group.  Serine and threonine side chains are protected as tert-butyl or trityl ether to be 
removed before the glycosylation step, achieved using TMSOTf. 
To illustrate the versatility of the approach, three glycopeptides were synthesized, 
including compounds with 1,2-cis linkages, requiring elongation on the glycan side and 
with more than one glycosylation site. All the syntheses were performed in good yields 
and selectivity and established the Glyconeer as a promising system to address the 
challenges in glycopeptides assembly (Scheme 1.41). The possibility of accessing large 
and complex oligosaccharides is particularly powerful in terms of understanding the 
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specificity of various enzymes. The knowledge acquired through the synthesis of 
furanose-containing oligosaccharides was useful to study the xylan-degrading enzyme 
since the arabinoxylans are suitable for a large number of applications, including biofuels 
and nutritional and pharmaceutical functions.  
 
Scheme 1.41. Glycopeptide synthetic sequence 
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The synthetic approach is based on the Fmoc strategy for the elongation of the linear 
chain and using fully orthogonal Nap and 2-(azidomethyl)benzoyl (Azmb) for the 
branching. After incubation with the enzyme, the fragments were studied using LC-
MS.569 
A similar strategy has been used to study the hydrolysis of mixed-linked glucan 
chains by lichenase enzyme. This family of glycans is composed by linear 1,3- and 1,4-
linked glucans, which form a gel-like material, important for the structural functions of 
the cells. Although the synthetic approach is similar to the general one used by Seeberger 
and co-workers, the formation of the 1,3- linkages was particularly challenging, requiring 
two glycosylation steps to avoid the formation of the deletion sequence. Again, the 
oligosaccharides were incubated with the enzyme and the digestion product analyzed via 
LC-MS, revealing new important features of the behavior of the enzyme.570 
The synthesis of oligosaccharide libraries has become one of the most useful 
applications of Glyconeer 2.1. In addition to the aforementioned examples, Seeberger and 
co-workers have recently synthesized libraries of homo- and heterooligomers of 
mannose, glucose and glucosamine. The purpose of the library was to understand the 
correlation between the oligomer conformation and their macroscopic properties.571  
A combination of the automated glycan assembly and computational studies 
revealed a significant structural diversity within a series of synthetic oligomers, even 
within the ones comprising the same structural constituents albeit with the different 
position of the glycosidic linkages.  The study clearly showcases the power of the 
automated synthesis as a tool for a better understanding of the biological significance of 
oligosaccharides. 
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Scheme 1.42. The synthesis of a representative galactosylated xyloglucan for 
generating of oligosaccharide libraries 
Pfrengle and co-workers also contributed to the field by synthesizing numerous libraries 
of plant-related oligosaccharides.556,569,572 Two significant examples include the assembly 
of arabinoxylans and galactoxyloglucans, both being epitopes for monoclonal antibodies 
that could be used as probes to study the cell wall properties. The approach for the 
synthesis of both libraries is similar. The backbone is assembled using dibutyl phosphate 
donors, and the branching is achieved using ethyl thioarabinofuranosides or galactosyl 
phosphates. The xylogluco disaccharides were presynthesized prior the automation step 
to bypass the challenge of introducing 1,2-cis linkage at the later stage of the synthesis. 
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As depicted in Scheme 1.42, the assembly of the galactosylated xyloglucan 1.200 
involved the reiteration of the glycosylation and deprotection steps with glucose building 
block 1.197. The leaving group was activated with TMSOTf and the temporary Fmoc 
group was removed with triethylamine in dimethylformamide. The immobilized 
trisaccharide was then glycosylated with the preassembled disaccharide 1.198 to obtain 
the xylose-decorated sequence. At last, the oligosaccharide was further elongated using 
galactosyl donor 1.199 and the target was cleaved and deprotected to afford the desired 
hexasaccharide 1.200 in 7% overall yield. 
 
1.3.5. HPLC-assisted oligosaccharide synthesis 
Demchenko, Stine, and their co-workers developed a new experimental set-up 
based on an unmodified HPLC instrument. The system consisted of an Omnifit column 
containing pre-swelled beads of the TentaGel-NH2 polymer. The column was then 
connected to the HPLC system consisting of a ternary reciprocating pump, a UV detector 
with variable range and a computer to operate the instrument through regular HPLC 
management software.514 The glycosyl acceptor was already loaded on the resin prior to 
the insertion into the column and two different solutions containing glycosyl donor and 
promoter were mixed in the pump head and then activated donor was delivered to the 
column. The reaction time needed for such a protocol was short, typically 30-60 minutes 
and afterwards the system was purged with fresh solvent leaving the clean resin carrying 
the disaccharide, which could be further elongated through deprotection-glycosylation 
cycles. The efficacy and the versatility of the HPLC approach has to be proven, but the 
first application revealed its potential. 
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Scheme 1.43.  HPLC-assisted automated oligosaccharide synthesis 
As shown in Scheme 1.43, the synthesis of pentasaccharide 1.203 was 
successfully accomplished starting from the TentaGel-NH2 resin preloaded with acceptor 
1.202. However, the loading could also be performed directly using the HPLC sequence. 
Donor 1.201, equipped with benzoyl ester in a neighboring position to ensure 
stereoselectivity and Fmoc protecting group at C-6 for chain elongation, was pumped into 
the system together with a solution of TMSOTf as promoter. After 1h of recirculation of 
the solution, the system was washed with dichloromethane, followed by the deprotection 
of Fmoc performed with piperidine in DMF for 5 minutes, and again a sequential purging 
step using dichloromethane. The glycosylation-washing-deprotection-washing sequence 
was repeated until oligosaccharide of the desired length was obtained. After that, the 
product was cleaved from the solid support by using a recirculating solution of NaOMe in 
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methanol-dichloromethane to afford pentasaccharide 1.203 in 62% yield in 7 h total time 
(vs 14 days for manual synthesis). 
 
 
Scheme 1.44.  The use of an autosampler as the mode for reagent delivery for the 
HPLC-based automation 
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The most recent contribution by Demchenko and Stine is the use of autosampler 
in a new HPLC system as solution for delivering the promoter in the glycosylation 
step.502 Autosamplers in modern HPLC have the advantage of being easily programmable 
to enhance automation of the polymer-supported synthesis. The study covered many 
aspects, starting from the efficiency of different solid phases, revealing JandaJel to be the 
most attractive for HPLC-mediated synthesis. The effectiveness of different leaving 
groups ranging from reactive O-imidates and phosphate to less reactive thioimidates and 
thioglycosides was investigated. The chosen TCAI allowed to obtain pentasaccharide 
1.206 in 67% yield over three glycosylation steps and two deprotection steps (Scheme 
1.44). 
To address some drawbacks of the solid phase synthesis using polymer supports, 
Demchenko and Stine introduced the Surface-Tethered Iterative Carbohydrate Synthesis 
(STICS, vide supra).438 For the purpose of the automation experiment small pieces of 
nanoporous gold were integrated in the Omnifit column,437 and the synthesis was 
conducted as in polymer-supported HPLC-based synthesis. The immobilization of the 
glycosyl acceptor 1.208 on the support is achieved using sulfur-containing linkers, such 
as lipoic acid, and the glycan assembly is performed. The HPLC pump was used to 
circulate donor 1.207 through the Omnifit column containing nanoporous gold chips 
(Scheme 45). To investigate the effect of the spacer, C4, C8 and C8OC8 were considered, 
and the series of parallel experiments showed that longer chain spacers between the 
glycosyl acceptor and the lipoic acid anchor increase the yield of disaccharide 1.209 from 
60% to 90%.437 
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Scheme 1.45.  HPLC-assisted surface-tethered synthesis of disaccharides 1.209 
 
1.3.6. Electrochemical activation platform for automation 
Chalcogenoglycosides that can be activated by electrochemical methods573-578 
served as a novel automation platform introduced by Nokami and co-workers.515 The 
glycosylation step is based on electrochemical activation of thioglycoside donors with the 
formation of the corresponding glycosyl triflate as the reactive intermediate. A dedicated 
synthesizer was developed specifically for this application, using commercially available 
components. Thus, the instrument was equipped with a chiller and a cooling bath, a 
power supply for constant current electrolysis, and a syringe pump. The assembly and all 
the hardware are controlled using the LabVIEW software. The reaction occurs in a H-
type divided cell, with a carbon-felt anode and a platinum plate cathode. The glycosyl 
donor is activated in the anodic chamber, and the acceptor is added using the syringe 
pump. 
  




The annotated image is used with permission from Professor Toshiki Nokami 
Scheme 1.46.  Automated solution phase synthesis using electrochemical activation 
In the original application, the synthesis of a series of β-(1→6)-linked N-
acetylglucosamino glycans were assembled. As depicted in Scheme 46, the optimized 
aryl thioglycoside donor 1.210 was preactivated via anodic oxidation at -80 °C and 1.0 
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F/mol at 1.73 Volts for 40 minutes, resulting in the formation of the anomeric triflate 
1.211 which reacted with the glycosyl acceptor 1.212 at -50-60 °C for 30 minutes. The 
obtained disaccharide 1.213 was then ready for activation, since the reaction proceeds 
with the growth of the glycan on the donor side, and the illustrated preactivation-
glycosylation steps were repeated to synthesize the pentasaccharide 1.214 in 31% overall 
yield, with an average of 75% yield per cycle. The whole assembly required 10 hours.515 
Given the potential of such a method, which has the advantages of both the 
solution-phase and the automated synthesis, Nokami and co-workers recently developed 
a few additional applications for the electrochemical activation of chalcogenides.579-
582One target reported by Nokami was TGM-chitotriomycin,579,580,582 a molecule of 
interest for the development of safer pesticides due to its selectivity in the inhibition of 
fungal and entomic glucosaminidases. This 1,2-trans linked glucosamino glycan was 
assembled using a similar approach affording a tetrasaccharide product in 41% overall 
yield.  
Another molecule of interest was a GPI anchor core trisaccharide, an 
oligomannoside of interest to show the advantages of novel strategies for oligosaccharide 
synthesis.581 The study  started with the evaluation of the oxidation potential of different 
building blocks, all characterized by a participating group at the C-2 or the C-6, such as 
acetyl or pivaloyl. The studied compounds were compared to the 4-fluorophenyl 2,3,4,6-
tetra-O-benzyl-1-thio-α-D-mannopyranoside and to better understand the changes in the 
potential DFT calculations were performed. 
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Scheme 1.47. Electrochemical approach to the core trisaccharide of GPI anchors 
To verify the selectivity of the selected donors a test was performed with the 
assembly of different disaccharides using the electrochemical pre-activation strategy 
(vide supra). Anodic oxidation was performed at -80 °C in the presence of Bu4NOTf with 
1.00 F/mol of electricity. The proposed mechanism involves the formation of the 
anomeric triflate, which is then displaced by the neighboring group to form an 
acyloxonium ion, which undergoes substitution to afford the desired product. This was 
applied to the assembly of the core trisaccharide of GPI anchor oligosaccharide as shown 
in Scheme 1.47. The sequence was completed to provide trisaccharide 1.220 in 40% 
overall yield. 
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1.4. Conclusions and outlook 
To keep pace with the expanding areas of glycosciences, it is critical to make 
glycans more accessible to the general chemical, biomedical and industrial audiences. 
The advancement of automation strategies and their broader adoption will be crucial to 
meeting this need. Fundamental new developments will be required both in the 
generalization of the automation strategies and in the optimization of methods for 
glycoside synthesis and oligosaccharide assembly needed for reliable implementation 
into automation. Manual strategies for oligosaccharide synthesis in solution require 
specialist knowledge of all aspects of carbohydrate chemistry and fine tuning of reactivity 
levels and reaction conditions. Manual polymer- or tag-supported synthesis helps to 
streamline the synthesis and purification, but still requires specialized knowledge of 
carbohydrate synthesis. The automated platform developed by Seeberger introduces an 
idea of operational simplicity; however, it requires a sophisticated and expensive 
synthesizer, and dedicated and appropriately trained personnel. 
More recent developments of automation platforms make use of common 
laboratory equipment including parallel synthesizers syringe pumps, microreactors, and 
HPLC components. These approaches offer a promise to deliver simple automation using 
commonly available and relatively inexpensive equipment. The modular character these 
synthesizers allows for endless opportunities to implement existing accessories including 
reagent delivery modules and detecting systems that can be operated by standard 
computer software. Some automation platforms already are capable of reaction 
monitoring in real-time helping to reduce the amount of reagents needed and the reaction 
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time. Although a viability of these new approaches and platforms has been demonstrated, 
many, if not all, automation platforms are still in need of major refinement. Further 
development of existing and new platforms for the automated synthesis is becoming a 
significant area of research. 
One of the greatest unsolved challenges is the need for dedicated automation-
amenable reaction conditions. Many aspects of the automated synthesis including 
polymer supports and tags, large scale synthesis amenability, availability of affordable 
“off-the-shelf” reagent kits, catalytic, stereoselective and operationally simple 
glycosylations, streamlined synthesis or broader commercial availability of building 
blocks still need to be improved to expedite the synthesis of glycans. Broad availability 
of synthetic glycan sequences and libraries and/or affordable and accessible tools and 
technologies for automation will greatly enhance study of the roles of carbohydrates in 
biological and disease pathways. The produced libraries of synthetic compounds can be 
readily integrated with the currently available glycan microarray technologies. 
The full potential of automated techniques is yet to be explored, and the versatility 
has to be improved to reach the diversity of manual, solution phase techniques. While 
most automated platforms are still in development, manual synthesis in solution will 
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2.1. Introduction 
While understanding the structure and functions of carbohydrates is difficult,1-3 it 
is glycosylation that is flawlessly executed by enzymes4-5 has proven a particularly 
challenging reaction to chemists. With the aid of modern methods, strategies, and 
technologies, the formation of many glycosidic bonds can now be achieved.6-10 The 
development of glycosylation reactions that will offer new capabilities for obtaining 
complex glycans with exclusive stereoselectivity and enhanced purity remains an 
important area of research in the field of synthetic chemistry. The goal of controlling 
glycosylation has been pursued in many ways, with main focus recently shifting to studying 
stereoelectronics and conformation of the starting material and key reaction intermediates. 
Although some model studies have helped to establish general trends,11-18 practical 
application of the stereoelectronic and conformational factors to stereocontrol of 
glycosylations is still limited.  
Fraser-Reid’s seminal work on the armed-disarmed approach showed that the 
building block reactivity can be modulated through the choice of protecting groups.19-20 In 
recent years, the scope of the original armed-disarmed concept has been expanded, and a 
number of reactivity levels that extend beyond the traditional armed-disarmed boundary 
have been established.21 Following other early work in the area,22-24 our group reported that 
2-O-benzyl-3,4,6-tri-O-benzoyl protected donors are less reactive (superdisarmed) than 
their disarmed per-Bz counterparts.25 This unexpected protecting group effect was 
explained by the existence of the O2/O5 cooperative effect that takes into consideration the 
stabilization of reaction intermediates, rather than only the electronics of the starting 
material. While studying the activation of superdisarmed thioglycosides with Br2, we 
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developed conditions at which the β-bromide was the only intermediate leading to products 
(Scheme 2.1A).26 The oxacarbenium ion either did not form or had no contribution to the 
formation of glycosides. As a result, the nucleophilic displacement of the β-bromide 
intermediate took place in the concerted fashion leading to exclusive α-stereoselectivity of 
all glycosylations. Since the α-bromide remained totally unreactive in this reaction, α-
thioglycoside precursor was fond to be a more suitable precursor to generate the desired β-
bromide intermediate stereoselectively (Scheme 2.1B). This strategic adjustment led to 
improved yields, however, unreactive glycosyl acceptors still produced only moderate 
yields.   
 
Scheme 2.1. Previous glycosidations of thioglycosides with Br2 
To enhance the reaction rates and achieve more practical yields, we also 
investigated per-benzylated armed thioglycosides (Scheme 2.1C). Although those reactive 
donors could indeed be glycosidated quite rapidly in the presence of Br2 providing good 
yields, a decreased stereoselectivity was encountered.26 These reactions proceeded via the 
intermediacy of the α-bromide that was sufficiently reactive in the armed series to couple 
with an acceptor. Low temperature NMR experiments27 showed that the β-bromide was 
also present at the early stage of the reaction. However, it was thought to be an insignificant 
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intermediate en route to the product formation due to its rapid anomerization into the α-
counterpart 
Described herein is our dedicated effort to extend the bromine-promoted 
glycosylation reaction to the investigation of glycosyl donors of the superarmed series. 
There are two known concepts for superarming glycosyl donors. The first concept, wherein 
the enhancement of reactivity was achieved by changing the equatorial-rich 4C1 
conformation to an axial-rich skew-boat conformation by creating steric congestion with t-
butyldimethylsilyl (TBS) protecting groups at the C-2, 3 and 4, was introduced by Bols 
and co-workers.28-32 The second concept introduced by our group involves the electronic 
superarming using conventions of the O2/O5 cooperative effect. According to this effect, 
intermediates obtained from the 2-O-benzoyl-3,4,6-tri-O-benzyl-protected glycosyl donors 
are stabilized both anchimerically by the ester substituent at O-2 and electronically by the 
O-5 that is surrounded by electron-rich ethers.33-35 Bols’ and our groups have also jointly 
developed glycosyl donors with combined conformational and anchimeric superarming.36-
37 However, none of the superarmed donors developed to date can be applied to the 
stereoselective synthesis of 1,2-cis glycosides. The development of highly reactive 
(superarmed) α-stereoselective glycosyl donors would be very useful for all investigators 
working on synthesizing 1,2-cis-linked glycans in solution and solid supports.38  
 
2.2. Results and discussion 
With a goal of investigating superarmed glycosyl donors in application to 1,2-cis 
glycosylation, we began studying conformational properties of a series of β-ethylthio 
glycosides β-2.1-2.3, prepared from a common diol precursor β-2.1.39 1H spectrum was 
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recorded at rt and the coupling constants were consistent with those expected for the 
standard 4C1 chair conformation, typical for D-glucose derivatives.
40-42 We have also 
recorded a 13C {1H} NMR spectrum, and the list of signals is included in Table 2.1. Diol 
precursor β-2.1 was then protected with TBS groups at C-3 and C-4 positions to obtain 
compound β-2.2. 1H and 13C NMR spectra were recorded at rt. The coupling constants 
obtained from the 1H spectrum clearly showed an increasing distortion in the conformation 
of β-2.2 from the standard 4C1 conformation observed for β-2.1. The 
HHJ values were 
consistent with the previously reported values for similar compounds.21, 28-30 The difference 
was particularly noticeable in the values for J2,3 and J3,4. Thus, J2,3 decreases noticeably 
from 9.2 in β-2.1 to 3.9 Hz in β-2.2 and J3,4 decreases from 9.2 Hz in β-2.1 to 5.0 Hz in β-
2.2. This change was also associated with a shift of the anomeric proton downfield from 
4.51 in β-2.1 to 4.79 ppm in β-2.2. This shift could be a sign of a particular distribution of 
functional groups around the ring. The remaining ring protons H-2-5 are all shifted 
downfield when TBS groups are added.  
A further conformational change was observed for 3,4-di-O-triisopropylsilyl 
(TIPS) glucoside β-2.3 as judged by the coupling constants of J2,3 = J3,4 = J4,5 = 0 Hz. The 
value could be related to compound β-2.3 adopting an axial-rich conformation to release 
the steric strain caused by bulky silyl groups at C-3,4. All ring proton signals H-2-5 in β-
2.3 experience even greater downfield Δδ shift than those recorded for β-2.2, while the 
shifts for the H-6 protons are not affected by the 3,4-O-silylation. 
Interesting trends have also been observed by comparing the 13C {1H} NMR spectra 
of compounds β-2.1-2.3. The chemical shifts of C-1, C-2 and C-5 were found to be 
particularly diagnostic of the conformational changes undergone by the ring. The trend 
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identified is in shifting of the C-1 and C-3 signals upfield, whereas C-2, C-4 and C-5 shift 
downfield. For example, the C-1 signal moves from 85.06 for β-2.1 to 82.81 of β-2.2 and 
to 81.23 ppm for β-2.3. In contrast, C-5 shifts from 77.82 to 79.41 to 80.79 ppm in the 
same sequence of compounds.  
 
Cmpd Signal 1H NMR, ppm J, Hz 13C NMR, ppm 
β-2.1 H/C-1 4.51 (d) J1,2 = 9.7 85.06 
 H/C-2 3.28 (dd) J2,3 = 9.2 80.87 
 H/C-3 3.63 (dd) J3,4 = 8.7 77.95 
 H/C-4 3.47 (dd) J4,5 = 9.2 70.13 
 H/C-5 3.55-3.59 (m) ND 77.82 
 H/C-6 
4.57 (br d) 
4.69-6.62 (m) 
J6a,6b = 12.1 64.16 
β-2.2 H/C-1 4.79 (d) J1,2 = 8.3 82.81 
 H/C-2 3.42 (dd) J2,3 = 3.9 82.50 
 H/C-3 3.91-3.86 (m) J3,4 = 5.0 76.45 
 H/C-4 3.80 (t) J4,5 =5.0 71.68 
 H/C-5 3.97-3.91 (m) 
J5,6a = 7.4 





J6a,6b = 11.3 65.52 
β-2.3 H/C-1 5.05 (d) J1,2 = 8.5 81.23 
 H/C-2 3.60 (d) J2,3 = 0 83.09 
 H/C-3 4.16 (bs) J3,4 = 0 70.89 
 H/C-4 4.27 (bs) J4,5 =0 75.71 
 H/C-5 4.24 (t) 
J5,6a = 6.9 





J6a,6b = 11.0 66.13 
 
Table 2.1.  NMR data for thioglycosides β-2.1-2.3 
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Due to the significant changes in the coupling constants, ring distortion was 
anticipated. Computational experiments were set up to investigate whether the in silico 
data would support the experimental data, in collaboration with the laboratory of Prof. 
Laura Belvisi. The calculations were conducted by Dr. Monica Civera. A series of 
computational studies was performed on the compounds β-2.1-2.3. Computational models 
of thioglycosides β-2.2 and β-2.3 were built by implementing the following workflow. 1) 
Monte Carlo/Energy Minimization (MC/EM) conformational search was carried out at the 
molecular mechanics level (OPLS2005 force field) leaving all dihedral angles free to move. 
2) Representative minimum-energy geometries of MC/EM search was optimized at the 
DFT B3LYP/6-31G* level of theory. 3) The obtained stationary points were confirmed as 
minima by calculating vibrational frequencies at the same level of theory and their 
thermochemical properties, including the final denoted total Gibbs free energy, were 
computed. DFT minimum energy structures and relative energy differences, resulting from 
these computational studies, are summarized in Table 2.2. 
Cmpd Conformation Relative energy 
β-2.2 4C1 chair 0.00 kcal mol
-1 
 1C4 chair 0.75 kcal mol
-1 
 3,OB boat 1.32 kcal mol-1 
 2SO skew-boat 2.53 kcal mol
-1 
β-2.3 
3S1 skew-boat 0.00 kcal mol-1 
 
1C4 chair 2.24 kcal mol-1 
 
2SO skew-boat 4.72 kcal mol-1 
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Table 2.2. DFT B3LYP/6-31G* minimum energy structures of thioglycosides β-2.2 
and β-2.3 with relative Gibbs free energies 
In the case of compound β-2.2, the standard 4C1 chair conformation is the most 
stable, whereas the axial-rich 1C4 chair and 
3,OB boat conformations lie 0.75 and 1.32 kcal 
mol-1, respectively, above the minimum energy structure, likely contributing to the 
conformational equilibrium. Interestingly, the axial-rich skew-boat conformation 3S1 was 
located by DFT calculations as the lowest energy minimum of the 3,4-OTIPS glucoside β-
2.3 (Figure 2.1), followed by the 1C4 chair at 2.24 kcal mol
-1. The computational data 
achieved for thioglycosides β-2.2 and β-2.3 match well the experimental trend, with the 
calculated coupling constant values of the most stable skew-boat conformation of β-2.3 
being very close to the experimental ones (See appendix, Table A-1 and A-2) 
 
Figure 2.1. DFT-optimized 3S1 skew-boat conformation of the 3,4-OTIPS 
thioglucoside β-2.3 (hydrogens and phenyl groups have been omitted for clarity in 
the ball and stick 3D-representation) 
To study the reactivity of thioglycoside β-2.2, the respective bromide 2.4 was 
generated by the reaction with Br2 following previously established reaction conditions.
26 
We theorized that the activation of superarmed donors with Br2 will allow us to investigate 
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whether the conformational superarming may offer additional stabilization modes to the 
anticipated β-bromide intermediate. When donors in the traditional 4C1 conformation are 
used for the synthesis of β-bromides, the latter are able to undergo conformational changes 
to adopt the axial or pseudoaxial orientation (Figure 2.2).43 Since this adopted 
conformation is unstable, the β-bromide equilibrates into the thermodynamically stable α-
counterpart and hence returns to its original 4C1 conformation. Conversely, if the starting 
donor is already present as a skew-boat, as determined for the conformationally superarmed 
donors, the formation of β-bromide will additionally reinforce the all-axial conformation. 
If the axial β-bromide is stabilized by the anomeric effect, as in compounds with the 
preferred 1C4 conformation (Figure 2.2), it will be both kinetically and thermodynamically 
stable and will not equilibrate (or will equilibrate much slower) into the α-counterpart. The 
analogy is found in Matsuda and Shuto’s study of xylose derivatives and their observation 
of altered anomeric effect and reversed stereoselectivity in glycosylations.44-45 However, 
the hexose chair is much more difficult to flip due to the CH2OR substituent at C-5 that has 
a strong propensity to reside equatorially.46 
 
Figure 2.2. Conformation and stereoselectivity of β-bromides 
Thus, bromide 2.4 obtained from 3,4-O-TBS donor β-2.2 was studied using a 300 
MHz NMR as depicted in Scheme 2.2. Molecular bromine was injected into a frozen 
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solution of the donor in CDCl3. The mixture was allowed to melt at -50 °C and then 
1H 
NMR spectra were recorded at different time points. The starting material has been 
completely consumed within the first 5 min of the reaction monitoring, as judged by 
disappearance of the diagnostic signal for H-2 at 3.42 ppm. The presence of both α- and β-
bromides 2.4 was also detected at this timepoint. The signal for H-1 at 6.50 ppm is 
diagnostic, but it cannot be used for quantifying the ratios of bromides because it coincides 
for both anomers. In this respect, reaction monitoring using more diagnostic signals at 3.94 
ppm for H-2, H-3 of β-2.4 and at 3.25 ppm for H-2 of α-2.4 was proven most convenient.  
As shown in Scheme 2.2, the anomeric mixture of bromides 2.4 has almost 
completely converted into the α-anomer at 30 min timepoint. Also evident at this timepoint 
is the presence of a decomposed by-product due to the anticipated partial loss of TBS 
protecting groups. This was an indication that the chosen starting β-thioglycoside is 
probably not the most suitable precursor for generating the β-bromide, even with the 
assistance of the TBS groups. It should be noted that we also attempted to convert 
thioglycoside β-2.3 into the corresponding bromide. Unfortunately, this attempt was largely 
unsuccessful due to a very rapid cleavage of TIPS groups the presence of Br2, perhaps due 
to a significant weakening of the O-Si bonds due to the steric congestion that these 
compounds experience.  
In the attempt of achieving a more stereocontrolled formation of the reactive β-
bromide intermediate, we turned our attention to investigating α-configured SEt donor. The 
analogy can be found in our previous study wherein superdisarmed α-SEt precursor 
produced the corresponding β-bromide predominantly.26 Starting from diol α-2.1, we 
obtained TBS and TIPS protected thioglycosides, α-2.2 and α-2.3, respectively. The 
Matteo Panza | UMSL 2019 | Page  149 
 
coupling constants calculated from their proton NMR spectra clearly demonstrated the 
conformational changes taking place. Thus, in the series of compounds α-2.1, α-2.2 and α-
2.3, the J2,3 value decreases from 9.5 to 7.4 to 3.7 Hz. Coupling constants J3,4 and J4,5 
behave similarly showing a steady decrease (Table 2.3). Differently from the β-series, no 
dramatic signal shifts were observed in the 1H and 13C NMR spectra of the α-series. As a 
matter of fact, the chemical shift difference between α-2.1 and α-2.2 is minimal, with 
somewhat more significant changes observed for α-2.3. This observation may be an 
indication of notable changes taking place upon transition from TBS to sterically more 
demanding TIPS groups. 
 
Scheme 2.2. Conversion of 3,4-di-O-TBS β-SEt glucoside β-2.2 into α,β-bromides 2.4 
The computational data for α-thioglycosides was also consistent with the 
experimental observations. Computational models of thioglycosides α-2.2 and α-2.3 were 
built by implementing the same protocol as that applied to the β-series. Only 4C1 and 
1C4 
chair conformations were located as minimum energy structures, showing the importance 
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of the axial-rich 1C4 chair geometry for compound α-2.3 always higher than that for α-2.2, 
according to both relative SCF DFT/B3LYP and Gibbs free energies (see appendix, Tables 
A-3 and A-4). 
To study the reactivity of this series of compounds, the NMR monitoring of the 
formation of anomeric bromide 2.4 from thioglycoside α-2.2 was conducted. The 
procedure used herein was the same as that applied to the β-counterpart of 2.2 (vide supra). 
After 5 minutes, only β-bromide 2.4 was detected. At the 10-minute timepoint, the 
intermediate is still largely β-2.4, and only a small peak at δ ≈ 3.3 ppm is indicating the 
beginning of the anomerization process to α-2.4. Only after 2 hours, the reactive bromide 
β-2.4 has completely anomerized to α-2.4.  
Computational models of α- and β-bromides 2.4 were built by implementing the 
same protocol applied for thioglycosides yet using the LACVP basis set due to the presence 
of bromine atoms. Only standard 4C1 chair conformations were achieved for compound α-
2.4, whereas a distorted 1,4B boat (or an unusual 4S2 skew-boat) conformation was located 
by DFT calculations as the lowest energy minimum of compound β-2.4 (Appendix, Tables 
A-5-2.-6). 
Having acquired the evidence of adequate stability of the reactive intermediate β-2.4, 
glycosidations of donor α-2.2 with model glycosyl acceptors were conducted. At first, 
when Br2 was added to the reaction mixture containing donor α-2.2 and a glycosyl acceptor 
at -50°C we observed that the formation of the desired disaccharide was accompanied by 
the formation of multiple by-products. These products were formed as a result of 
competing side reactions including hydrolysis and partial deprotection of the TBS groups. 
Therefore, to suppress the side reactions, we chose to add a sub-stoichiometric amount of 
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a base to each glycosylation reaction mixture. Three basic additives were investigated: 
triethylamine (TEA), N,N-diisopropylethylamine (DIPEA) and 1,8-diazabicycloundec-7-
ene (DBU), and all three provided comparable results. 
 
Cmpd Signal 1H NMR, ppm J, Hz 13C NMR, ppm 
α-2.1 H/C-1 5.44 (d) J1,2 = 5.4 82.69 
 H/C-2 3.64 (dd) J2,3 = 9.5 78.56 
 H/C-3 3.85 (t) J3,4 = 9.4 73.60 
 H/C-4 3.50 (t) J4,5 = 9.4 70.21 
 H/C-5 4.32 (ddd) 
J5,6a = 5.1 





J6a,6b = 12.1 63.98 
α-2.2 H/C-1 5.41 (d) J1,2 = 4.9 82.54 
 H/C-2 3.61 (dd) J2,3 = 7.4 79.25 
 H/C-3 3.96-3.93 (m) J3,4 = 6.0 73.92 
 H/C-4 3.65 (dd) J4,5 = 8.7 72.95 
 H/C-5 4.35-4.31 (m) 
J5,6a = 7.0 





J6a,6b = 11.5 64.52 
α-2.3 H/C-1 5.41 (d) J1,2 = 3.4 79.73 
 H/C-2 3.68 (t) J2,3 = 3.7 78.31 
 H/C-3 4.26-4.22 (m) J3,4 = 2.7 71.94 
 H/C-4 3.96 (dd) J4,5 = 4.9 71.39 
 H/C-5 4.42-4.37 (m) 
J5,6a = 7.9 





J6a,6b = 11.8 63.48 
 
Table 2.3.  NMR data for thioglycosides α-2.1-2.3 
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Under these reaction conditions, glycosidation of donor α-2.2 with primary 6-OH glycosyl 
acceptor 2.5 afforded the desired disaccharide 2.6 in high yields of 82-95% and with 
complete α-stereoselectivity (entry 1, Table 2.4). Glycosidation of donor α-2.2 with 
secondary 2-OH glycosyl acceptor 2.7 afforded the desired disaccharide 2.8 in good yields 
of 74-79% and with good α-stereoselectivity (α/β = 8-13/1, entry 2). Highly reactive 
aliphatic alcohols such as iPrOH, cyclohexanol, and benzyl alcohol were investigated, 
affording the target glucosides 2.9-2.11 in high yields 78-99%, albeit unremarkable 
stereoselectivity (α/β = 2-5/1, entries 3-5). This poor stereoselectivity may be a result of a 
direct displacement of the anomeric α-bromide with powerful nucleophiles that does not 
take place with sugar acceptors. 3,4-OTIPS protected donor α-2.3 provided a similar 
reactivity trend, summarized in Table 2.5, but its glycosidations were compromised by the 
competing silyl group cleavage, even in the presence of a base (see the experimental for 
additional experimental data). 
 
2.3. Conclusions 
We expanded the application of Br2-mediated glycosidation of thioglycosides to 
glycosyl donors of the superarmed series. Over the course of this study, we investigated 
the formation of the reactive intermediates that were monitored and characterized by NMR 
spectroscopic techniques. An extensive conformational analysis of the donor through 
coupling constants values and carbon-hydrogen correlation was performed. Furthermore, 
the stability of β-bromide in solution over time was studied using NMR. The experimental 
data are supported by the molecular mechanic calculations and the DFT studies. 
Glycosylation reactions were performed with a group of standard acceptors, achieving high 
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yields and high to complete stereoselectivity sugar acceptors. These results complement 
our other recent studies dedicated to the activation of glycosyl halides.47-50 
 



















































Table 2.4. Glycosidation of 3,4-O-TBS donor α-2.2 
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Table 2.5. Reactions of 3,4-O-TIPS donor 
 






















































2.4.1. General experimental 
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were removed 
under reduced pressure at <40 °C. CH2Cl2 was distilled from CaH2 directly prior to 
application. Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated 
in vacuo at 390 °C for 16 h in the first instance and then for 2-3 h at 390 °C directly prior 
to application. Optical rotations were measured at ‘Jasco P-2000’ polarimeter. Unless noted 
otherwise, 1H NMR spectra were recorded in CDCl3 at 300 or 600 MHz, 
13C NMR spectra 
were recorded in CDCl3 at 75 or 151 MHz. HRMS determinations were made with the use 
of a mass spectrometer with FAB ionization and ion-trap detection. 
 
2.4.2. Synthesis of glycosyl donors and acceptors 
 
Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-D-glucopyranoside (α-2.1).  Et3N (12 mL) was 
added to a stirring solution of ethyl 2-O-benzyl-1-thio-α-D-glucopyranoside37 (2.17, 560 
mg, 1.8 mmol) in MeCN (25 mL). The resulting solution was cooled at -30 °C, a solution 
of BzCN (237 mg, 1.9 mmol) in MeCN (20 mL) was added, and the resulting mixture was 
stirred for 2 h at -30 °C. After that, the reaction was quenched with MeOH (~ 2 mL), and 
the volatiles were removed in vacuo. The residue was purified by column chromatography 
on silica gel (hexanes-ethyl acetate gradient elution) to give the title compound as a white 
amorphous solid in 70% yield (527 mg). Analytical data for α-2.1: Rf = 0.6 
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(methanol/DCM, 1/9, v/v); []D
22 +151.3 (c 1, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 
8.01-8.06 (m, 2H, aromatic), 7.56 (dd, 1H, J = 10.6, 4.3 Hz, aromatic), 7.43 (t, 2H, J = 7.8 
Hz, aromatic), 7.39 (d, 2H, J = 7.0 Hz, aromatic), 7.35 (dd, 2H, J = 10.1, 4.7 Hz, aromatic), 
7.31 (dd, J = 8.3, 6.0 Hz, 1H, aromatic), 5.44 (d, 1H, J1,2 = 5.4 Hz, H-1), 4.73 (d, 1H, 
2J = 
11.4 Hz, CH2Ph), 4.69 (dd, 1H, J6a,6b = 12.1 Hz, H-6a), 4.49-4.55 (m, 2H, H-6b, CH2Ph), 
4.32 (ddd, 1H, J5,6a = 1.9 Hz, J5,6b = 5.1 Hz, H-5), 3.85 (dd, 1H, H-3), 3.64 (dd, 1H, J2,3 = 
9.5 Hz, H-2), 3.50 (dd, 1H, J3,4 = J4,5 = 9.4 Hz, H-4), 3.17 (s, 1H, OH), 2.97 (s, 1H, OH), 
2.55 (m, 2H, CH2CH3), 1.26 (t, 3H, J = 7.4 Hz, CH2CH3) ppm; 
13C NMR (151 MHz, 
CDCl3): δ, 167.06 (C=O), 137.41 (aromatic), 133.34 (aromatic), 129.89 (x2, aromatic), 
129.83 (aromatic), 128.67 (x2, aromatic), 128.51 (x2, aromatic), 128.39 (x2, aromatic), 
128.30 (aromatic), 82.69 (C-1), 78.56 (C-2), 73.60 (C-3), 72.10 (CH2Ph), 70.21 (C-4), 
69.86 (C-5), 63.98 (C-6), 23.95 (CH2CH3), 14.89 (CH2CH3) ppm; HR-FAB MS [M+Na]
+ 
calcd for C22H26NaO6S
+ 441.1348, found 441.1338. 
 
Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-1-thio-α-D-
glucopyranoside (α-2.2).  TBSOTf (1.8 mL, 8.1 mmol) was added to a solution of α-2.1 
(1.35 g, 3.2 mmol) in 2,6-lutidine (12 mL) and the resulting mixture was stirred for 16 h at 
100 °C. After that, the reaction mixture was diluted with DCM (~100 mL) and washed 
successively with 1 M HCl (3 x 10 mL), sat. aq. NaHCO3 (3 x 10 mL), and water (3 x10 
mL). The organic layer was separated, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (hexanes-ethyl acetate 
gradient elution) to afford the title compound as a colorless syrup in 99% yield (2.05 g). 
Analytical data for α-2.2: Rf = 0.8 (ethyl acetate/hexane, 1/4, v/v); []D22 +97.8 (c 1, 
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CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 8.08-8.03 (m, 2H, aromatic), 7.56 (t, J = 7.4 Hz, 
1H, aromatic), 7.43 (dd, J = 14.1, 7.3 Hz, 4H, aromatic), 7.33 (t, J = 7.4 Hz, 2H, aromatic), 
7.28 (t, J = 7.3 Hz, 1H, aromatic), 5.41 (d, J1,2 = 4.9 Hz, 1H, H-1), 4.63 (d, 
2J = 11.3 Hz, 
1H, CH2Ph), 4.59 (dd, J5,6a = 2.1, J6a,6b = 11.5 Hz, 1H, H-6a), 4.55 (d, 1H, CH2Ph), 4.38 
(dd, J5,6b = 7.0 Hz, 1H, H-6b), 4.35-4.31 (m, 1H, H-5), 3.95 (m, J3,4 = 8.7 Hz, 1H, H-3), 
3.65 (dd, J4,5 = 6.0 Hz, 1H, H-4), 3.61 (dd, J2,3 = 7.4 Hz, 1H, H-2), 2.61-2.49 (m, 2H, 
CH2CH3), 1.21 (t, J = 7.4 Hz, 3H, CH2CH3), 0.92 (s, 9H, Si
tBu), 0.86 (s, 9H, SitBu), 0.15 
(s, 3H, SiMe), 0.10 (s, 3H, SiMe), 0.04 (s, 3H, SiMe), 0.00 (s, 3H, SiMe) ppm; 13C NMR 
(151 MHz, CDCl3): δ, 166.51 (C=O), 137.79 (aromatic), 133.08 (aromatic), 130.22 
(aromatic), 129.76 (x2, aromatic), 128.46 (x2, aromatic), 128.43 (x2, aromatic), 128.30 
(x2, aromatic), 127.87 (aromatic), 82.49 (C-1), 79.19 (C-2), 73.86 (C-3), 72.90 (C-4), 72.50 
(CH2Ph), 71.60 (C-5), 64.47 (C-6), 26.42 (x3, SiC(CH3)3), 26.20 (x3, SiC(CH3)3), 23.75 
(CH2CH3), 18.33 (SiC(CH3)3), 18.23 (SiC(CH3)3), 14.86 (CH2CH3), -2.60 (SiMe), -2.80 
(SiMe), -3.38 (SiMe), -4.15 (SiMe) ppm; HR-FAB MS [M+Na]+  calcd for 
C34H54NaO6SSi2
+  669.3072, found 669.3082. 
 
Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-triisopropylsilyl-α-D-glucopyranoside 
(α-2.3).  TIPSOTf (1.46 mL, 5.4 mmol) was added dropwise to a solution α-2.1 (450 mg, 
1.08 mmol) in 2,6-lutidine (8.0 mL) and the resulting mixture was stirred for 16 h at 100 
°C. After that, the reaction mixture was diluted with DCM (~50 mL) and washed 
successively with 1 M aq. HCl (3 x 10 mL), NaHCO3 (3 x 10 mL) and water (3 x 10 mL). 
The organic layer was separated, dried with MgSO4, and concentrated in vacuo. The 
residue purified by column chromatography on silica gel (hexanes-ethyl acetate gradient 
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elution) to obtain the title compound as a colorless syrup in 99% yield (782 mg). Analytical 
data for α-2.3: Rf = 0.8 (ethyl acetate/hexane, 1/4, v/v); []D
23 +58.1 (c 0.7, CHCl3); 
1H 
NMR (600 MHz, CDCl3): δ, 8.06 (d, J = 8.1 Hz, 2H, aromatic), 7.57-7.53 (m, 1H, 
aromatic), 7.42 (dd, J = 15.1, 7.4 Hz, 4H, aromatic), 7.31 (t, J = 7.6 Hz, 2H, aromatic), 
7.25 (dd, J = 10.2, 4.0 Hz, 1H, aromatic), 5.41 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.74 (dd, J5,6a = 
7.9, J6a,6b = 11.8 Hz, 1H, H-6a), 4.70-4.63 (m, 2H, CH2Ph), 4.45 (dd, J5,6b = 3.4 Hz, 1H, H-
6b), 4.42-4.37 (m, 1H, H-5), 4.26-4.22 (m, J3,4 = 2.7 Hz, 1H, H-3), 3.96 (dd, J4,5 = 4.9 Hz, 
1H, H-4), 3.68 (dd, J2,3 = 3.7 Hz, 1H, H-2), 2.71-2.59 (m, 2H), 1.23 (t, J = 7.4 Hz, 3H), 
1.10-1.01 (m, 42H) ppm; 13C NMR (151 MHz, CDCl3): δ, 166.53 (C=O), 138.08 
(aromatic), 133.06 (aromatic), 130.20 (aromatic), 129.81 (x2, aromatic), 128.37 (x2, 
aromatic), 128.17 (x2, aromatic), 127.82 (x2, aromatic), 127.56 (aromatic), 79.73 (C-1), 
78.31 (C-2), 75.12 (C-5), 72.49 (CH2Ph), 71.94 (C-3), 71.39 (C-4), 63.48 (C-6), 24.81 
(CH2CH3), 18.40 (x3, iPr), 18.32 (x3, iPr), 18.30 (x3, iPr), 18.29 (x3, iPr), 17.83 (iPr), 
15.13 (CH2CH3), 12.97(x2, iPr), 12.77(x2, iPr), 12.40 (iPr) ppm; HR-FAB MS [M+Na]
+  
calcd for C34H54NaO6SSi2
+  753.4016, found 753.4031. 
 
Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranoside (β-2.1) was synthesized in 
accordance with the reported procedure37 and its analytical data were in accordance with 
that previously described.37 Selected analytical data for β-2.1: 1H NMR (600 MHz, CDCl3): 
δ, 8.06 (d, J = 8.0 Hz, 2H, aromatic), 7.58 (t, J = 7.4 Hz, 1H, aromatic), 7.45 (t, J = 7.1 Hz, 
2H, aromatic), 7.42-7.27 (m, J = 30.7, 16.7, 7.4 Hz, 5H, aromatic), 4.97 (d, 2J = 11.0 Hz, 
1H, CH2Ph), 4.69-4.62 (m, 2H, H-6a, CH2Ph), 4.57 (br d, J6a,6b = 12.1 Hz, 1H, H-6b), 4.51 
(d, J1,2 = 9.7 Hz, 1H, H-1), 3.63 (dd, J3,4 = 8.7 Hz, 1H, H-3), 3.59-3.55 (m, 1H, H-5), 3.47 
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(dd, J4,5 = 9.2 Hz, 1H, H-4), 3.28 (dd, J2,3 = 9.2 Hz, 1H, H-2), 3.09 (br s, 1H, OH), 2.82-
2.69 (m, 2H, CH2CH3), 2.66 (br s, 1H, OH), 1.32 (t, J = 7.4 Hz, 3H, CH2CH3) ppm; 
13C 
NMR (151 MHz, CDCl3): δ, 167.26 (C=O), 138.03 (aromatic), 133.44 (aromatic), 129.99 
(x2, aromatic), 129.76 (aromatic), 128.78 (x2, aromatic), 128.54 (x2, aromatic), 128.49 
(x2, aromatic), 128.32 (aromatic), 85.06 (C-1), 80.87 (C-2), 77.95 (C-3), 77.82 (C-5), 75.30  
(CH2Ph), 70.13 (C-4), 64.16 (C-6), 25.32 (CH2CH3), 15.26 (CH2CH3). 
 
Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-1-thio-β-D-
glucopyranoside (β-2.2) was synthesized in accordance with the reported procedure and 
its analytical data were in accordance with that previously described.36  Analytical data for 
β-2.2: Rf = 0.8 (ethyl acetate/hexane 1/4 v/v); 
1H NMR (600 MHz, CDCl3): δ, 8.09-8.01 
(m, 2H, aromatic), 7.56 (t, J = 7.4 Hz, 1H, aromatic), 7.48-7.27 (m, 7H, aromatic), 4.87-
4.77 (m, 2H, J1,2 = 8.4 Hz, H-1, ½ CH2Ph), 4.68 (d, 
2J = 11.2 Hz, 1H, CH2Ph), 4.61 (dd, 
J5,6a = 4.9, J6a,6b = 11.3 Hz, 1H, H-6a), 4.41 (dd, J5,6b = 7.4 Hz, 1H, H-6b), 3.97-3.91 (m, 
1H, H-5), 3.91-3.86 (m, J3,4 = 5.0 Hz, 1H, H-3), 3.80 (dd, J4,5 = 5.0 Hz, 1H, H-4), 3.42 (dd, 
J2,3 = 3.9 Hz, 1H, H-2), 2.83-2.61 (m, 2H, CH2CH3), 1.28 (t, J = 7.4 Hz, 3H, CH2CH3), 
0.92 (s, 9H, SitBu), 0.89 (s, 9H, SitBu), 0.11 (s, 3H, SiMe), 0.09 (s, 6H, SiMe2), 0.05 (s, 
3H, SiMe) ppm; 13C NMR (151 MHz, CDCl3): δ, 166.34 (C=O), 138.42 (aromatic), 133.09 
(aromatic), 130.19 (aromatic), 129.74 (x2, aromatic), 128.43 (x2, aromatic), 128.26 (x2, 
aromatic), 127.71 (x2, aromatic), 127.56 (aromatic), 82.81 (C-1), 82.50 (C-2), 79.41 (C-
5), 76.44 (C-3), 73.51 (CH2Ph), 71.68 (C-4), 65.52 (C-6), 26.31 (x3, SiC(CH3)3), 26.06 
(x3, SiC(CH3)3), 25.37 (CH2CH3), 18.20 (SiC(CH3)3), 18.14 (SiC(CH3)3), 15.21 
(CH2CH3), -3.30 (SiMe), -3.41 (SiMe), -3.89 (SiMe), -4.26 (SiMe) ppm.   




(β-2.3) was obtained in 99% yield (amount) as described for the synthesis of α-2.3. 
Analytical data for β-2.3: Rf = 0.7 (ethyl acetate/hexane 1/4 v/v); []D
23 -7.0 (c 1, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 8.04 (d, J = 8.0 Hz, 2H, aromatic), 7.56 (t, J = 7.4 Hz, 1H, 
aromatic), 7.43 (t, J = 7.1 Hz, 2H, aromatic), 7.36-7.23 (m, 5H, aromatic), 5.05 (d, J1,2 = 
8.5 Hz, 1H, H-1), 4.91 (d, 2J = 11.3 Hz, 1H, ½ CH2Ph), 4.66-4.59 (m, 2H, J5,6a = 6.6 Hz, 
H-6a, ½ CH2Ph), 4.50 (dd, J5,6b = 6.6 Hz, J6a,6b = 11.0, 1H, H-6b), 4.27 (br s, 1H, H-4), 4.24 
(dd, 1H, H-5), 4.16 (d, J3,4 = 3.0 Hz, 1H, H-3), 3.60 (d, 1H, H-2), 2.83-2.68 (m, 2H), 1.32 
(m, J = 7.4, 1.5 Hz, 3H, CH2CH3), 1.08 (s, 21H), 1.01 (m, 21H) ppm; 
13C NMR (151 MHz, 
CDCl3): δ, 166.39 (C=O), 138.74 (aromatic), 133.05 (aromatic), 130.28 (aromatic), 129.80 
(x2, aromatic), 128.37 (x2, aromatic), 128.10 (x2, aromatic), 127.75 (x2, aromatic), 127.38 
(aromatic), 83.09 (C-2), 81.23 (C-1), 80.79 (C-5), 75.71 (C-4), 73.62 (CH2Ph), 70.89 (C-
3), 66.13 (C-6), 25.27 (CH2CH3), 18.31 (x3, iPr), 18.24 (x3, iPr), 18.15 (x6, iPr), 15.32 
(CH2CH3), 12.48 (x3, iPr), 12.33 (x3, iPr) ppm; HR-FAB MS [M+Na]
+  calcd for 
C34H54NaO6SSi2
+  753.4016, found 753.4025. 
 
Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.5) was synthesized in accordance 
with the reported procedure and its analytical data was in accordance with that previously 
described.58-59 
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Methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.7) was synthesized in accordance 
with the reported procedure and its analytical data was in accordance with that previously 
described.58-59 
 
2.4.3. Synthesis of glycosides 
General glycosylation procedure.  A mixture of a glycosyl donor (0.046 mmol), 
glycosyl acceptor (0.046 mmol), and freshly activated molecular sieves (3 Å, 120 mg) in 
CH2Cl2 (2.0 mL) was stirred under argon for 3 h at rt. The mixture was cooled to -50 °C, 
Br2 (0.092 mmol, 15.0 µL) and a base (0.014 mmol) were added and the resulting mixture 
was stirred for 5 min. After that, the reaction mixture was allowed to warm to rt and stirred 
for additional 16 h. Triethylamine (~0.1 mL) was added, the solid was filtered off and 
rinsed successively with CH2Cl2. The combined filtrate (~60 mL) was concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (toluene-ethyl 
acetate gradient elution) to afford the corresponding glycoside. 
 
Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6) was prepared as a 
colorless syrup from donor α-2.2 and acceptor 2.5 in accordance with the general procedure 
in the presence of TEA, DBU or DIPEA in 82, 95 or 95% yield, respectively. Analytical 
data for 2.6: Rf = 0.65 (ethyl acetate/toluene, 1/9, v/v); []D
24 +83.9 (c 1, CHCl3); 
1H NMR 
(300 MHz, CDCl3): δ, 8.00 (d, J = 7.6 Hz, 2H, aromatic), 7.53 (t, J = 7.3 Hz, 1H, aromatic), 
7.43-7.14 (m, 24H, aromatic), 4.96 (d, 2J = 11.0 Hz, 1H, CH2Ph), 4.90-4.74 (m, 3H, CH2Ph, 
H-1’), 4.68 (d, 2J = 12.0 Hz, 1H, ½ CH2Ph), 4.64-4.43 (m, 6H, H-1, 6b’, 2 x CH2Ph,), 4.24 
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(dd, J5’,6a’ = 6.7 Hz, J6a’,6b’= 11.5, 1H, H-6a’), 4.06-3.89 (m, J3’,4’= 9.2 Hz 3H, H-3, 3’, 5), 
3.79-3.68 (m, 2H, H-5, 6b), 3.59-3.49 (m, 2H, H-4, 6a), 3.44 (dd, J4’,5’= 9.2 Hz, 1H, H-4’), 
3.40-3.22 (m, 5H, H-2, 2’, OCH3), 0.89 (s, 9H, Si
tBu), 0.85 (s, 9H, SitBu), 0.13 (s, 3H, 
SiMe), 0.10 – -0.06 (m, 9H, 3x SiMe); 13C NMR (151 MHz, CDCl3): δ, 166.4, 139.1, 138.5, 
138.4, 133.0, 130.4, 129.8, 128.5 (x3), 128.4 (x2), 128.2, 128.1, 128.0, 127.8 (x2), 127.7, 
127.6, 98.0, 96.4, 82.3, 80.4 (x2), 78.4, 77.4, 77.2, 77.0, 75.7, 75.2, 74.1, 73.5, 73.1, 72.5, 
71.0, 70.4, 65.8, 64.4, 55.1, 26.8, 26.4, 18.6, 18.3, 0.1, -2.0, -2.1, -2.8, -3.9 ppm; HR-FAB 
MS [M+Na]+  calcd for C60H80NaO12Si2
+  1071.5086, found 1071.5088. 
 
Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-
glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8) was prepared as a 
colorless syrup from donor α-2.2 and acceptor 2.7 in accordance with the general procedure 
in the presence of TEA, DBU or DIPEA in 79, 74 or 74% yield, respectively. Selected 
analytical data for α-2.8: Rf = 0.6 (ethyl acetate/toluene, 1/9, v/v); 
1H NMR (300 MHz, 
CDCl3) δ, 8.10-8.04 (m, 2H, aromatic), 7.47-7.10 (m, 29H, aromatic), 5.25 (d, J1’,2’ = 3.4 
Hz, 1H, H-1’), 5.11 (d, 2J = 11.0 Hz, 1H, ½ CH2Ph), 4.99 (d, J1,2 = 3.2 Hz, 1H, H-1), 4.84-
4.38 (m, 10H, H-6a’, 4 ½ CH2Ph), 4.22 (dd, J6a’,6b’= 11.4, J5’,6b’= 7.0 Hz, 1H, H-6b’), 4.14-
3.93 (m, 5H, H-2’, 3, 3’, 4, 5’), 3.83-3.76 (m, 1H, H-6a), 3.69 (br s, 1H, H-6b), 3.61-3.47 
(m, 2H, H-4’, 5), 3.42 (dd, J2,3 = 9.0 Hz, 1H, H-2), 3.27 (s, 3H, OCH3), 0.89 (s, 10H, Si
tBu), 
0.82 (s, 9H, SitBu), 0.15 (s, 3H, SiMe), 0.09 (d, J = 2.9 Hz, 5H, SiMe), -0.04 (m, 6H, 2 x 
SiMe); 13C NMR (151 MHz, CDCl3) δ 166.5, 138.8, 138.5, 138.3, 138.1, 133.0, 130.3, 
129.9, 128.6, 128.5, 128.4, 128.2, 128.0, 127.9, 127.8 (x3), 127.7 (x2), 127.6, 96.4, 91.8, 
81.2, 79.4, 77.8, 75.8, 75.2, 74.6, 74.5, 73.6, 72.9, 71.4, 71.3, 70.4, 69.1, 64.6, 54.8, 26.7, 
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26.4, 18.5, 18.3, 0.1, -2.0, -2.2, -2.9, -3.9 ppm; Selected analytical data for β-2.8: Rf = 0.6 
(ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 3.36 (s, 3H, OCH3) ppm; 
13C NMR (151 MHz, CDCl3): δ, 103.2, 100.2, 83.4, 81.4, 80.9, 78.3, 77.8, 76.0, 75.4, 75.1, 
73.7, 73.0, 71.5, 70.1, 69.0, 65.6 ppm; HR-FAB MS [M+Na]+  calcd for C60H80NaO12Si2
+  
1071.5086, found 1071.5081. 
 
Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-
glucopyranoside (2.9) was prepared as a colorless syrup from donor α-2.2 and isopropanol 
in accordance with the general procedure in the presence of TEA, DBU or DIPEA in 99, 
94 or 94% yield, respectively. Selected analytical data for α-2.9: Rf = 0.7 (ethyl acetate/ 
toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.91 (d, 1H, J1,2 = 3.5 Hz, H-1), 3.55 
(dd, 1H, J4,5 = 8.1 Hz, H-4), 3.30 (dd, 1H, J2,3 = 9.2 Hz, H-2) ppm; 
13C NMR (151 MHz, 
CDCl3): δ, 95.0 (C-1) ppm. Selected analytical data for β-2.9: Rf = 0.7 (ethyl 
acetate/toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.75 (d, 1H, J1,2 = 7.2 Hz, H-1); 
13C NMR (151 MHz, CDCl3): δ, 101.0 (C-1) ppm; HR-FAB MS [M+Na]
+ calcd for 
C35H56NaO7Si2
+ 667.3457, found 667.3469. 
 
Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-
glucopyranoside (2.10) was prepared as a colorless syrup from donor α-2.2 and 
cyclohexanol in accordance with the general procedure in the presence of TEA, DBU or 
DIPEA in 99, 78 or 78% yield, respectively. Selected analytical data for α-2.10: Rf = 0.8 
(ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.96 (d, J1,2 = 3.4 Hz, 1H, 
H-1), 4.65 (dd, J5,6a = 2.1 Hz, J6a,6b= 11.5, 1H, H-6a), 4.27 (dd, J5,6b = 7.6 Hz, 1H, H-6b), 
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4.02 (dd, J3,4 = 9.5 Hz, 2H, H-3, 5), 3.52 (dd, J4,5 = 8.3 Hz, 1H, H-4), 3.30 (dd, J2,3 = 9.2 
Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 96.4 (C-1) ppm. Selected analytical 
data for β-2.10: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 MHz, CDCl3): δ, 
4.74 (d, J1,2 = 7.2 Hz, 1H, H-1) ppm; 
13C NMR (151 MHz, CDCl3): δ, 100.8 (C-1) ppm; 
HR-FAB MS [M+Na]+  calcd for C38H60NaO7Si2
+  707.3775, found 707.3779. 
 
Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-
glucopyranoside (2.11) was prepared as a colorless syrup from donor α-2.2 and benzyl 
alcohol in the presence of TEA, DBU or DIPEA in 99, 81 or 84% yield, respectively. 
Selected analytical data for α-2.11: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 
MHz, CDCl3): δ, 4.83 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.09  (m, J4,5 = 9.2 Hz, 1H, H-4), 4.00 
(m, J5,6a = 6.9, J5,6b = 2.1 Hz, 3H, H-5), 3.59 (dd, J3,4 = 8.0 Hz, 1H, H-3), 3.36 (dd, J2,3= 9.1 
Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 95.4 (C-1), 64.6 (C-6) ppm.  Selected 
analytical data for β-2.11: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, 
CDCl3): δ, 4.80 (d, J1,2= 6.8 Hz, 1H, H-1), 3.93-3.86 (m, 1H, H-4), 3.84-3.73 (m, 2H, H-3, 
5), 3.44 (dd, J2,3 = 4.8 Hz, 1H, H-2) ppm; 
13C NMR (151 MHz, CDCl3): δ, 100.7 (C-1), 
65.4 (C-6) ppm; HR-FAB MS [M+Na]+  calcd for C39H56NaO7Si2




2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12) was prepared as a colorless syrup from 
donor α-2.3 and acceptor 2.5 in the presence of TEA, DBU or DIPEA in 81, 70 or 68% 
yield, respectively. Analytical data for α-2.12: Rf = 0.7 (ethyl acetate/ toluene, 1/9, v/v); 
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[]D
24 +58.7 (c 1, CHCl3); 
1H NMR (300 MHz, CDCl3): δ, 8.01 (d, J = 7.4 Hz, 2H, 
aromatic), 7.53 (t, J = 7.3 Hz, 1H, aromatic), 7.43-7.13 (m, 23H, aromatic), 5.09 (d, J1’,2’ = 
2.2 Hz, 1H, H-1’), 4.95 (d, 2J = 11.1 Hz, 1H, ½ CH2Ph), 4.86-4.64 (m, 5H, 2 ½ CH2Ph), 
4.61-4.42 (m, 5H, J1,2 = 3.5 Hz, H-1, 6a’, 6b’, CH2Ph), 4.24-4.17 (m, 1H, H-5’), 4.17-4.10 
(m, 1H, H-3’), 4.05-3.90 (m, 2H, H-3, 5), 3.86-3.79 (m, 1H, H-4’), 3.71 (dd, J5,6a = 2.7, 
J6a,6b = 9.4 Hz, 1H, H-6a), 3.66-3.53 (m, 2H, H-4, 6b), 3.53-3.46 (m, 1H, H-2’), 3.36 (dd, 
J2,3 = 9.5 Hz, 1H, H-2), 3.29 (s, 3H, OCH3), 1.02 (m, 42H, 2 x SiiPr3) ppm; 
13C NMR (151 
MHz, CDCl3): δ, 166.5, 139.2, 138.7, 138.6, 138.4, 133.1, 130.3, 129.8, 128.5, 128.5, 
128.2, 128.1, 128.0 (x 2), 127.9 (x 2), 127.7, 127.6, 127.5, 98.2, 95.5, 82.2, 80.3, 78.2, 
78.1, 77.4, 77.2, 77.0, 75.7, 75.3, 74.3, 74.1, 73.6, 72.5, 72.0, 70.5, 65.9, 63.9, 55.1, 29.8, 
18.5, 18.4, 18.4, 18.3, 13.5, 13.3, 0.1 ppm; HR-FAB MS [M+Na]+  calcd for 
C66H92NaO12Si2
+  1155.6025, found 1155.6021. 
 
 Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-
glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13) was prepared as a 
colorless syrup from donor α-2.3 and acceptor 2.7 in the presence of TEA, DBU or DIPEA 
in 24, 50 or 35% yield, respectively. Selected analytical data for α-2.13: Rf = 0.6 (ethyl 
acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.33 (d, J1’,2’ = 3.3 Hz, 1H, H-
1’), 4.99 (d, J1,2 = 2.7 Hz, 1H, H-1), 3.28 (s, 3H, OCH3) ppm.  Selected analytical data for 
β-2.13: Rf = 0.6 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.23 (d, 
J1’,2’ = 6.4 Hz, 1H, H-1’), 5.07 (d, J1,2 = 3.5 Hz, 1H, H-1), 3.36 (s, 3H, OCH3) ppm; HR-
FAB MS [M+Na]+ calcd for C66H92NaO12Si2
+  1155.6025, found 1155.6029. 
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Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-glucopyranoside 
(2.14) was prepared as a colorless syrup from donor α-2.3 and isopropyl alcohol in the 
presence of TEA, DBU or DIPEA in 99, 70 or 72% yield, respectively. Selected analytical 
data for α-2.14: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 MHz, CDCl3): δ, 
5.12 (d, J1,2 = 2.9 Hz, 1H, H-1), 3.45 (dd, J2,3 = 6.4 Hz, 1H, H-2) ppm: 
13C NMR (151 MHz, 
CDCl3): δ, 93.8 (C-1) ppm.  Selected analytical data for β-2.14: Rf = 0.8 (ethyl acetate/ 
toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.17 (d, J1,2 = 6.7 Hz, 1H, H-1), 3.54 (d, 
1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 99.2 (C-1) ppm; HR-FAB MS [M+Na]
+  
calcd for C41H68NaO7Si2
+  751.4396, found 751.4402. 
 
Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-glucopyranoside 
(2.15) was prepared as a colorless syrup from donor α-2.3 and cyclohexyl alcohol in the 
presence of TEA, DBU or DIPEA in 99, 74 or 86% yield, respectively. Selected analytical 
data for α-2.15: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 MHz, CDCl3): δ, 
5.17 (d, J1,2 = 3.0 Hz, 1H, H-1), 3.79 (dd, J3,4 = 7.0, J4,5 = 5.2 Hz, 1H, H-4), 3.45 (dd, J2,3 = 
6.6 Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 93.4 (C-1) ppm.  Selected 
analytical data for β-2.15: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, 
CDCl3): δ, 5.20 (d, J1,2 = 6.5 Hz, 1H, H-1), 3.53 (m, 1H, H-2) ppm; 
13C NMR (151 MHz, 
CDCl3): δ, 98.7 (C-1) ppm; HR-FAB MS [M+Na]
+ calcd for C44H72NaO7Si2




(2.16) was prepared as a colorless syrup from donor α-2.3 and benzyl alcohol in the 
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presence of TEA, DBU and DIPEA in 99, 61 or 44% yield, respectively. Selected analytical 
data for α-2.16: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 MHz, CDCl3): δ, 
5.03 (d, J1,2 = 2.9 Hz, 1H, H-1), 4.85 (d, 
2J = 12.4 Hz, 1H, ½ CH2Ph), 4.67 (d, 
2J = 11.8 Hz, 
1H, ½ CH2Ph), 4.61-4.45 (m, 4H, H-6a, 6b, CH2Ph), 4.25 (m, 1H, H-5), 4.14 (dd, J3,4 = 4.5 
Hz, 1H, H-3), 3.85 (dd, J4,5 = 6.4 Hz, 1H, H-4), 3.51 (dd, J2,3 = 6.0 Hz, 1H, H-2) ppm; 
13C 
NMR (151 MHz, CDCl3): δ, 94.2 (C-1), 64.2 (C-6) ppm.  Selected analytical data for β-
2.16: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 
1H NMR (300 MHz, CDCl3): δ, 5.14 (d, J1,2 
= 6.4 Hz, 1H, H-1), 4.94 (d, 2J = 12.0 Hz, 1H, ½ CH2Ph), 4.79 (d, 
2J = 11.7 Hz, 1H, ½ 
CH2Ph), 4.71-4.61 (m, 2H, H-6b, ½ CH2Ph), 4.61-4.52 (m, 2H, H-6a, ½ CH2Ph), 4.27 (m, 
J5,6a = J5,6b = 6.8 Hz, 1H, H-5), 4.16 (d, J3,4 = 3.3 Hz, 1H, H-3), 4.10 (d, 1H, H-4), 3.62 (d, 
1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 99.8 (C-1), 66.0 (C-6) ppm; HR-FAB MS 
[M+Na]+ calcd for C45H68NaO7Si2
+  799.4396, found 799.4413. 
 
2.4.4. NMR studies of reaction intermediates 
NMR studies were performed at 300 MHz. Molecular bromine (2.0 eq) was injected 
into a frozen solution of the donor (15 mg) in CDCl3. The mixture was allowed to melt at 
-50 °C and then 1H NMR spectra were recorded at different time points. 
 
2.4.5. Computational studies 
 
All calculations were run using the Schrödinger suite of programs through the 
Maestro graphical interface.51 A protocol that relies on the following steps was 
implemented to identify representative minimum-energy geometries. 
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Molecular Mechanics calculations. Monte Carlo/energy minimization (MC/EM) 
conformational searches52 of thioglycosides β-2.2, β-2.3, α-2.2 and α-2.3 and of Br 
derivatives β-2.4 and α-2.4 were performed as the first step within the framework of 
MacroModel version 11.1,53 using the OPLS2005 force field54 and the implicit water or 
chloroform GB/SA solvation model,55 to generate starting geometries for subsequent DFT 
calculations. The torsional space of each glycoside was randomly varied with the usage-
directed Monte Carlo conformational search. A ring-closure bond was defined in the six-
membered pyranose ring. For each search, at least 1000 starting structures for each variable 
torsion angle were generated and minimized until the gradient was <0.05 kJÅ-1mol-1 using 
the truncated Newton–Raphson algorithm.56 Duplicate conformations and those with 
energy >6 kcalmol-1 above the global minimum were discarded. 
DFT optimization and thermochemical analysis. Representative structures 
obtained from the above-described conformational search (sampling both the pyranose ring 
conformations and the substituent orientations) were fully optimized with DFT calculations 
at the B3LYP/6-31G* level (β-2.2, β-2.3, α-2.2 and α-2.3) or at the B3LYP/LACVP level 
(β-2.4 and α-2.4) of theory using the Jaguar version 9.1.57 Default convergence criteria 
were employed. The obtained stationary points were confirmed as minima by frequency 
calculation at the same level of theory and their thermochemical properties, including the 
final total Gibbs free energy, were computed. The relative energies (both SCF Energy 
DFT/B3LYP and Total Gibbs free energy) of the most stable conformations located by the 
DFT calculations for the pyranose ring in each compound are reported in Tables A-1 to A-
6. The structures are characterized by the values of the four pyranose HCCH dihedral 
angles and the corresponding vicinal 3J HCCH calculated by Schrodinger Maestro V16. 
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oligosaccharide synthesis: the 
implementation of the two-way split 
valve as a mode of complete 
automation 
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3.1. Introduction 
With improved understanding of functions of glycans, the demand for robust 
methods to produce both natural glycans and their mimetics has increased.1-2 Traditional 
glycan synthesis in solution involves reiteration of glycosylation-deprotection steps, with 
aqueous work-up to remove excess reagents after most steps, and purification of most 
intermediates. Many advanced strategies that streamline oligosaccharide synthesis are 
based on either chemoselective or selective activation of building blocks.3 Fraser-Reid’s 
armed-disarmed,4-5 Danishefsky’s,6 Roy’s7 and Boons’8 active-latent, Ogawa-Ito’s 
orthogonal,9-10 Ley’s tunable,11-12 Wong’s programmable,13-14 and Huang-Ye’s 
preactivation15 are among the most effective strategies known for glycan synthesis in 
solution. Nevertheless, there is still no universal synthetic route to glycans, and this type 
of synthesis requires relevant training and qualifications, so it is practically impossible to 
implement these reactions outside specialized labs. This significantly hampers the 
development in glycosciences, whereas other biopolymers, peptides16-17 and 
oligonucleotides,18 can now be produced by machines. Efforts to automate solution 
synthesis of glycans using parallel synthesizers have been reported by Takahashi,19-20 
Pohl,21-24 and Nokami.25-26 Being still relatively unexplored, these approaches offer viable 
alternatives to automated enzymatic syntheses being developed by Wong,27-28 Nishimura,29 
Chen,30-32 Wang,33-34 and Boons.35 
 
3.2. Results and discussion 
Solid-phase synthesis also involves reiteration of glycosylation-deprotection steps, 
but it eliminates the need for conventional reaction work-up and purification of 
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intermediates.36-38 Another strength of the solid phase synthesis is its automation 
amenability, which was demonstrated in 2001 by Seeberger who adapted a peptide 
synthesizer to glycan synthesis.39-42 In 2012, Seeberger reported “the first fully automated 
solid-phase oligosaccharide synthesizer”43 that was then commercialized as Glyconeer 
2.1.44 Also in 2012, Demchenko and Stine reported HPLC-based automation (HPLC-A) of 
solid phase synthesis.45 The underpinning idea for this technology is to use the standard lab 
equipment that will allow recording a successful synthetic sequence as a computer 
program. To advance our original HPLC-A set-up based on Tentagel,45 we identified 
JandaJel resin as a more efficient support for HPLC-A.46 We also implemented the standard 
analytical HPLC autosampler for delivering TMSOTf, the promoter for glycosylation.46 
This approach was recently applied to the synthesis of the N-glycan core pentasaccharide.47  
Even with the addition of the autosampler to deliver the promoter of glycosylation, 
the manual component of HPLC-A remained. The building block intake/delivery remained 
semi-manual because the reagent bottle swap required the operator. Also switching 
between the reaction and discharge/collection modes required the operator intervention. To 
enhance our automation capabilities, reported herein is our enhanced HPLC-A platform 
that incorporates a preparative autosampler to deliver all building blocks and all reagents 
for all steps of the synthesis and a standard two-way split valve. In this application, the 
split valve was programmed to switch between the discharge and the product collection 
modes, 1 and 2, respectively (Figure 3.1). 
Matteo Panza | UMSL 2019 | Page  180 
 
 
Figure 3.1.  Modified HPLC-A set-up to achieve complete automation 
  
This new automated set-up completely eliminates all variabilities that could be 
caused by the operator. No operator intervention is necessary after the software start button, 
initiating the programmed synthetic sequence, has been pressed and until the final product 
has been delivered to the collection flask. This approach was showcased by the synthesis 
of regular and alternating 1→6 and 1→4-linked glucans 3.1-3.3 shown in Figure 3.1. The 
HPLC was programmed to perform the entire sequence of reactions consisting of a series 
of glycosylations with Fmoc deprotections in between, followed by the off-resin cleavage, 
and collection of the final product, all in 12 h in the completely automated “press of a 
button” mode. To perform the assembly of all oligosaccharide sequences described herein 
we chose building blocks 3.4-3.7 shown in Figure 3.1. Glycosyl donor 3.4 and acceptors 
3.6 and 3.7 were synthesized as previously reported,45-46 while trichloroacetimidate donor 
3.5 was derived from known thioglycoside precursor.43, 48 
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Figure 3.2. Glycan sequences 3.1-3.3 obtained in the fully automated mode and 
building blocks 3.4-3.7 needed for all syntheses 
 
In accordance with our approach, the first building block, glycosyl acceptor, is 
conjugated to the resin on a large scale (5-10 g of the resin) prior the automation steps. The 
extent of loading is determined by cleavage/validation sequence on a small portion (50 mg) 
of the entire load. This approach helps to avoid overestimation of loading and to ensure 
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reproducibility of multiple experiments. Resin functionalized with glycosyl acceptor 3.6 or 
3.7 (typical scale 50 mg, typical loading 0.02 mmol) is then packed in an Omnifit column 
and the latter is integrated into the HPLC system. Glycosyl donors 3.4 and/or 3.5, promoter 
(TMSOTf), and other reagents such as piperidine for Fmoc removal are dissolved in 
separate vials that are placed into the autosampler tray. All subsequent steps are automated 
by programming the standard operation software without manual intervention. 
All glycosylation sequences follow the same basic blueprint. The resin is 
washed/swelled with the HPLC grade methylene chloride. Then, the flow rate is lowered, 
and the donor and promoter are delivered as follows. The robotic arm of the autosampler 
brings the vial containing the donor from the sample tray to the needle that draws the 
programmed amount of the donor solution. The robotic arm of the autosampler returns the 
donor vial to the sample tray and then brings the vial containing the promoter solution to 
the needle. The needle draws the required amount of the promoter, and the donor and 
acceptor are premixed in the “needle seat,” a capillary that connects the needle to the valve 
of the autosampler. The resulting solution of the pre-activated donor is then injected into 
the system. After that, the autosampler needle is washed using a dedicated vial in the 
autosampler tray to avoid cross contamination with vials used in subsequent steps. In our 
current configuration, recirculation previously performed for each glycosylation, has been 
substituted by multiple injections. This ensures that the system is supplemented with small 
portions of fresh preactivated donor until the glycosylation completed, as accessed by the 
detector monitored at 254 nm. The number of injections, and the amount of the donor 
utilized for every injection can be tuned to ensure that only the desired amount of the donor 
has been delivered. For instance, 7.5 equiv of donor 3.4 were utilized for each glycosylation 
Matteo Panza | UMSL 2019 | Page  183 
 
step for the synthesis of 1→6 linked pentasaccharide 3.1, and 10 equiv of the respective 
donors were used to obtain 1→4 linkages in glycans 3.2 and 3.3. 
The glycosylations were followed by the Fmoc group removal, and this operation 
is performed by delivering a solution of piperidine in DMF/CH2Cl2. This step is monitored 
at 254 and 301 nm, with the second wavelength being specific for monitoring 
dibenzofulvene-piperidine adduct. Once the desired oligosaccharide sequence is achieved 
via the reiteration of the glycosylation and deprotection steps, the reagent for cleavage, 
sodium methoxide in methanol-DCM, is delivered to affect the off-resin cleavage. At this 
stage, the split valve is programmed to direct the flow towards the collection flask (Figure 
3.1, mode 2).  
A representative protocol, general for the synthesis of all target glycans, is 
exemplified by the synthesis of glycan 3.1 as depicted in Scheme 3.2. Compound 3.8 is 
obtained with the iterations of glycosylations and Fmoc removal steps. The complete 
sequence of synthetic steps is built as lists of multiple operations including draw, mix, and 
inject commands. These operations are then modulated as needed for the synthesis of a 
particular target. This approach allows for flexible adaptation to specific targets to 
maximize the efficiency and yield. Compound 3.9, resulting from the off-resin cleavage, is 
manipulated through a series of post-automation steps, which include acetylation and 
purification via column chromatography, to afford the final product 3.1 in 33% yield. The 
final yields for glycans 3.2 and 3.3 were 20% and 30%, respectively. Differently from 
glycan 3.1, (1→4) linked compound 3.2 and compound 3.3 with alternating (1→6) and 
(1→4) linkages were obtained through benzoylation after the off-resin cleavage step. 
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Scheme 3.1. Automated synthesis of glycan 3.1 
 
3.3. Conclusions 
A new experimental set-up for the HPLC-based automated synthesizer has been 
developed. The sequences were written to achieve complete automation of all steps, 
starting from delivering sugar building blocks to obtaining glycan targets in the collection 
flask. This was made possible by implementing the new two-way switch valve used to 
direct the flow and by programming the preparative autosampler to deliver all reagents for 
all steps of the synthesis. Machine-assisted synthesis also helps to eliminate variabilities, 
and to accurately reproduce experiments multiple times. This in turn will simplify the 
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implementation of our protocols in other interested labs, all pre-recorded computer 




3.4.1. General methods 
The reactions were performed using commercial reagents and the ACS grade 
solvents were purified and dried according to standard procedures. HPLC grade solvents 
used for automation were utilized without purification. Column chromatography was 
performed on silica gel 60 (70−230 mesh) or using flash purification system Biotage Isolera 
One, reactions were monitored by TLC on Kieselgel 60 F254. The compounds were 
detected by examination under UV light and by charring with 10% sulfuric acid in 
methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 was distilled 
from CaH2 directly prior to application. Amberlite IR20 (H
+) was washed three times with 
MeOH and stored under MeOH. Optical rotations were measured using a Jasco ‘P-2000’ 
polarimeter. 1H NMR spectra were recorded at 300 or 600 MHz, 13C NMR spectra were 
recorded at 75 or 150 MHz. The 1H chemical shifts are referenced to the signal of the 
residual CHCl3 (δH = 7.24 ppm). The 
13C chemical shifts are referenced to the central 
signal of CDCl3 (δC = 77.23 ppm). HRMS determinations were made with the use of a 
mass spectrometer with FAB ionization and ion-trap detection. Agilent 1260 infinity II 
HPLC System and Agilent 1260 Variable Wavelength UV−vis Detector were used to 
assemble the automated synthesizer. 
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3.4.2. Set up of the HPLC-A synthesizer 
The HPLC based synthesizer has been assembled using  
• 1260 Agilent Infinity II series Quaternary Pump  
• Variable Wavelength Detector with dual-wavelength mode 
• The Autosampler is the preparative module from 1260 Infinity series. The 
autosampler is equipped a 900 µL preparative loop and two trays holding 15 x 6 mL vials 
each. The wells of the left tray are numbered from 1 to 15 while the ones of the right tray 
are numbered from 101 to 115. 
• The valve is a 2-way 6-port Quick Change Valve. 
• The column utilized is an Omnifit Solvent Plus 50 mm. 
The synthesis sequences are programmed using Chemstation software and the 
autosampler programming option. 
Figure 3.3. The synthesizer set up with the two channels of the valve 
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3.4.3. Synthesis of glycosyl donors and glycosyl acceptors 
2,3,4-Tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)-α/β-D-glucopyranosyl 
trichloroacetimidate (3.4) was obtained in accordance with the reported procedure and its 
analytical data were in accordance with that previously described.[1] 
2-O-Benzoyl-3,6-di-O-benzyl-4-O-(9-fluorenylmethoxycarbonyl)-α/β-D-
glucopyranosyl trichloroacetimidate (3.5). Water (8.0 mL) and N-bromosuccinimide 
(NBS, 1.25 g, 7.03 mmol) were added to a solution of ethyl 2-O-benzoyl-3,6-di-O-benzyl-
4-O-(9-fluorenylmethoxycarbonyl)-1-thio-β-D-glucopyrano-side[2] (3.10, 4.50 g, 6.39 
mmol) in methylene chloride (80 mL) and the resulting mixture was stirred vigorously for 
2 h at rt. The reaction was quenched with 10% aq. Na2S2O3 and diluted with methylene 
chloride (~120 mL). The organic phase was separated and washed with brine (2 x 30 mL), 
dried with MgSO4 and concentrated in vacuo. The residue was filtered through a pad of 
silica gel (hexanes - ethyl acetate isocratic elution, 7/3, v/v) to afford 2-O-benzoyl-3,6-di-
O-benzyl-4-O-(9-fluorenylmethoxycarbonyl)-D-glucopyranose (3.11). Crude residue 
containing hemiacetal 3.11 (3.53 g, 5.14 mmol) was dissolved in anhydrous methylene 
chloride (80 mL). Trichloroacetonitrile (7.73 mL, 77.10 mmol) and NaH (60% suspension 
in mineral oil, 0.025 g, 0.62 mmol) were added and the resulting mixture was stirred under 
argon for 3 h at rt. The volatiles were removed under the reduced pressure, and the residue 
was purified using a Biotage Isolera One (50 g SNAP ULTRA cartidge, hexane - ethyl 
acetate elution) to afford the title compound as an amorphous solid (3.90 g, 73% over two 
steps, α/β = 12.5/1). Selected analytical data for 3.5α: Rf = 0.54 (hexane/ethyl acetate, 7/3, 
v/v); 1H NMR (300 MHz, CDCl3): δ, 8.54 (s, 1H), 8.02-7.93 (m, 2H, aromatic), 7.77 (dd, 
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2H, J = 7.4, 2.7 Hz, aromatic), 7.68-7.51 (m, 4H, aromatic), 7.48-7.05 (m, 20H, aromatic), 
6.67 (d, 1H, J1,2 = 3.5 Hz, H-1), 5.41 (dd, 1H, J2,3 = 10.0 Hz, H-2), 5.24 (dd, 1H, J3,4 = J4,5 
= 9.9 Hz, H-4), 4.69 (s, 2H, CH2Ph), 4.61-4.52 (m, 2H, CH2Ph), 4.42-4.21 (m, 4H, H-3, 5, 
6a, CH/Fmoc), 4.15 (dd, 1H, J5,6a = J6a,6b = 6.9 Hz, H-6b), 3.77-3.60 (m, 2H, CH2/Fmoc) 
ppm; 13C NMR (75 MHz, CDCl3): δ, 165.36, 160.50, 154.25, 143.34, 143.21, 141.41, 
137.75, 137.51, 133.58, 129.93, 129.16, 128.56, 128.44, 128.34, 128.04, 128.02, 127.88, 
127.79, 127.32, 125.18, 125.10, 120.22, 93.62, 90.96, 76.60, 74.99, 74.54, 73.71, 72.28, 
71.54, 70.21, 68.52, 46.80; HR-TOF MS [M+Na+] calcd 852.15044 found 852.15296.  
Selected analytical data for 3.5β: Rf = 0.50 (hexane/ethyl acetate, 7/3, v/v); 
1H NMR 
(300 MHz, CDCl3): δ, 5.97 (d, 1H, H-1), 5.61 (m, 1H, H-2) ppm. 
Conjugate 3.6 was obtained from methyl 2,3-di-O-benzyl-6-O-(3-hydroxycarbonylpropa-
noyl)-α-D-glucopyranoside  and JandaJel in accordance with the reported procedure.4 The 
acceptor loading of 0.40 mmol/g for conjugate 3.6 was determined by direct cleavage from 
the solid support (50 mg of resin) and quantifying on HPLC to mimic conditions for the 
subsequent reactions.  
Conjugate 3.7 was obtained by reaction of 8-(3-carboxypropanoyloxy)oct-1-yl 2,3,4-tri-
O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside with JandaJel performed in 
accordance with the reported procedure.4 The acceptor loading of 0.33 mmol/g for 
conjugate 3.7 was determined by direct cleavage from the solid support (50 mg of resin) 
and quantifying on HPLC to mimic conditions for the subsequent reactions. 
 
3.4.4. Preparation of the reagent vials 
All the solutions were freshly prepared using the HPLC grade solvents and kept at 
room temperature for the duration of the synthesis. 
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Donor: a solution of glycosyl donor (0.08-0.2 mmol) in CH2Cl2 (3.5 mL). 
Promoter: a solution of TMSOTf (0.04-0.16 mmol) in CH2Cl2 (2.0 mL 
Reagents for Fmoc removal: a solution of piperidine in DMF (5.0 mL, 2/3, v/v). 
Reagents for cleaving off the resin: a solution prepared from 1M NaOMe in MeOH 
(1.5 mL), CH2Cl2 (1.0 mL) and MeOH (1.0 mL). 
Washing solutions and blanks: methylene chloride (6.0 mL). 
 
3.4.5. The automated assembly of oligosaccharides 
All reactions were carried out using 50 mg of preloaded resin. The acceptor is 
loaded on the resin prior automation, therefore the loading depended on the batch of the 
resin. Syntheses with acceptors 3.6 and 3.7 were performed with 0.02 and 0.0165 mmol, 
respectively. 
Glycosylations.  The sequences are comprehensive of washings of the resin pre 
and after glycosylation steps. The glycosylations are split in two interations of 5 injections 
each. The donor and the promoter are drawn from the vial, mixed in the needle seat and 
the injected. Once the activated donor has passed through the column, the same operation 
is repeated. The resin is washed with CH2Cl2 and DMF and 5 more injections are 
performed. The volume of solvent in the vials is constant, hence the concentration of donor 
and promoter varies depending on the equivalents required to successfully glycosylate the 
acceptor. Figure 3.3 depicts the programming of the components of the synthesizer. 3.3A 
shows the pump timetable, 3.3B shows the autosampler programming and 3.3C the variable 
wave-length detector (VWD). The valve was on position 1 during the whole sequence. 








Figure 3.4. Settings of the components of the HPLC synthesizer during glycosylation 
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Fmoc removal.  The reaction is monitored at λ = 250 and λ = 301 nm. The 
dibenzofulvene absorbance at 301 nm is a clear indication of the reaction completion. The 
removal is completed within 1 hour, including the washings and the resin is reacidified 
with TMSOTf as a last step. Even in this case, the valve was left in position 1 (waste) for 
the duration of the sequence. Figure 3.4 A, B and C depicts the settings of the pump, 
autosampler and VWD, respectively. 
Final cleavage.  The cleavage is performed in Zemplen conditions, with the 
solution prepared as reported above. The valve after the 30 seconds of the sequence 
switches from position 1 to position 2 and divert the flow to the collection flask. The 
reaction is monitored at both 250 and 301 nm and the sequence consist of 4 consecutive 
injections of the cleaving solution. Figure 3.5 A, B and C depicts the settings of the 
modules. 
Detection.  Representative UV traces for each sequence are depicted in Figure 3.6 
A, B and C. The absorbance of the donor at λ = 301 nm is significantly lower compared to 
250 nm, therefore the signals are not saturated and in some cases is easier to understand 
the proceeding of the reaction. The glycosylation trace A shows a progressive increase in 
the concentration of the donor with the number of injections, indication of the lower 
availability of free acceptor that can still be glycosylated. The Fmoc removal trace B clearly 
indicates the majority of the temporary protecting group being removed in the first injection 
of the piperidine solution, with only minor amounts cleaved in the following injections. 
The final cleavage trace C shows high absorbance during the injections, corresponding the 
the prograssive cleavage of the oligosaccharides from the resin and the Bz and Fmoc 
groups from the glycans. The absorbance decreases progressively during the washings. 









Figure 3.5. Settings of the components of the HPLC synthesizer during Fmoc removal 








Figure 3.6.  Settings of the components of the HPLC synthesizer during the final 
cleavage 
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A. Representative trace for Glycosylation 
 
B. Representative trace for Fmoc removal 
 
C. Representative trace for the final cleavage 
Figure 3.7.  UV traces for the synthetic steps 
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glucopyranoside (3.1).  Automation modules: The Omnifit column is filled with resin 
(50 mg) preloaded with acceptor 3.7 (0.016 mmol). The vials were prepared according to 
the general methods and organized as depicted below. Vial 1 contains donor 3.4 (71 mg, 
0.08 mmol, 5.0 equiv), vial 2 contains of TMSOTf (14 µL, 0.08 mmol, 5.0 equiv), and vial 
3 contains a piperidine-DMF solution prepared as indicated in the general methods. Vials 
B, W and C are blank, washing, and final off-resin cleavage, respectively, were prepared 
as described in the general methods.   
Vial trays organization: 
 
Automation Sequence:  
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
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Fmoc removal 60 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Final Cleavage 50 min 
Post Automation:  The reaction mixture collected from cleavage step was 
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with 
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was 
evaporated and dried in vacuo for 1 h.  The crude was dissolved in pyridine (2.0 mL) and 
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at 
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was 
evaporated and co-evaporated with toluene. The residue was purified by column 
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 3.1 
in 33% (10.0 mg, 0.0055 mmol) yield. Analytical data for 3.1: Rf = 0.50 (hexane/acetone, 
1/1, v/v); []D
21 -2.7 (c 1, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 7.39 – 7.21 (m, 15H), 
5.23 – 5.05 (m, 6H), 5.02 – 4.83 (m, 9H), 4.80 – 4.74 (m, 2H), 4.71 (d, J = 3.2 Hz, 1H), 
4.62 (d, J = 12.0 Hz, 1H), 4.58 – 4.47 (m, 5H), 4.27 (dd, J = 12.3, 4.9 Hz, 1H), 4.15 – 4.02 
(m, 5H), 4.01 – 3.84 (m, 5H), 3.76 – 3.47 (m, 13H), 3.33 (dd, J = 16.0, 6.5 Hz, 1H), 2.14 – 
1.87 (m, 42H), 1.67 – 1.53 (m, 8H), 1.31 (s, 8H) ppm; 13C NMR (151 MHz, CDCl3): δ, 
171.41, 170.78, 170.43, 170.32, 170.27, 170.24, 169.81, 169.74, 169.66, 169.61, 169.59, 
169.53, 169.32, 169.19, 138.97, 138.40, 138.27, 128.75, 128.56, 128.50, 128.15, 128.09, 
127.99, 127.97, 127.69, 101.00, 100.77, 100.63, 96.80, 81.98, 80.17, 77.54, 75.76, 75.13, 
73.29, 73.27, 73.17, 73.10, 72.92, 72.85, 72.78, 72.10, 71.51, 71.49, 71.24, 71.12, 71.10, 
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69.75, 69.24, 69.16, 69.10, 68.49, 68.43, 68.16, 68.15, 68.12, 68.07, 64.77, 62.05, 62.02, 
61.95, 29.85, 29.60, 29.51, 29.49, 29.36, 28.74, 26.32, 26.08, 21.20, 20.92, 20.89, 20.87, 





glucopyranosyl)-(1→4)-6-O-benzoyl-2,3-di-O-benzyl-α-D-glucopyranoside (3.2).  
Automation modules: The Omnifit column is filled with resin (50 mg) preloaded with 
acceptor 3.6 (0.02 mmol). The vials were prepared according to the general methods and 
organized as depicted below. Vial 1 contains donor 3.5 (160 mg, 0.20 mmol, 10.0 equiv), 
vial 2 contains of TMSOTf (5 µL, 0.03 mmol, 1.5 equiv), and vial 3 contains a piperidine-
DMF solution prepared as indicated in the general methods. Vials B, W and C are blank, 
washing, and final off-resin cleavage, respectively, were prepared as described in the 
general methods. 
Vial trays organization: 
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Automation Sequence:  
Glycosylation 120 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Glycosylation 120 min 
Final Cleavage 50 min 
Post Automation: The reaction mixture collected from cleavage step was 
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with 
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was 
evaporated and dried in vacuo for 1 h.  The crude was dissolved in pyridine (2.0 mL) and 
benzoyl chloride (0.5 mL) was added. The resulting mixture was stirred under argon at 
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was 
evaporated and co-evaporated with toluene. The residue was purified by column 
chromatography on silica gel (hexanes-ethyl acetate gradient elution) to afford compound 
3.2 in 20% (10.3 mg, 0.0044 mmol) yield. Analytical data for 3.2: Rf = 0.20 
(hexane/EtOAc, 7/3, v/v); []D
21 +25.7 (c 1, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 8.07 
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– 7.68 (m, 38H), 7.68 – 6.59 (m, 196H), 5.40 – 5.31 (m, 6H), 5.20 – 5.08 (m, 7H), 5.05 – 
4.94 (m, 7H), 4.94 – 4.78 (m, 12H), 4.73 (dd, J = 9.8 Hz, 8H), 4.63 – 4.28 (m, 42H), 4.28 
– 4.02 (m, 22H), 4.02 – 3.72 (m, 26H), 3.68 (s, 5H), 3.65 – 3.42 (m, 22H), 3.42 – 3.15 (m, 
31H), 2.87 (d, J = 8.8 Hz, 1H), 2.75 (d, J = 10.1 Hz, 3H) ppm; 13C NMR (151 MHz, 
CDCl3): δ, 165.87, 165.34, 165.13, 165.08, 165.02, 164.90, 164.86, 164.79, 138.90, 
138.76, 138.38, 138.16, 137.81, 137.54, 133.59, 133.38, 133.09, 132.96, 129.84, 129.60, 
129.00, 128.65, 128.57, 128.45, 128.27, 128.12, 127.93, 127.68, 127.39, 127.30, 127.12, 
127.02, 101.31, 100.16, 100.03, 99.97, 97.91, 80.41, 80.28, 80.06, 79.88, 79.45, 78.29, 
77.37, 77.16, 76.95, 76.44, 76.13, 75.18, 74.90, 74.72, 74.48, 74.00, 73.88, 73.78, 73.56, 
73.44, 72.09, 69.95, 68.43, 67.45, 67.16, 62.84, 55.31, 32.08, 29.85, 29.51, 29.28, 22.85, 





Automation modules: The Omnifit column is filled with resin (50 mg) preloaded with 
acceptor 3.6 (0.02 mmol). The vials were prepared according to the general methods and 
organized as depicted below. Vial 1 contains donor 3.4 (130 mg, 0.15 mmol, 7.5 equiv), 
vial 2 contains of TMSOTf (10 µL, 0.05 mmol, 2.5 equiv), and vial 3 contains a piperidine-
DMF solution prepared as indicated in the general methods. Vial 4 contains donor 3.5 (83 
mg, 0.10 mmol, 5.0 equiv) and vial 2 contains of TMSOTf (7.5 µL, 0.04 mmol, 2.0 equiv). 
Vials B, W and C are blank, washing, and final off-resin cleavage, respectively, were 
prepared as described in the general methods.  
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Vial trays organization: 
 
Automation Sequence:  
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Final Cleavage 50 min 
Post Automation: The reaction mixture collected from cleavage step was 
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with 
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was 
evaporated and dried in vacuo for 1 h.  The crude was dissolved in pyridine (2.0 mL) and 
benzoyl chloride (0.5 mL) was added. The resulting mixture was stirred under argon at 
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was 
evaporated and co-evaporated with toluene. The residue was purified by column 
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chromatography on silica gel (hexanes-ethyl acetate gradient elution) to afford compound 
3.3 in 30% (13 mg, 0.0066 mmol) yield. Analytical data for 3.3: Rf = 0.15 (hexane/EtOAc, 
7/3, v/v); []D
21 +1.8 (c 1, CHCl3); 
1H NMR (600 MHz, CDCl3): δ, 7.98 – 7.71 (m, 26H), 
7.61 – 7.12 (m, 66H), 7.05 – 6.87 (m, 9H), 5.66 (m, 2H), 5.53 – 5.46 (m, 2H), 5.43 – 5.39 
(m, 1H), 5.33 – 5.26 (m, 2H), 5.17 – 5.12 (m, 1H), 4.91 (dd, J = 11.5, 6.2 Hz, 4H), 4.77 
(dd, J = 14.6, 9.6 Hz, 2H), 4.69 (d, J = 12.0 Hz, 1H), 4.63 – 4.58 (m, 2H), 4.55 (d, J = 12.5 
Hz, 1H), 4.41 (dd, J = 20.2, 7.6 Hz, 3H), 4.33 (d, J = 12.1 Hz, 1H), 4.07 (ddd, J = 18.1, 
10.4, 6.3 Hz, 4H), 3.89 – 3.85 (m, 1H), 3.81 – 3.68 (m, 7H), 3.61 (dd, J = 12.4, 7.2 Hz, 
1H), 3.50 – 3.44 (m, 3H), 3.39 – 3.34 (m, 1H), 3.33 – 3.22 (m, 4H), 3.14 – 3.07 (m, 1H), 
2.76 (d, J = 9.6 Hz, 1H), 1.26 (s, 17H), 0.94 – 0.77 (m, 5H) ppm; 13C NMR (151 MHz, 
CDCl3): δ, 166.16, 166.08, 165.84, 165.79, 165.63, 165.50, 165.32, 165.26, 165.20, 
164.82, 139.23, 138.49, 138.41, 138.24, 138.16, 133.76, 133.54, 133.49, 133.44, 133.31, 
133.25, 133.15, 133.06, 129.97, 129.91, 129.84, 129.69, 129.61, 129.16, 129.09, 128.95, 
128.89, 128.80, 128.66, 128.52, 128.48, 128.42, 128.37, 128.35, 128.22, 128.20, 128.11, 
128.05, 127.98, 127.85, 127.50, 127.44, 127.22, 100.66, 100.59, 100.51, 98.16, 80.71, 
80.63, 80.60, 77.83, 77.76, 76.21, 74.86, 74.26, 74.21, 73.67, 73.26, 73.05, 72.47, 72.20, 
72.11, 69.94, 69.78, 68.55, 67.22, 66.82, 63.12, 63.08, 55.37, 32.08, 31.10, 29.85, 29.52, 
22.85 ppm; HR-TOF MS [M+NH4
+] calcd 1995.6984 found 1995.7010. 
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polymer support for the solid-phase 
oligosaccharide synthesis 
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4.1. Introduction 
With the advances of the field of glycosciences and the increasing number of 
structures elucidated and applied in all areas of the field, the need for reliable approaches 
to the synthesis of glycans has grown exponentially.1,2 Traditional glycan synthesis in 
solution involves iteration of glycosylation and deprotection steps, but some advanced 
strategies based on either chemoselective or selective activation of building blocks help 
to streamline the oligosaccharide assembly significantly.3 However, no universal route to 
glycans can be established, which dramatically hinders progress in glycosciences, 
whereas other biopolymers, peptides4,5 and oligonucleotides,6 can be produced by 
automated machines. Solid-phase synthesis (SPS) eliminates the need for conventional 
reaction work-up and purification of intermediates,7-9 and offers promising automation 
amenability. Since early efforts in 2001,10-13 Seeberger et al. developed a dedicated 
automated oligosaccharide synthesizer in 201214 that was later commercialized as 
Glyconeer 2.1.  
Also in 2012, we reported High Performance Liquid Chromatography equipment-
based automation (HPLC-A) of SPS.15 The general idea for developing the HPLC-A is 
that a computer interface coupled with standard HPLC components will allow recording a 
successful automated sequence as a computer program that can then be reproduced with 
the “press of a button.” However, SPS of glycans suffers from certain inherent 
weaknesses. “The chemistry and biology of carbohydrates has been a Cinderella field,”16 
and the area of SPS wherein everything is “borrowed” from other fields illustrates this 
problem very clearly. For example, instead of developing dedicated supports, commercial 
resins designed specifically for peptide or nucleotide SPS17-19 are meticulously evaluated 
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to determine their possible suitability for glycan synthesis, which often demands different 
characteristics.20 
Presented herein is the first step of our strategic goal to tackle the key weaknesses 
in our previous automation efforts, and those of the SPS in general, both automated and 
manual. While HPLC-A and other automated approaches have a potential to 
revolutionize the way glycan synthesis is conducted, all current platforms suffer from 
inherent weaknesses of SPS as applied to glycans, among which is poor compatibility of 
existing commercial resins. Seeberger automation relies on the traditional polystyrene-
based Merrifield resin. Our original HPLC-A set-up was based on Tentagel, a polystyrene 
grafted with PEG chains.15 Later on, we identified JandaJel polystyrene resin crosslinked 
with tetrahydrofuran-derived chains as a better support for HPLC-A.21 Although JandaJel 
has better swelling properties compared to the traditional Merrifield resin, it has low 
stability in the presence of large amounts of trimethylsilyl trifluoromethanesulfonate 
(TMSOTf).22  
 
4.2. Results and Discussion 
JandaJel and more traditional Merrifield or Tentagel resins21 are all based on 
polystyrene, but differ in functionalization / crosslinking, albeit none were designed 
specifically with the SPS of glycans in mind.23 Cross-linked polystyrenes are 
mechanically stable and can be obtained on a large scale from broadly available and 
inexpensive precursors. However, phenol-based cross-linking used in JandaJel (4.1, 
Figure 4.1) may potentially have marginal stability under strongly (Lewis) acidic 
conditions that are commonly employed in SPS of glycans. Although this degradation 
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was not thought to significantly hinder general progress, we came to the realization that 
beads designed for peptides do not have the necessary properties suitable for glycan SPS. 
To address this potential weakness, described herein is the investigation of benzyl 
alcohol-derived ethylene glycol chain cross-linking (4.2, Figure 4.1) due to the 
anticipated greater stability of such structures under (strongly) acidic reaction 
conditions.24,25 This type of resin was first synthesized by Itsuno et al,25 but its 
application in SPS is unknown. Interestingly, benzylic attachments have been considered 
by Janda and co-workers,26,27 but were deemed inferior due to their marginal stability 
toward strongly basic reagents, such as BuLi.  
 
Figure 4.1. Selection of the attachment strategies and cross-linkers 
To increase the swelling properties in polar protic solvents, we chose to replace 
the tetrahydrofuran chain used by Janda with the diethylene glycol (DEG) derived 
structure 4.2 depicted in Figure 4.1. Ethylene-glycol,28 its homologs, and other similar 
molecules27 have been previously investigated as crosslinkers, but the application of such 
resins in SPS is unknown.25 Crosslinker monomer 4.2 was synthesized using para-
vinylbenzyl chloride 4.3 and diethylene glycol 4.4 in the presence of NaH in DMF, 
affording the desired compound in a good yield 85% (Scheme 4.1). The cross-linker 
monomer 4.2 was then used in the synthesis of a 2% cross-linked polymer 4.6. 
Monomers 4.2, 4.3, and 4.5 in a respective ratio of 2/10/88 (w/w/w) were polymerized in 
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the presence of benzoyl peroxide, sodium chloride and Arabic gum in water at 85 °C for 
16 h following a procedure previously described by Janda.22 The desired polymer 4.6 was 
then purified using a Soxhlet extractor and i-PrOH. The chlorobenzyl group was further 
functionalized following Gabriel’s synthesis protocol, wherein the chloride was displaced 
with phthalimide in DMF at 55 °C. The resulting phthlaloyl group was then removed 
with hydrazine hydrate in a mixture of MeOH and chloroform. This two-step procedure 
produced PanzaGel 4.7 equipped with the primary amine functional groups (Scheme 4.1) 
with a nominal loading capacity of 1.0 mmol/g. 
 
Scheme 4.1. Synthesis of PanzaGel 4.7 
Then, the swelling properties of the polymer were investigated. Swelling was measured 
following described procedures,29 using a syringe equipped with a sintered frit. The 
volume of dry resin was measured, then solvent was introduced in the syringe and the 
mixture was allowed to equilibrate for 1 h. After being vortexed, extra solvent was 
removed using another syringe. As listed in Table 1, both polar and non-polar solvents 
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were tested, all of them showing good swelling, similar to the volumes reported for 
JandaJel.22 The exception is MeOH, which still exhibits better swelling if compared to 
data available for JandaJel.  
 
Solvent 
Volume of resin (mL/g) 
PanzaGel JandaJel22 Merrifield22 
None 1.75 1.5 1.5 
CH2Cl2 9.0 11.8 5.8 
MeOH 2.5 1.5 1.8 
DMF 8.5 14 4.2 
THF 10.0 12 5.4 
Toluene 8.0 ND ND 
 
Table 4.1. Comparison of swelled JandaJel and Panzagel 
A set of experiments were then conducted to determine physical properties of the 
resin and recorded in collaboration with Prof. Stine laboratory by Dharmendra Neupane . 
Thermal degradation properties of PanzaGel was assessed by thermogravimetric analysis 
(TGA). As shown in Figure 4.2, the thermal decomposition of PanzaGel 4.7 was 
investigated at various temperatures. PanzaGel was found thermally stable up to 360 °C, 
but about 97% weight loss occurs by 460 °C. To assess the chemical stability of 
PanzaGel, the polymer was treated with trimethylsilyl trifluoromethanesulfonate, as this 
Lewis acid was found to degrade JandaJel.30 Upon treatment of 100 mg of resin with 100 
µL of TMSOTf in 1.0 mL of methylene chloride for 1 h, which exceeds the typical 
conditions employed in chemical glycosylations using polymer supports, no 
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decomposition was observed. The thermal decomposition temperature and the SEM 
images of the polymer showed no significant difference before and after the treatment 
with TMSOTf. PanzaGel treated with TMSOTf decomposed by about 85% upon heating 
to 600 °C leaving behind a residue, indicating a chemical structure unaltered by the 
prolonged contact with the acid.  
 
Figure 4.2. Thermogravimetric analysis (TGA) plots (black line) and Weight 
derivatives curves (red line) of PanzaGel 
The prepared polymer was also investigated by scanning electron microscopy, 
with images recorded by Dharmendra Neupane. As shown in Figure 4.3, polymer 4.7 was 
prepared in the form of monospheres with an average size of 157.64 µm (average of 30 
polymer beads). Nitrogen adsorption/desorption isotherm plots have been used to 
evaluate the pore volume (Vp) and the surface area (S) of the synthesized material. The 
total pore volume was calculated as 0.0033 mL/g. The BET surface area was found to be 
0.84 m2/g.  
To explore the synthetic application of the novel resin, we then moved on to 
synthesize disaccharide 4.8 and pentasaccharide 4.9 (Figure 4.4). Our lab has recently 
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achieved a full automation of the synthesis of oligosaccharides using a two-way spilt 
valve.31 Differently from our previous experimental set up involving reagent delivery 
with a preparative autosampler, herein we investigated an HPLC system equipped with 
an analytical autosampler instead. This module is common on HPLC systems, which 
would allow to broaden the scope of HPLC-A. To accommodate this adjustment, a higher 
concentration of donor 4.11 was used. 7.5 equiv of donor were dissolved in 2.7 mL of 
methylene chloride and the donor solution was split in two vials. 
 
Figure 4.3. SEM images of PanzaGel polymer at 100x (a) and 150x magnification (b) 
The autosampler was programmed to draw 500 µL of donor 4.11 solution (0.12 
mmol) and 100 µL of TMSOTf solution in methylene chloride, mix them in the needle 
seat and inject them onto the column. After 1.0 minute, the appropriate amount of time 
needed to allow all of the activated donor to flow into the column containing the 
acceptor-bound resin 4.10, the flowrate was lowered to 0.02 ml/min to maximize the time 
of exposure of the acceptor to the reactive donor. The flow rate was kept at the minimum 
level for 10 min, then increased to 1.0 mL/min of CH2Cl2 to wash the column and prepare 
for a new injection of the activated donor. The same operation was repeated for five 
iterations and the glycosylation sequence was completed by alternating washings of 
methylene chloride and DMF. Following the glycosylation step, the temporary Fmoc 
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group was removed using a 20% solution of piperidine in DMF. Three injections of the 
piperidine solution were performed, and the reaction was followed using the variable 
wavelength detector set at 301 nm. The sequence was completed by washings using 
CH2Cl2 and DMF. Last, the polystyrene resin was reacidified through an injection of 
TMSOTf. The two reactions were repeated to afford the target glycans. As previously 
described, the two-way split valve diverts the flow to a collection flask. The compounds 
are then cleaved using a solution of sodium methoxide in MeOH/CH2Cl2 (1/1, v/v). The 
partially deprotected oligosaccharides, through a series a post automation steps afforded 
the target glycans 4.8 and 4.9 in 80% and 30% yield, respectively. Noticeably, both 
syntheses were conducted at room temperature and without utilizing an inert atmosphere. 
 
Figure 4.4. Target compounds and building blocks to investigate how well the new resin 
works in application to SPS 
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4.3. Conclusions 
A new polystyrene-based resin for polymer supported glycan synthesis has been 
developed. The resin showed similar swelling properties to other existing solid supports 
but superior TMSOTf stability compared to JandaJel that was routinely used in our lab. 
The synthesis of these resins is fairly straightforward, and the length of the linker and its 
composition can easily be varied to achieve best results in terms of swelling, mechanical 
and chemical stability, flow-through applicability, and loading capacity. The glycan 
synthesis performed at the end of this study showcased how the improved polymeric 
support works in application to the HPLC-A. The target oligosaccharides were obtained 
using the same spilt valve introduced recently in the HPLC-A, albeit with the use of an 
analytical autosampler. New sequences were specifically developed for this modified set-
up. A new solid support available specifically for oligosaccharide synthesis will increase 




4.4.1. General Methods 
The reactions were performed using commercial reagents and the ACS grade 
solvents were purified and dried according to standard procedures. HPLC grade solvents 
used for automation were utilized without any further purification. Column 
chromatography was performed on silica gel 60 (70−230 mesh) or on Biotage Isolera 
One, reactions were monitored by TLC on Kieselgel 60 F254. The compounds were 
detected by examination under UV light and by charring with 10% sulfuric acid in 
methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 was 
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distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with 
CaH2 and then distilled and stored over molecular sieves (3 Å). Amberlite IR20 (H
+) was 
washed three times with MeOH and stored under MeOH. Optical rotations were 
measured using a Jasco ‘P-2000’ polarimeter. IR spectra were recorded using an Agilent 
Cary 630 FTIR or a Thermo Nicolet Avatar 360 FTIR. 1H NMR spectra were recorded at 
300 or 600 MHz, 13C NMR spectra were recorded at 75 or 150 MHz. The 1H chemical 
shifts are referenced to the signal of the residual CHCl3 (δH = 7.26 ppm). The 
13C 
chemical shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm). HRMS 
determinations were made with the use of a mass spectrometer with FAB ionization and 
ion-trap detection. Agilent 1260 infinity II HPLC System and Agilent 1260 Variable 
Wavelength UV−vis Detector were used to assemble the automated synthesizer. 
 
4.4.2. Set up of the HPLC-A synthesizer 
The HPLC based synthesizer has been assembled using  
• 1260 Agilent Infinity I series Quaternary Pump  
• Variable Wavelength Detector with single-wavelenght mode 
• The Autosampler is the analytical module from 1260 Infinity series. The 
autosampler is equipped a 900 µL loop and one tray holding 100 x 2 mL 
vials. 
• The valve is a 2-way 6-port Quick Change Valve. 
• The column utilized is an Omnifit Solvent Plus 50 mm. 
The synthesis sequences are programmed using Chemstation software and the 
autosampler programming option. 
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Figure 4.5. The synthesizer set up 
 
4.4.3. Synthesis of Panzagel crosslinker and Panzagel resin 
Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2) was obtained in accordance with the 
reported procedure and its analytical data were in accordance with that previously 
described.30 Selected analytical data for 2:  Rf = 0.49 (hexane/acetone, 7/3, v/v); 
1H NMR 
(300 MHz, CDCl3) δ 7.38 (d, J = 8.2 Hz, 4H, aromatic), 7.30 (d, J = 8.2 Hz, 4H, 
aromatic), 6.71 (dd, J = 17.6, 10.9 Hz, 2H, CHCH2), 5.74 (dd, J = 17.6, 0.8 Hz, 2H, 
CHCH2-trans), 5.23 (dd, J = 10.9, 0.7 Hz, 2H, CHCH2-cis), 4.56 (s, 4H, PhCH2), 3.66 (m 
16H, OCH2CH2); 
13C NMR (75 MHz, CDCl3) δ 137.94 (CCH2), 136.98 (CCH), 136.59 
(CCHCH2), 128.02 (CH aromatic), 126.28 (CH aromatic), 113.83 (CH2CH), 73.02 
(PhCH2), 70.77 (CH2O), 69.46 (CH2O). 
 
Panzagel-Cl Resin (4.6) was obtained in accordance with the reported procedure.27 In a 
round bottom flask equipped with a paddle mechanical stirrer, acacia gum (9 g) and NaCl 
(5.62 g) were added to water (225 mL) under vigorous stirring. Flush Ar through the 
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resulting solution to deoxygenate. Styrene (11.7 mL, 102 mmol), vinylbenzyl chloride 
(2.1 mL, 15 mmol), cross-linker 4.2 (0.79g, 2.34 mmol) and benzoyl peroxide (0.22g) 
were dissolved in chlorobenzene (15 mL). The resulting solution was added dropwise to 
the aqueous mixture under vigorous stirring and the emulsion was heated at 85 °C for 
16h. The obtained beads were washed in a sintered funnel with water (2x50 mL), acetone 
(2x50 mL), methylene chloride (2x70 mL) and methanol (2x50 mL). The polymer was 
then further purified in a Soxhlet extractor with iPrOH for 16 h and dried in vacuo. The 
beads were analyzed using solid state FT-IR.  
 
Panzagel-NH2 Resin (4.7) 
Panzagel-Cl beads (6, 1.0 g) and dimethylformamide (15 mL) were added to a 
round-bottom flask equipped with a mechanical stirrer, and the resin was allowed to swell 
for 1 h at rt.  Potassium phthalimide (1.0 g) was added, and the resulting mixture was 
stirred for 16 h at 55 °C. The resin was filtered off and washed successively with CH2Cl2 
(3 x 30 mL), MeOH (3 x 30 mL), acetone (3 x 30 mL) and water (3 x 30 mL) and dried at 
60 °C in vacuo. The resulting resin and MeOH/CHCl3 (20 mL, 3/7, v/v) were added to a 
found-bottom flask equipped with a mechanical stirrer, and the resin was allowed to swell 
for 1 h at rt. H2NNH2-H2O (3.0 mL) was added and the resulting mixture was stirred at rt 
for 48 h. The resin was filtered off and washed successively with CH2Cl2 (3 x 30 mL), 
MeOH (3 x 30 mL), acetone (3 x 30 mL) and water (3 x 30 mL) and dried at 60 °C in 
vacuo. The polymer was characterized using FT-IR, SEM, BET and the presence of NH2 
groups was confirmed using the Kaiser test. Analytical data for 4.7: FT-IR: 3025, 2920, 
1493, 1452, 1082, 1028, 820, 756 cm-1. 
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4.4.4. Synthesis of glycosyl donors and glycosyl acceptors 
2,3,4-Tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)- α/β-D-glucopyranosyl 
trichloroacetimidate (4.11) was obtained in accordance with the reported procedure and 
its analytical data were in accordance with that previously described.15 
 
Conjugate 4.10 was obtained by reaction of 8-(3-carboxypropanoyloxy)oct-1-yl 2,3,4-
tri-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside with JandaJel in accordance with 
the reported procedure.21 The loading of 0.33 mmol/g for 4.10 was determined by direct 
cleavage from the solid support (50 mg) on HPLC to mimic conditions for the subsequent 
reactions. 
 
4.4.5. Preparation of the reagent vials 
All the solutions were freshly prepared using the ACS-grade solvents and kept at 
room temperature for the duration of the synthesis. 
Donor: a solution of glycosyl donor (0.120 mmol) in CH2Cl2 (2.7 mL), split in 
two vials containing 1.6 mL and 1.1 mL of solution. 
Promoter: a solution of TMSOTf (0.124 mmol) in CH2Cl2 (500 µL). Both the 
amounts were doubled to prepare an excess of acidic solution to acidify the resin after 
Fmoc removal. 
Reagents for Fmoc removal: a solution of piperidine in DMF (2.5 mL, 2/3, v/v). 
Reagents for cleaving the products from the resin: a solution prepared from 1M 
NaOMe in MeOH (1.5 mL), CH2Cl2 (1.0 mL) and MeOH (1.0 mL), split equally in 2 
vials. 
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Washing solutions and blanks: methylene chloride in W1, MeOH in W2 and 
methylene chloride in B (2.0 mL). 
 
4.4.6. The automated assembly of oligosaccharides 
All reactions were carried using 50 mg of the preloaded resin. The acceptor was 
loaded on the resin prior automation, therefore the loading depended on the batch of the 
resin. Syntheses with acceptor 4.10 were performed with 0.0165 mmol. 
 
Glycosylation. The sequences included washing of the resin before and after 
glycosylation steps. The glycosylations were performed in five iterations of donor 
injections. The donor and the promoter are drawn from the vial, mixed in the autosampler 
needle seat and the injected. The flowrate was then lowered to maximize the presence of 
the donor in the column. Once the activated donor has passed through the column, the 
same operation was repeated. At the end of the glycosylation the resin was washed with 
CH2Cl2 and DMF.  
Figure 4.6 depicts programming of the components of the synthesizer. Figure 
4.6A shows the pump timetable, Figure 4.6B shows the autosampler programming. The 
valve was in position 1 during the whole sequence. 
 
Fmoc removal.  The reaction was monitored using the UV detector set at λmax = 
301 nm. The dibenzofulvene absorbance at 301 nm is a clear indication of the reaction 
completion. The removal is completed within 1 h, including the washings and the resin is 
reacidified with TMSOTf as a last step. Even in this case, the valve was left in postion 1 
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(waste) for the duration of the sequence. In figure 4.7 A, B and C the settings of the 
pump, autosampler and VWD respectively, are reported. Default volume is 500 µL. 
 
Final cleavage from the resin.  The cleavage is performed in Zemplen 
conditions, with the solution prepared as reported above. The valve after the 30 seconds 
of the sequence switches from position 1 to position 2 and divert the flow to the 
collection flask. The reaction is monitored at both 250 nm and the sequence consists of 4 
consecutive injections of the cleaving solution. In figure 4.8 A, B and C are depicted the 








Figure 4.6. Settings of the components of the HPLC synthesizer during glycosylation. 
 
A 







Figure 4.7. Settings of the components of the HPLC synthesizer during Fmoc removal. 
 







Figure 4.8.  Settings of the components of the HPLC synthesizer during the final 
cleavage. 
Detection.  Representative UV traces for each sequence are depicted in Figure 
4.9A and B. The absorbance of the donor at λ = 301 nm is significantly lower compared 
to 250 nm, therefore the signals are not saturated and in some cases is easier to 
understand the proceeding of the reaction. 
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The Fmoc removal trace A clearly indicates the majority of the temporary 
protecting group being removed in the first injection of the piperidine solution, with only 
minor amounts cleaved in the following injections. 
The final cleavage trace B shows high absorbance during the injections, 
corresponding the the prograssive cleavage of the oligosaccharides from the resin and the 
Bz and Fmoc groups from the glycans. The absorbance decreases progressively during 
the washings.
A. Representative trace for Fmoc removal 
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B. Representative trace for the final cleavage 
Figure 4.9.  UV traces for the synthetic steps 
 
4.4.7. Synthesis of oligosaccharides 
8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-
O-benzyl-α-D-glucopyranoside (4.8).   
Automation modules: The Omnifit column is filled with resin (50 mg) preloaded 
with acceptor 4.10 (0.016 mmol). The vials were prepared according to the general 
methods and organized as depicted below. Vials 1 and 3 contain donor 4.11 solution (106 
mg, 0.12 mmol, 7.5 equiv) split as described in the general methods, vial 2 contains of 
TMSOTf (22 µL, 0.12 mmol, 7.5 equiv), and vial 3 contains a piperine-DMF solution 
prepared as indicated in the general methods. Vials B, W and C are blank, washing, and 
final off-resin cleavage, respectively, were prepared as described in the general methods.  
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Vial tray organization: 
 
Automation Sequence:  
Glycosylation 120 min 
Fmoc removal 60 min 
Post Automation:  The reaction mixture collected from cleavage step was 
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with 
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was 
evaporated and dried in vacuo for 1h.  The crude was dissolved in pyridine (2.0 mL) and 
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at 
room temperature for 16h. The reaction was quenched with MeOH, then the solvent was 
evaporated and co-evaporated with toluene. The residue was purified by column 
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 4.8 
in 80% yield. Analytical data matched what has been previously reported.32 
 





glucopyranoside (4.9).   
Automation modules: The Omnifit column is filled with resin (50 mg) preloaded 
with acceptor 4.10 (0.016 mmol). The vials were prepared according to the general 
methods and organized as depicted below. Vials 1 and 3 contain a solution of donor 4.11 
(106 mg, 0.12 mmol, 7.5 equiv) split as described in the general methods, vial 2 contains 
of TMSOTf (22 µL, 0.12 mmol, 7.5 equiv), and vial 3 contains a piperine-DMF solution 
prepared as indicated in the general methods. Vials B, W and C are blank, washing, and 
final off-resin cleavage, respectively, were prepared as described in the general methods.   
 
Vial tray organization 
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Automation Sequence:  
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Fmoc removal 60 min 
Glycosylation 120 min 
Final Cleavage 50 min 
Post Automation:  The reaction mixture collected from cleavage step was 
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with 
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was 
evaporated and dried in vacuo for 1h.  The crude was dissolved in pyridine (2.0 mL) and 
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at 
room temperature for 16h. The reaction was quenched with MeOH, then the solvent was 
evaporated and co-evaporated with toluene. The residue was purified by column 
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 4.9 
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Scheme A-1. Conversion of 3,4-di-O-TBS α-SEt glucoside α-2.2 into α,β-bromides 
2.4 
 
Table A-1. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 









Conformation E (kcal/mol) G (kcal/mol) Dihedral angle (degrees) Calculated J (Hz) 
4C1 chair 0.00 0.00 H-C1-C2-H (172.6°) J1,2 = 8.7 
   H-C2-C3-H (-167.0°) J2,3 = 7.7 
   H-C3-C4-H (172.5°) J3,4 = 8.3 
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   H-C4-C5-H (-176.5°) J4,5 = 9.0 
     
1C4 chair 2.83 0.75 H-C1-C2-H (85.5°) J1,2 = 0.8 
   H-C2-C3-H (-79.1°) J2,3 = 1.7 
   H-C3-C4-H (75.2°) J3,4 = 2.2 
   H-C4-C5-H (-80.2°) J4,5 = 0.8 
     
3,OB  boat 2.74 1.32 H-C1-C2-H (120.9°) J1,2 = 3.1 
   H-C2-C3-H (-78.7°) J2,3 = 1.7 
   H-C3-C4-H (91.4°) J3,4 = 0.4 
   H-C4-C5-H (-147.0°) J4,5 = 6.5 
    
 
2SO skew-boat 3.39 2.53 H-C1-C2-H (151.4°) J1,2 = 7.0 
   H-C2-C3-H (175.2°) J2,3 = 9.6 
   H-C3-C4-H (163.2°) J3,4 = 6.9 
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Table A-2. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 










Conformation E (kcal/mol) G (kcal/mol) Dihedral angle (degrees) Calculated J (Hz) 
3S1 skew-boat 0.00 0.00 H-C1-C2-H (156.4°) J1,2 = 7.5 
   H-C2-C3-H (-96.1°) J2,3 = 0.3 
   H-C3-C4-H (66.9°) J3,4 = 3.3 
   H-C4-C5-H (-100.0°) J4,5 = 1.0 
     
1C4 chair 1.66 2.24 H-C1-C2-H (90.9°) J1,2 = 0.8 
   H-C2-C3-H (-82.4°) J2,3 = 1.3 
   H-C3-C4-H (73.8°) J3,4 = 2.3 
   H-C4-C5-H (-77.2°) J4,5 = 0.9 
    
 
2SO skew-boat 4.33 4.72 H-C1-C2-H (153.8°) J1,2 = 7.3 
   H-C2-C3-H (178.0°) J2,3 = 9.4 
   H-C3-C4-H (156.8°) J3,4 = 5.9 
   H-C4-C5-H (-106.2°) J4,5 = 1.4 
 






























Table A-3. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 










Conformation E (kcal/mol) G (kcal/mol) Dihedral angle (degrees) Calculated J (Hz) 
1C4 chair 2.10 0.00 H-C1-C2-H (-49.1°) J1,2 = 1.1 
   H-C2-C3-H (-75.0°) J2,3 = 2.2 
   H-C3-C4-H (74.7°) J3,4 = 2.2 
1C4 chair 3S1 skew-boat 
2SO skew-boat 
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   H-C4-C5-H (-80.6°) J4,5 = 0.8 
     
4C1 chair 0.00 0.39 H-C1-C2-H (47.5°) J1,2 = 5.7 
   H-C2-C3-H (-173.3°) J2,3 = 8.5 
   H-C3-C4-H (174.9°) J3,4 = 8.6 



















Table A-4. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 











Conformation E (kcal/mol G (kcal/mol) Dihedral angle (degrees) Calculated J (Hz) 
1C4 chair 0.58 0.00 H-C1-C2-H (-47.3°) J1,2 = 1.3 
   H-C2-C3-H (-75.2°) J2,3 = 2.1 
   H-C3-C4-H (74.8°) J3,4 = 2.2 
1C4 chair 4C1 chair 
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   H-C4-C5-H (-79.5°) J4,5 = 0.8 
     
4C1 chair 0.00 1.07 H-C1-C2-H (46.4°) J1,2 = 5.8 
   H-C2-C3-H (-172.7°) J2,3 = 8.5 
   H-C3-C4-H (174.6°) J3,4 = 8.5 




















Table A-5. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 




















1,4B boat or unusual 4S2 
skew-boat 
0.00 0.00 H-C1-C2-H (54.7°) J1,2 = 2.9 
1C4 chair 
4C1 chair 
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   H-C2-C3-H (-95.0°) J2,3 = 0.3 
   H-C3-C4-H (149.3°) J3,4 = 4.6 
   H-C4-C5-H (-178.4°) J4,5 = 9.0 
     
4C1 chair 3.09 2.89 H-C1-C2-H (169.0°) J1,2 = 7.8 
   H-C2-C3-H (-168.3°) 
J2,3 = 8.0 
   H-C3-C4-H (173.5°) 
J3,4 = 8.4 
   H-C4-C5-H (-177.3°) 
J4,5 = 9.0 
    
 
2SO skew-boat 1.84 4.88 H-C1-C2-H (141.3°) J1,2 = 5.1 
   H-C2-C3-H (178.8°) J2,3 = 9.4 
   H-C3-C4-H (159.3°) J3,4 = 6.3 
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Table A-6. DFT-optimized structures (hydrogens and protecting groups have been 
omitted for clarity in 3D ball and stick representations) and calculated coupling 












Conformation E (kcal/mol) G (kcal/mol) Dihedral angle (degrees) Calculated J (Hz) 
4C1 chair 0.00 0.00 H-C1-C2-H (59.7°) J1,2 = 3.8 
   H-C2-C3-H (177.4°) 
J2,3 = 9.6 
   H-C3-C4-H (176.6°) 
J3,4 = 8.8 
   H-C4-C5-H (-175.3°) 
J4,5 = 9.0 
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  α-2.1 
 
 
CDCl3 600 MHz 
Figure A-1: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-D-
glucopyranoside (α-2.1)   
 
CDCl3 151 MHz 
Figure A-2: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-D-
glucopyranoside (α-2.1) 
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  α-2.1 
 
 
CDCl3 600 MHz 
Figure A-3: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-D-
glucopyranoside (α-2.1) 
   
  





CDCl3 600 MHz 
Figure A-4: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-1-thio-α-D-glucopyranoside (α-2.2) 
 
CDCl3 151 MHz 
Figure A-5: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-1-thio-α-D-glucopyranoside (α-2.2) 








CDCl3 600 MHz 









CDCl3 600 MHz 
Figure A-7: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-
triisopropylsilyl-α-D-glucopyranoside (α-2.3) 
 
CDCl3 151 MHz 
Figure A-8: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-
triisopropylsilyl-α-D-glucopyranoside (α-2.3)  





CDCl3 600 MHz 









CDCl3 600 MHz 
Figure A-10: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-
di-O-triisopropylsilyl-α-D-glucopyranoside (α-2.3) 
  




CDCl3 600 MHz 
Figure A-11: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)   
 
CDCl3 151 MHz 
Figure A-12: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)    






CDCl3 600 MHz 
Figure A-13: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)   
  




CDCl3 600 MHz 
Figure A-14: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)   
  





CDCl3 600 MHz 




CDCl3 151 MHz 
Figure A-16: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-
triisopropylsilyl-β-D-glucopyranoside (β-2.3) 







 CDCl3 600 MHz 










CDCl3 600 MHz 
Figure A-18: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-
di-O-triisopropylsilyl-β-D-glucopyranoside (β-2.3)   
  





CDCl3 300 MHz 
Figure A-19: 1H NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6) 
 
CDCl3 151 MHz 
Figure A-20: 13C NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6)   






CDCl3 300 MHz  
Figure A-21: 2-D NMR COSY spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-
di-O-tert-butyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (2.6)    




CDCl3 300 MHz 




CDCl3 151 MHz 
Figure A-23: 13C NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8) 






CDCl3 300 MHz 




Matteo Panza | UMSL 2019 | Page  263 
 
  2.9 
 
CDCl3 300 MHz 




CDCl3 151 MHz 
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  2.9 
 
CDCl3 300 MHz 
Figure A-27: 2-D NMR COSY spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-
O-tert-butyldimethylsilyl-α/β-D-glucopyranoside (2.9) 
  




CDCl3 300 MHz 
Figure A-28: 1H NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α/β-D-glucopyranoside (2.10)   
 
 
CDCl3 151 MHz 
Figure A-29: 13C NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α/β-D-glucopyranoside (2.10)   





CDCl3 300 MHz 
Figure A-30: 2-D NMR COSY spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-
O-tert-butyldimethylsilyl-α/β-D-glucopyranoside (2.10)    
  




CDCl3 300 MHz 




CDCl3 151 MHz 
 
Figure A-32: 13C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-
butyldimethylsilyl-α/β-D-glucopyranoside (2.11) 





CDCl3 600 MHz 
Figure A-33: 2-D NMR COSY spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
tert-butyldimethylsilyl-α/β-D-glucopyranoside (2.11) 
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 2.12 
CDCl3 300 MHz 
Figure A-34: 1H NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12) 
 
CDCl3 151 MHz 
Figure A-35: 13C NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12) 





CDCl3 300 MHz 
Figure A-36: 2-D NMR COSY spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-
di-O-triisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
(2.12)  




CDCl3 300 MHz 
Figure A-37: 1H NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13) 
 
CDCl3 151 MHz 
Figure A-38: 13C NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13) 
  






CDCl3 300 MHz 
Figure A-39: 2-D NMR COSY spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-
di-O-triisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside 
(2.13)  





CDCl3 300 MHz 




CDCl3 151 MHz 
Figure A-41: 13C NMR spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α/β-D-glucopyranoside (2.14) 







CDCl3 300 MHz 
Figure A-42: 2-D NMR COSY spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-
O-triisopropylsilyl-α/β-D-glucopyranoside (2.14) 
 




CDCl3 300 MHz 
Figure A-43: 1H NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α/β-D-glucopyranoside (2.15) 
 
CDCl3 151 MHz 
Figure A-44: 13C NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α/β-D-glucopyranoside (2.15)  






CDCl3 300 MHz 
Figure A-45:  2-D NMR COSY spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-
di-O-triisopropylsilyl-α/β-D-glucopyranoside (2.15)  




CDCl3 300 MHz 
Figure A-46: 1H NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α-D-glucopyranoside (α-2.16) 
 
CDCl3 151 MHz 
Figure A-47: 13C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-α-D-glucopyranoside (α-2.16) 






CDCl3 300 MHz 








CDCl3 300 MHz 
Figure A-49: 1H NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-β-D-glucopyranoside (β-2.16) 
 
CDCl3 151 MHz 
Figure A-50: 13C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-
triisopropylsilyl-β-D-glucopyranoside (β-2.16)  








CDCl3 300 MHz 










CDCl3 600 MHz 










CDCl3 151 MHz 
Figure A-53: 13C NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-
O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.1)  
  






CDCl3  600 MHz 
Figure A-54: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-
acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-
(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-
glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.1)   








Figure A-55: IR spectrum of Panzagel-Chloride 
  









Figure A-56: IR spectrum of Panzagel-NH2 
  






Figure A-57: IR spectrum of glycoconjugate 4.10 
 
  




CDCl3 300 MHz 
Figure A-58: 1H NMR spectrum of Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2) 
 
CDCl3 75 MHz 
Figure A-59: 13C NMR spectrum of Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2)  













CDCl3 300 MHz 









CDCl3 300 MHz 
Figure A-62: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-
acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.8) 
 








CDCl3 600 MHz 














CDCl3  600 MHz 








Figure A-65: Thermogravimetric analysis (TGA) plots (black line) and Weight 




Figure A-66: SEM images of Panzagel-TMSOTf  polymer at a)100x and b) 150x 
magnifications 
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Figure A-67: BET adsorption-desorption curves of the Panzagel 
 
